id	sid	tid	token	lemma	pos
dpc-4805	1	1	dermatology	dermatology	NOUN
dpc-4805	1	2	:	:	PUNCT
dpc-4805	1	3	practical	practical	ADJ
dpc-4805	1	4	and	and	CCONJ
dpc-4805	1	5	conceptual	conceptual	ADJ
dpc-4805	1	6	original	original	ADJ
dpc-4805	1	7	article	article	NOUN
dpc-4805	1	8	|	|	ADV
dpc-4805	1	9	dermatol	dermatol	ADJ
dpc-4805	1	10	pract	pract	NOUN
dpc-4805	1	11	concept	concept	NOUN
dpc-4805	1	12	.	.	PUNCT
dpc-4805	2	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	2	2	1	1	NUM
dpc-4805	2	3	gender	gender	NOUN
dpc-4805	2	4	-	-	PUNCT
dpc-4805	2	5	related	relate	VERB
dpc-4805	2	6	therapeutical	therapeutical	ADJ
dpc-4805	2	7	response	response	NOUN
dpc-4805	2	8	to	to	PART
dpc-4805	2	9	apremilast	apremilast	VERB
dpc-4805	2	10	:	:	PUNCT
dpc-4805	2	11	new	new	ADJ
dpc-4805	2	12	insights	insight	NOUN
dpc-4805	2	13	in	in	ADP
dpc-4805	2	14	a	a	DET
dpc-4805	2	15	tailored	tailor	VERB
dpc-4805	2	16	management	management	NOUN
dpc-4805	2	17	of	of	ADP
dpc-4805	2	18	psoriasis	psoriasis	NOUN
dpc-4805	2	19	emanuele	emanuele	PROPN
dpc-4805	2	20	trovato1	trovato1	PROPN
dpc-4805	2	21	,	,	PUNCT
dpc-4805	2	22	federico	federico	PROPN
dpc-4805	2	23	bardazzi2	bardazzi2	PROPN
dpc-4805	2	24	,	,	PUNCT
dpc-4805	2	25	vito	vito	PROPN
dpc-4805	2	26	di	di	PROPN
dpc-4805	2	27	lernia3	lernia3	NOUN
dpc-4805	2	28	,	,	PUNCT
dpc-4805	2	29	monica	monica	PROPN
dpc-4805	2	30	corazza4	corazza4	PROPN
dpc-4805	2	31	,	,	PUNCT
dpc-4805	2	32	claudia	claudia	NOUN
dpc-4805	2	33	lasagni5	lasagni5	PROPN
dpc-4805	2	34	,	,	PUNCT
dpc-4805	2	35	francesca	francesca	PROPN
dpc-4805	2	36	prignano6	prignano6	NOUN
dpc-4805	2	37	1	1	NUM
dpc-4805	2	38	dermatology	dermatology	NOUN
dpc-4805	2	39	unit	unit	NOUN
dpc-4805	2	40	,	,	PUNCT
dpc-4805	2	41	department	department	NOUN
dpc-4805	2	42	of	of	ADP
dpc-4805	2	43	medical	medical	ADJ
dpc-4805	2	44	,	,	PUNCT
dpc-4805	2	45	surgical	surgical	ADJ
dpc-4805	2	46	and	and	CCONJ
dpc-4805	2	47	neurological	neurological	ADJ
dpc-4805	2	48	sciences	science	NOUN
dpc-4805	2	49	,	,	PUNCT
dpc-4805	2	50	university	university	PROPN
dpc-4805	2	51	of	of	ADP
dpc-4805	2	52	siena	siena	PROPN
dpc-4805	2	53	,	,	PUNCT
dpc-4805	2	54	siena	siena	PROPN
dpc-4805	2	55	,	,	PUNCT
dpc-4805	2	56	italy	italy	PROPN
dpc-4805	2	57	2	2	NUM
dpc-4805	2	58	dermatology	dermatology	NOUN
dpc-4805	2	59	unit	unit	NOUN
dpc-4805	2	60	,	,	PUNCT
dpc-4805	2	61	ircss	ircss	PROPN
dpc-4805	2	62	aou	aou	PROPN
dpc-4805	2	63	di	di	PROPN
dpc-4805	2	64	bologna	bologna	PROPN
dpc-4805	2	65	,	,	PUNCT
dpc-4805	2	66	bologna	bologna	PROPN
dpc-4805	2	67	,	,	PUNCT
dpc-4805	2	68	italy	italy	PROPN
dpc-4805	2	69	3	3	NUM
dpc-4805	2	70	dermatology	dermatology	NOUN
dpc-4805	2	71	unit	unit	NOUN
dpc-4805	2	72	,	,	PUNCT
dpc-4805	2	73	arcispedale	arcispedale	PROPN
dpc-4805	2	74	santa	santa	PROPN
dpc-4805	2	75	maria	maria	PROPN
dpc-4805	2	76	nuova	nuova	PROPN
dpc-4805	2	77	,	,	PUNCT
dpc-4805	2	78	azienda	azienda	PROPN
dpc-4805	2	79	usl	usl	PROPN
dpc-4805	2	80	-	-	PUNCT
dpc-4805	2	81	irccs	irccs	NOUN
dpc-4805	2	82	di	di	PROPN
dpc-4805	2	83	reggio	reggio	PROPN
dpc-4805	2	84	emilia	emilia	PROPN
dpc-4805	2	85	,	,	PUNCT
dpc-4805	2	86	reggio	reggio	PROPN
dpc-4805	2	87	emilia	emilia	PROPN
dpc-4805	2	88	,	,	PUNCT
dpc-4805	2	89	italy	italy	PROPN
dpc-4805	2	90	4	4	NUM
dpc-4805	2	91	section	section	NOUN
dpc-4805	2	92	of	of	ADP
dpc-4805	2	93	dermatology	dermatology	NOUN
dpc-4805	2	94	,	,	PUNCT
dpc-4805	2	95	department	department	NOUN
dpc-4805	2	96	of	of	ADP
dpc-4805	2	97	medical	medical	ADJ
dpc-4805	2	98	sciences	sciences	PROPN
dpc-4805	2	99	,	,	PUNCT
dpc-4805	2	100	university	university	NOUN
dpc-4805	2	101	of	of	ADP
dpc-4805	2	102	ferrara	ferrara	NOUN
dpc-4805	2	103	,	,	PUNCT
dpc-4805	2	104	ferrara	ferrara	NOUN
dpc-4805	2	105	,	,	PUNCT
dpc-4805	2	106	italy	italy	PROPN
dpc-4805	2	107	5	5	NUM
dpc-4805	2	108	dermatological	dermatological	ADJ
dpc-4805	2	109	clinic	clinic	NOUN
dpc-4805	2	110	,	,	PUNCT
dpc-4805	2	111	department	department	NOUN
dpc-4805	2	112	of	of	ADP
dpc-4805	2	113	specialized	specialized	ADJ
dpc-4805	2	114	medicine	medicine	NOUN
dpc-4805	2	115	,	,	PUNCT
dpc-4805	2	116	university	university	PROPN
dpc-4805	2	117	of	of	ADP
dpc-4805	2	118	modena	modena	PROPN
dpc-4805	2	119	,	,	PUNCT
dpc-4805	2	120	modena	modena	PROPN
dpc-4805	2	121	,	,	PUNCT
dpc-4805	2	122	italy	italy	PROPN
dpc-4805	2	123	6	6	NUM
dpc-4805	2	124	dermatology	dermatology	NOUN
dpc-4805	2	125	section	section	NOUN
dpc-4805	2	126	,	,	PUNCT
dpc-4805	2	127	department	department	NOUN
dpc-4805	2	128	of	of	ADP
dpc-4805	2	129	health	health	PROPN
dpc-4805	2	130	science	science	NOUN
dpc-4805	2	131	,	,	PUNCT
dpc-4805	2	132	university	university	NOUN
dpc-4805	2	133	of	of	ADP
dpc-4805	2	134	florence	florence	NOUN
dpc-4805	2	135	,	,	PUNCT
dpc-4805	2	136	florence	florence	NOUN
dpc-4805	2	137	,	,	PUNCT
dpc-4805	2	138	italy	italy	PROPN
dpc-4805	2	139	key	key	ADJ
dpc-4805	2	140	words	word	NOUN
dpc-4805	2	141	:	:	PUNCT
dpc-4805	2	142	psoriasis	psoriasis	NOUN
dpc-4805	2	143	,	,	PUNCT
dpc-4805	2	144	small	small	ADJ
dpc-4805	2	145	-	-	PUNCT
dpc-4805	2	146	molecule	molecule	NOUN
dpc-4805	2	147	,	,	PUNCT
dpc-4805	2	148	obesity	obesity	NOUN
dpc-4805	2	149	,	,	PUNCT
dpc-4805	2	150	weight	weight	NOUN
dpc-4805	2	151	,	,	PUNCT
dpc-4805	2	152	body	body	NOUN
dpc-4805	2	153	mass	mass	NOUN
dpc-4805	2	154	index	index	NOUN
dpc-4805	2	155	citation	citation	NOUN
dpc-4805	2	156	:	:	PUNCT
dpc-4805	2	157	trovato	trovato	PROPN
dpc-4805	2	158	e	e	PROPN
dpc-4805	2	159	,	,	PUNCT
dpc-4805	2	160	bardazzi	bardazzi	NOUN
dpc-4805	2	161	f	f	PROPN
dpc-4805	2	162	,	,	PUNCT
dpc-4805	2	163	di	di	PROPN
dpc-4805	2	164	lernia	lernia	PROPN
dpc-4805	2	165	v	v	PROPN
dpc-4805	2	166	,	,	PUNCT
dpc-4805	2	167	corazza	corazza	PROPN
dpc-4805	2	168	m	m	NOUN
dpc-4805	2	169	,	,	PUNCT
dpc-4805	2	170	lasagni	lasagni	NOUN
dpc-4805	2	171	c	c	NOUN
dpc-4805	2	172	,	,	PUNCT
dpc-4805	2	173	prignano	prignano	PROPN
dpc-4805	2	174	f.	f.	PROPN
dpc-4805	2	175	gender	gender	NOUN
dpc-4805	2	176	-	-	PUNCT
dpc-4805	2	177	related	relate	VERB
dpc-4805	2	178	therapeutical	therapeutical	ADJ
dpc-4805	2	179	response	response	NOUN
dpc-4805	2	180	to	to	PART
dpc-4805	2	181	apremilast	apremilast	VERB
dpc-4805	2	182	:	:	PUNCT
dpc-4805	2	183	new	new	ADJ
dpc-4805	2	184	insights	insight	NOUN
dpc-4805	2	185	in	in	ADP
dpc-4805	2	186	a	a	DET
dpc-4805	2	187	tailored	tailor	VERB
dpc-4805	2	188	management	management	NOUN
dpc-4805	2	189	of	of	ADP
dpc-4805	2	190	psoriasis	psoriasis	NOUN
dpc-4805	2	191	.	.	PUNCT
dpc-4805	3	1	dermatol	dermatol	NOUN
dpc-4805	3	2	pract	pract	PROPN
dpc-4805	3	3	concept	concept	NOUN
dpc-4805	3	4	.	.	PUNCT
dpc-4805	4	1	2025;15(1):4805	2025;15(1):4805	X
dpc-4805	4	2	.	.	PUNCT
dpc-4805	5	1	doi	doi	PROPN
dpc-4805	5	2	:	:	PUNCT
dpc-4805	5	3	https://doi.org/10.5826/dpc.1501a4805	https://doi.org/10.5826/dpc.1501a4805	PROPN
dpc-4805	5	4	accepted	accept	VERB
dpc-4805	5	5	:	:	PUNCT
dpc-4805	5	6	october	october	PROPN
dpc-4805	5	7	27	27	NUM
dpc-4805	5	8	,	,	PUNCT
dpc-4805	5	9	2024	2024	NUM
dpc-4805	5	10	;	;	PUNCT
dpc-4805	5	11	published	publish	VERB
dpc-4805	5	12	:	:	PUNCT
dpc-4805	5	13	january	january	PROPN
dpc-4805	5	14	2025	2025	NUM
dpc-4805	5	15	copyright	copyright	NOUN
dpc-4805	5	16	:	:	PUNCT
dpc-4805	6	1	©	©	PROPN
dpc-4805	6	2	2024	2024	NUM
dpc-4805	6	3	trovato	trovato	X
dpc-4805	6	4	et	et	PROPN
dpc-4805	6	5	al	al	PROPN
dpc-4805	6	6	.	.	PUNCT
dpc-4805	7	1	this	this	PRON
dpc-4805	7	2	is	be	AUX
dpc-4805	7	3	an	an	DET
dpc-4805	7	4	open	open	ADJ
dpc-4805	7	5	-	-	PUNCT
dpc-4805	7	6	access	access	NOUN
dpc-4805	7	7	article	article	NOUN
dpc-4805	7	8	distributed	distribute	VERB
dpc-4805	7	9	under	under	ADP
dpc-4805	7	10	the	the	DET
dpc-4805	7	11	terms	term	NOUN
dpc-4805	7	12	of	of	ADP
dpc-4805	7	13	the	the	DET
dpc-4805	7	14	creative	creative	ADJ
dpc-4805	7	15	commons	common	NOUN
dpc-4805	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4805	7	17	license	license	NOUN
dpc-4805	7	18	(	(	PUNCT
dpc-4805	7	19	by	by	ADP
dpc-4805	7	20	-	-	PUNCT
dpc-4805	7	21	nc-4.0	nc-4.0	NOUN
dpc-4805	7	22	)	)	PUNCT
dpc-4805	7	23	,	,	PUNCT
dpc-4805	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4805	7	25	,	,	PUNCT
dpc-4805	7	26	which	which	PRON
dpc-4805	7	27	permits	permit	VERB
dpc-4805	7	28	unrestricted	unrestricted	ADJ
dpc-4805	7	29	noncommercial	noncommercial	ADJ
dpc-4805	7	30	use	use	NOUN
dpc-4805	7	31	,	,	PUNCT
dpc-4805	7	32	distribution	distribution	NOUN
dpc-4805	7	33	,	,	PUNCT
dpc-4805	7	34	and	and	CCONJ
dpc-4805	7	35	reproduction	reproduction	NOUN
dpc-4805	7	36	in	in	ADP
dpc-4805	7	37	any	any	DET
dpc-4805	7	38	medium	medium	NOUN
dpc-4805	7	39	,	,	PUNCT
dpc-4805	7	40	provided	provide	VERB
dpc-4805	7	41	the	the	DET
dpc-4805	7	42	original	original	ADJ
dpc-4805	7	43	authors	author	NOUN
dpc-4805	7	44	and	and	CCONJ
dpc-4805	7	45	source	source	NOUN
dpc-4805	7	46	are	be	AUX
dpc-4805	7	47	credited	credit	VERB
dpc-4805	7	48	.	.	PUNCT
dpc-4805	8	1	funding	funding	NOUN
dpc-4805	8	2	:	:	PUNCT
dpc-4805	8	3	none	none	NOUN
dpc-4805	8	4	.	.	PUNCT
dpc-4805	9	1	competing	compete	VERB
dpc-4805	9	2	interests	interest	NOUN
dpc-4805	9	3	:	:	PUNCT
dpc-4805	9	4	none	none	NOUN
dpc-4805	9	5	.	.	PUNCT
dpc-4805	10	1	authorship	authorship	NOUN
dpc-4805	10	2	:	:	PUNCT
dpc-4805	10	3	all	all	DET
dpc-4805	10	4	authors	author	NOUN
dpc-4805	10	5	have	have	AUX
dpc-4805	10	6	contributed	contribute	VERB
dpc-4805	10	7	significantly	significantly	ADV
dpc-4805	10	8	to	to	ADP
dpc-4805	10	9	this	this	DET
dpc-4805	10	10	publication	publication	NOUN
dpc-4805	10	11	.	.	PUNCT
dpc-4805	11	1	corresponding	correspond	VERB
dpc-4805	11	2	author	author	NOUN
dpc-4805	11	3	:	:	PUNCT
dpc-4805	11	4	emanuele	emanuele	PROPN
dpc-4805	11	5	trovato	trovato	PROPN
dpc-4805	11	6	,	,	PUNCT
dpc-4805	11	7	unit	unit	NOUN
dpc-4805	11	8	of	of	ADP
dpc-4805	11	9	dermatology	dermatology	NOUN
dpc-4805	11	10	,	,	PUNCT
dpc-4805	11	11	department	department	NOUN
dpc-4805	11	12	of	of	ADP
dpc-4805	11	13	medical	medical	ADJ
dpc-4805	11	14	,	,	PUNCT
dpc-4805	11	15	surgical	surgical	ADJ
dpc-4805	11	16	and	and	CCONJ
dpc-4805	11	17	neurosciences	neuroscience	NOUN
dpc-4805	11	18	,	,	PUNCT
dpc-4805	11	19	university	university	PROPN
dpc-4805	11	20	of	of	ADP
dpc-4805	11	21	siena	siena	PROPN
dpc-4805	11	22	,	,	PUNCT
dpc-4805	11	23	siena	siena	PROPN
dpc-4805	11	24	,	,	PUNCT
dpc-4805	11	25	italy	italy	PROPN
dpc-4805	11	26	.	.	PUNCT
dpc-4805	12	1	e	e	X
dpc-4805	12	2	-	-	NOUN
dpc-4805	12	3	mail	mail	NOUN
dpc-4805	12	4	:	:	PUNCT
dpc-4805	12	5	emanuele.trovato@unisi.it	emanuele.trovato@unisi.it	NOUN
dpc-4805	12	6	introduction	introduction	NOUN
dpc-4805	12	7	:	:	PUNCT
dpc-4805	12	8	psoriasis	psoriasis	NOUN
dpc-4805	12	9	is	be	AUX
dpc-4805	12	10	a	a	DET
dpc-4805	12	11	chronic	chronic	ADJ
dpc-4805	12	12	immune	immune	NOUN
dpc-4805	12	13	-	-	PUNCT
dpc-4805	12	14	mediated	mediate	VERB
dpc-4805	12	15	skin	skin	NOUN
dpc-4805	12	16	condition	condition	NOUN
dpc-4805	12	17	.	.	PUNCT
dpc-4805	13	1	one	one	NUM
dpc-4805	13	2	of	of	ADP
dpc-4805	13	3	the	the	DET
dpc-4805	13	4	intriguing	intriguing	ADJ
dpc-4805	13	5	challenges	challenge	NOUN
dpc-4805	13	6	in	in	ADP
dpc-4805	13	7	studying	study	VERB
dpc-4805	13	8	psoriasis	psoriasis	NOUN
dpc-4805	13	9	has	have	AUX
dpc-4805	13	10	been	be	AUX
dpc-4805	13	11	identification	identification	NOUN
dpc-4805	13	12	of	of	ADP
dpc-4805	13	13	correlations	correlation	NOUN
dpc-4805	13	14	between	between	ADP
dpc-4805	13	15	this	this	DET
dpc-4805	13	16	disease	disease	NOUN
dpc-4805	13	17	and	and	CCONJ
dpc-4805	13	18	gender	gender	NOUN
dpc-4805	13	19	and	and	CCONJ
dpc-4805	13	20	body	body	NOUN
dpc-4805	13	21	weight	weight	NOUN
dpc-4805	13	22	.	.	PUNCT
dpc-4805	14	1	objectives	objective	NOUN
dpc-4805	14	2	:	:	PUNCT
dpc-4805	14	3	a	a	DET
dpc-4805	14	4	multicenter	multicenter	ADJ
dpc-4805	14	5	retrospective	retrospective	ADJ
dpc-4805	14	6	study	study	NOUN
dpc-4805	14	7	was	be	AUX
dpc-4805	14	8	conducted	conduct	VERB
dpc-4805	14	9	among	among	ADP
dpc-4805	14	10	patients	patient	NOUN
dpc-4805	14	11	with	with	ADP
dpc-4805	14	12	moderate	moderate	ADJ
dpc-4805	14	13	-	-	PUNCT
dpc-4805	14	14	to	to	ADP
dpc-4805	14	15	-	-	PUNCT
dpc-4805	14	16	severe	severe	ADJ
dpc-4805	14	17	psoriasis	psoriasis	NOUN
dpc-4805	14	18	who	who	PRON
dpc-4805	14	19	attended	attend	VERB
dpc-4805	14	20	the	the	DET
dpc-4805	14	21	outpatient	outpatient	NOUN
dpc-4805	14	22	clinics	clinic	NOUN
dpc-4805	14	23	of	of	ADP
dpc-4805	14	24	6	6	NUM
dpc-4805	14	25	university	university	NOUN
dpc-4805	14	26	hospitals	hospital	NOUN
dpc-4805	14	27	in	in	ADP
dpc-4805	14	28	italy	italy	PROPN
dpc-4805	14	29	.	.	PUNCT
dpc-4805	15	1	the	the	DET
dpc-4805	15	2	effects	effect	NOUN
dpc-4805	15	3	of	of	ADP
dpc-4805	15	4	apremilast	apremilast	NOUN
dpc-4805	15	5	on	on	ADP
dpc-4805	15	6	weight	weight	NOUN
dpc-4805	15	7	and	and	CCONJ
dpc-4805	15	8	body	body	NOUN
dpc-4805	15	9	mass	mass	NOUN
dpc-4805	15	10	index	index	NOUN
dpc-4805	15	11	(	(	PUNCT
dpc-4805	15	12	bmi	bmi	PROPN
dpc-4805	15	13	)	)	PUNCT
dpc-4805	15	14	according	accord	VERB
dpc-4805	15	15	to	to	ADP
dpc-4805	15	16	gender	gender	NOUN
dpc-4805	15	17	after	after	ADP
dpc-4805	15	18	24	24	NUM
dpc-4805	15	19	weeks	week	NOUN
dpc-4805	15	20	and	and	CCONJ
dpc-4805	15	21	48	48	NUM
dpc-4805	15	22	weeks	week	NOUN
dpc-4805	15	23	of	of	ADP
dpc-4805	15	24	therapy	therapy	NOUN
dpc-4805	15	25	were	be	AUX
dpc-4805	15	26	considered	consider	VERB
dpc-4805	15	27	.	.	PUNCT
dpc-4805	16	1	methods	method	NOUN
dpc-4805	16	2	:	:	PUNCT
dpc-4805	16	3	we	we	PRON
dpc-4805	16	4	enrolled	enrol	VERB
dpc-4805	16	5	retrospectively	retrospectively	ADV
dpc-4805	16	6	120	120	NUM
dpc-4805	16	7	adult	adult	NOUN
dpc-4805	16	8	patients	patient	NOUN
dpc-4805	16	9	with	with	ADP
dpc-4805	16	10	moderate	moderate	ADJ
dpc-4805	16	11	-	-	PUNCT
dpc-4805	16	12	to	to	ADP
dpc-4805	16	13	-	-	PUNCT
dpc-4805	16	14	severe	severe	ADJ
dpc-4805	16	15	psoriasis	psoriasis	NOUN
dpc-4805	16	16	who	who	PRON
dpc-4805	16	17	underwent	undergo	VERB
dpc-4805	16	18	apremilast	apremilast	ADJ
dpc-4805	16	19	treatment	treatment	NOUN
dpc-4805	16	20	for	for	ADP
dpc-4805	16	21	at	at	ADV
dpc-4805	16	22	least	least	ADV
dpc-4805	16	23	24	24	NUM
dpc-4805	16	24	weeks	week	NOUN
dpc-4805	16	25	.	.	PUNCT
dpc-4805	17	1	baseline	baseline	PROPN
dpc-4805	17	2	characteristics	characteristic	NOUN
dpc-4805	17	3	,	,	PUNCT
dpc-4805	17	4	including	include	VERB
dpc-4805	17	5	age	age	NOUN
dpc-4805	17	6	,	,	PUNCT
dpc-4805	17	7	gender	gender	NOUN
dpc-4805	17	8	,	,	PUNCT
dpc-4805	17	9	psoriasis	psoriasis	NOUN
dpc-4805	17	10	area	area	NOUN
dpc-4805	17	11	severity	severity	NOUN
dpc-4805	17	12	index	index	NOUN
dpc-4805	17	13	(	(	PUNCT
dpc-4805	17	14	pasi	pasi	NOUN
dpc-4805	17	15	)	)	PUNCT
dpc-4805	17	16	,	,	PUNCT
dpc-4805	17	17	comorbidities	comorbiditie	NOUN
dpc-4805	17	18	,	,	PUNCT
dpc-4805	17	19	smoking	smoking	NOUN
dpc-4805	17	20	and	and	CCONJ
dpc-4805	17	21	alcohol	alcohol	NOUN
dpc-4805	17	22	habits	habit	NOUN
dpc-4805	17	23	,	,	PUNCT
dpc-4805	17	24	relevant	relevant	ADJ
dpc-4805	17	25	medical	medical	ADJ
dpc-4805	17	26	history	history	NOUN
dpc-4805	17	27	and	and	CCONJ
dpc-4805	17	28	previous	previous	ADJ
dpc-4805	17	29	psoriasis	psoriasis	NOUN
dpc-4805	17	30	systemic	systemic	ADJ
dpc-4805	17	31	and	and	CCONJ
dpc-4805	17	32	biologic	biologic	NOUN
dpc-4805	17	33	treatments	treatment	NOUN
dpc-4805	17	34	were	be	AUX
dpc-4805	17	35	recorded	record	VERB
dpc-4805	17	36	.	.	PUNCT
dpc-4805	18	1	weight	weight	NOUN
dpc-4805	18	2	and	and	CCONJ
dpc-4805	18	3	bmi	bmi	NOUN
dpc-4805	18	4	were	be	AUX
dpc-4805	18	5	evaluated	evaluate	VERB
dpc-4805	18	6	at	at	ADP
dpc-4805	18	7	baseline	baseline	PROPN
dpc-4805	18	8	(	(	PUNCT
dpc-4805	18	9	t0	t0	NOUN
dpc-4805	18	10	)	)	PUNCT
dpc-4805	18	11	and	and	CCONJ
dpc-4805	18	12	at	at	ADP
dpc-4805	18	13	24	24	NUM
dpc-4805	18	14	(	(	PUNCT
dpc-4805	18	15	w24	w24	PROPN
dpc-4805	18	16	)	)	PUNCT
dpc-4805	18	17	and	and	CCONJ
dpc-4805	18	18	48	48	NUM
dpc-4805	18	19	weeks	week	NOUN
dpc-4805	18	20	(	(	PUNCT
dpc-4805	18	21	w48	w48	NOUN
dpc-4805	18	22	)	)	PUNCT
dpc-4805	18	23	.	.	PUNCT
dpc-4805	19	1	a	a	DET
dpc-4805	19	2	descriptive	descriptive	ADJ
dpc-4805	19	3	statistical	statistical	ADJ
dpc-4805	19	4	analysis	analysis	NOUN
dpc-4805	19	5	has	have	AUX
dpc-4805	19	6	been	be	AUX
dpc-4805	19	7	performed	perform	VERB
dpc-4805	19	8	.	.	PUNCT
dpc-4805	20	1	abstract	abstract	ADJ
dpc-4805	20	2	2	2	NUM
dpc-4805	20	3	original	original	ADJ
dpc-4805	20	4	article	article	NOUN
dpc-4805	20	5	|	|	ADV
dpc-4805	20	6	dermatol	dermatol	ADJ
dpc-4805	20	7	pract	pract	NOUN
dpc-4805	20	8	concept	concept	NOUN
dpc-4805	20	9	.	.	PUNCT
dpc-4805	21	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	21	2	introduction	introduction	NOUN
dpc-4805	21	3	psoriasis	psoriasis	NOUN
dpc-4805	21	4	is	be	AUX
dpc-4805	21	5	a	a	DET
dpc-4805	21	6	chronic	chronic	ADJ
dpc-4805	21	7	immune	immune	NOUN
dpc-4805	21	8	-	-	PUNCT
dpc-4805	21	9	mediated	mediate	VERB
dpc-4805	21	10	skin	skin	NOUN
dpc-4805	21	11	condition	condition	NOUN
dpc-4805	21	12	,	,	PUNCT
dpc-4805	21	13	posing	pose	VERB
dpc-4805	21	14	both	both	CCONJ
dpc-4805	21	15	physical	physical	ADJ
dpc-4805	21	16	and	and	CCONJ
dpc-4805	21	17	psychological	psychological	ADJ
dpc-4805	21	18	challenges	challenge	NOUN
dpc-4805	21	19	for	for	ADP
dpc-4805	21	20	patients	patient	NOUN
dpc-4805	21	21	[	[	X
dpc-4805	21	22	1	1	NUM
dpc-4805	21	23	]	]	PUNCT
dpc-4805	21	24	.	.	PUNCT
dpc-4805	22	1	this	this	DET
dpc-4805	22	2	complex	complex	ADJ
dpc-4805	22	3	dermatological	dermatological	ADJ
dpc-4805	22	4	condition	condition	NOUN
dpc-4805	22	5	is	be	AUX
dpc-4805	22	6	characterized	characterize	VERB
dpc-4805	22	7	by	by	ADP
dpc-4805	22	8	the	the	DET
dpc-4805	22	9	presence	presence	NOUN
dpc-4805	22	10	of	of	ADP
dpc-4805	22	11	red	red	ADJ
dpc-4805	22	12	,	,	PUNCT
dpc-4805	22	13	scaly	scaly	NOUN
dpc-4805	22	14	plaques	plaque	NOUN
dpc-4805	22	15	on	on	ADP
dpc-4805	22	16	the	the	DET
dpc-4805	22	17	skin	skin	NOUN
dpc-4805	22	18	,	,	PUNCT
dpc-4805	22	19	often	often	ADV
dpc-4805	22	20	accompanied	accompany	VERB
dpc-4805	22	21	by	by	ADP
dpc-4805	22	22	itching	itching	NOUN
dpc-4805	22	23	and	and	CCONJ
dpc-4805	22	24	pain	pain	NOUN
dpc-4805	22	25	.	.	PUNCT
dpc-4805	23	1	however	however	ADV
dpc-4805	23	2	,	,	PUNCT
dpc-4805	23	3	beyond	beyond	ADP
dpc-4805	23	4	the	the	DET
dpc-4805	23	5	physical	physical	ADJ
dpc-4805	23	6	aspect	aspect	NOUN
dpc-4805	23	7	,	,	PUNCT
dpc-4805	23	8	psoriasis	psoriasis	NOUN
dpc-4805	23	9	can	can	AUX
dpc-4805	23	10	heavily	heavily	ADV
dpc-4805	23	11	affect	affect	VERB
dpc-4805	23	12	quality	quality	NOUN
dpc-4805	23	13	of	of	ADP
dpc-4805	23	14	life	life	NOUN
dpc-4805	23	15	,	,	PUNCT
dpc-4805	23	16	impacting	impact	VERB
dpc-4805	23	17	self	self	NOUN
dpc-4805	23	18	-	-	PUNCT
dpc-4805	23	19	esteem	esteem	NOUN
dpc-4805	23	20	,	,	PUNCT
dpc-4805	23	21	social	social	ADJ
dpc-4805	23	22	relationships	relationship	NOUN
dpc-4805	23	23	,	,	PUNCT
dpc-4805	23	24	and	and	CCONJ
dpc-4805	23	25	even	even	ADV
dpc-4805	23	26	individuals	individual	NOUN
dpc-4805	23	27	emotional	emotional	ADJ
dpc-4805	23	28	well	well	ADV
dpc-4805	23	29	-	-	PUNCT
dpc-4805	23	30	being	be	AUX
dpc-4805	23	31	[	[	X
dpc-4805	23	32	2	2	NUM
dpc-4805	23	33	]	]	PUNCT
dpc-4805	23	34	.	.	PUNCT
dpc-4805	24	1	one	one	NUM
dpc-4805	24	2	of	of	ADP
dpc-4805	24	3	the	the	DET
dpc-4805	24	4	most	most	ADV
dpc-4805	24	5	intriguing	intriguing	ADJ
dpc-4805	24	6	challenges	challenge	NOUN
dpc-4805	24	7	in	in	ADP
dpc-4805	24	8	studying	study	VERB
dpc-4805	24	9	psoriasis	psoriasis	NOUN
dpc-4805	24	10	has	have	AUX
dpc-4805	24	11	been	be	AUX
dpc-4805	24	12	the	the	DET
dpc-4805	24	13	identification	identification	NOUN
dpc-4805	24	14	of	of	ADP
dpc-4805	24	15	correlations	correlation	NOUN
dpc-4805	24	16	between	between	ADP
dpc-4805	24	17	this	this	DET
dpc-4805	24	18	disease	disease	NOUN
dpc-4805	24	19	and	and	CCONJ
dpc-4805	24	20	various	various	ADJ
dpc-4805	24	21	factors	factor	NOUN
dpc-4805	24	22	,	,	PUNCT
dpc-4805	24	23	including	include	VERB
dpc-4805	24	24	gender	gender	NOUN
dpc-4805	24	25	and	and	CCONJ
dpc-4805	24	26	body	body	NOUN
dpc-4805	24	27	weight	weight	NOUN
dpc-4805	24	28	.	.	PUNCT
dpc-4805	25	1	in	in	ADP
dpc-4805	25	2	addition	addition	NOUN
dpc-4805	25	3	to	to	ADP
dpc-4805	25	4	environmental	environmental	ADJ
dpc-4805	25	5	exposures	exposure	NOUN
dpc-4805	25	6	(	(	PUNCT
dpc-4805	25	7	such	such	ADJ
dpc-4805	25	8	as	as	ADP
dpc-4805	25	9	air	air	NOUN
dpc-4805	25	10	pollution	pollution	NOUN
dpc-4805	25	11	and	and	CCONJ
dpc-4805	25	12	sunlight	sunlight	NOUN
dpc-4805	25	13	)	)	PUNCT
dpc-4805	25	14	and	and	CCONJ
dpc-4805	25	15	lifestyle	lifestyle	NOUN
dpc-4805	25	16	factors	factor	NOUN
dpc-4805	25	17	(	(	PUNCT
dpc-4805	25	18	diet	diet	NOUN
dpc-4805	25	19	and	and	CCONJ
dpc-4805	25	20	physical	physical	ADJ
dpc-4805	25	21	activity	activity	NOUN
dpc-4805	25	22	)	)	PUNCT
dpc-4805	25	23	,	,	PUNCT
dpc-4805	25	24	the	the	DET
dpc-4805	25	25	concept	concept	NOUN
dpc-4805	25	26	of	of	ADP
dpc-4805	25	27	the	the	DET
dpc-4805	25	28	exposome	exposome	NOUN
dpc-4805	25	29	also	also	ADV
dpc-4805	25	30	includes	include	VERB
dpc-4805	25	31	psychosocial	psychosocial	ADJ
dpc-4805	25	32	practices	practice	NOUN
dpc-4805	25	33	.	.	PUNCT
dpc-4805	26	1	meanwhile	meanwhile	ADV
dpc-4805	26	2	,	,	PUNCT
dpc-4805	26	3	its	its	PRON
dpc-4805	26	4	outcomes	outcome	NOUN
dpc-4805	26	5	,	,	PUNCT
dpc-4805	26	6	including	include	VERB
dpc-4805	26	7	epigenomics	epigenomic	NOUN
dpc-4805	26	8	,	,	PUNCT
dpc-4805	26	9	transcriptomics	transcriptomic	NOUN
dpc-4805	26	10	,	,	PUNCT
dpc-4805	26	11	proteomics	proteomic	NOUN
dpc-4805	26	12	,	,	PUNCT
dpc-4805	26	13	and	and	CCONJ
dpc-4805	26	14	metabolomics	metabolomic	NOUN
dpc-4805	26	15	,	,	PUNCT
dpc-4805	26	16	are	be	AUX
dpc-4805	26	17	gaining	gain	VERB
dpc-4805	26	18	attention	attention	NOUN
dpc-4805	26	19	as	as	ADP
dpc-4805	26	20	key	key	ADJ
dpc-4805	26	21	mechanisms	mechanism	NOUN
dpc-4805	26	22	in	in	ADP
dpc-4805	26	23	disease	disease	NOUN
dpc-4805	26	24	development	development	NOUN
dpc-4805	26	25	.	.	PUNCT
dpc-4805	27	1	the	the	DET
dpc-4805	27	2	term	term	NOUN
dpc-4805	27	3	“	"	PUNCT
dpc-4805	27	4	exposome	exposome	NOUN
dpc-4805	27	5	”	"	PUNCT
dpc-4805	27	6	refers	refer	VERB
dpc-4805	27	7	to	to	ADP
dpc-4805	27	8	all	all	DET
dpc-4805	27	9	the	the	DET
dpc-4805	27	10	environmental	environmental	ADJ
dpc-4805	27	11	factors	factor	NOUN
dpc-4805	27	12	,	,	PUNCT
dpc-4805	27	13	both	both	CCONJ
dpc-4805	27	14	infectious	infectious	ADJ
dpc-4805	27	15	and	and	CCONJ
dpc-4805	27	16	non	non	ADJ
dpc-4805	27	17	-	-	ADJ
dpc-4805	27	18	infectious	infectious	ADJ
dpc-4805	27	19	,	,	PUNCT
dpc-4805	27	20	that	that	SCONJ
dpc-4805	27	21	a	a	DET
dpc-4805	27	22	person	person	NOUN
dpc-4805	27	23	is	be	AUX
dpc-4805	27	24	exposed	expose	VERB
dpc-4805	27	25	to	to	ADP
dpc-4805	27	26	throughout	throughout	ADP
dpc-4805	27	27	their	their	PRON
dpc-4805	27	28	life	life	NOUN
dpc-4805	27	29	.	.	PUNCT
dpc-4805	28	1	it	it	PRON
dpc-4805	28	2	encompasses	encompass	VERB
dpc-4805	28	3	the	the	DET
dpc-4805	28	4	cumulative	cumulative	ADJ
dpc-4805	28	5	impact	impact	NOUN
dpc-4805	28	6	of	of	ADP
dpc-4805	28	7	these	these	DET
dpc-4805	28	8	factors	factor	NOUN
dpc-4805	28	9	on	on	ADP
dpc-4805	28	10	health	health	NOUN
dpc-4805	28	11	,	,	PUNCT
dpc-4805	28	12	potentially	potentially	ADV
dpc-4805	28	13	leading	lead	VERB
dpc-4805	28	14	to	to	ADP
dpc-4805	28	15	disease	disease	NOUN
dpc-4805	28	16	or	or	CCONJ
dpc-4805	28	17	influencing	influence	VERB
dpc-4805	28	18	its	its	PRON
dpc-4805	28	19	progression	progression	NOUN
dpc-4805	28	20	.	.	PUNCT
dpc-4805	29	1	the	the	DET
dpc-4805	29	2	exposome	exposome	NOUN
dpc-4805	29	3	plays	play	VERB
dpc-4805	29	4	a	a	DET
dpc-4805	29	5	role	role	NOUN
dpc-4805	29	6	in	in	ADP
dpc-4805	29	7	all	all	DET
dpc-4805	29	8	skin	skin	NOUN
dpc-4805	29	9	diseases	disease	NOUN
dpc-4805	29	10	,	,	PUNCT
dpc-4805	29	11	including	include	VERB
dpc-4805	29	12	psoriasis	psoriasis	NOUN
dpc-4805	29	13	.	.	PUNCT
dpc-4805	30	1	factors	factor	NOUN
dpc-4805	30	2	such	such	ADJ
dpc-4805	30	3	as	as	ADP
dpc-4805	30	4	lifestyle	lifestyle	NOUN
dpc-4805	30	5	habits	habit	NOUN
dpc-4805	30	6	(	(	PUNCT
dpc-4805	30	7	diet	diet	NOUN
dpc-4805	30	8	,	,	PUNCT
dpc-4805	30	9	smoking	smoking	NOUN
dpc-4805	30	10	,	,	PUNCT
dpc-4805	30	11	obesity	obesity	NOUN
dpc-4805	30	12	,	,	PUNCT
dpc-4805	30	13	sun	sun	NOUN
dpc-4805	30	14	exposure	exposure	NOUN
dpc-4805	30	15	)	)	PUNCT
dpc-4805	30	16	,	,	PUNCT
dpc-4805	30	17	pre	pre	ADJ
dpc-4805	30	18	-	-	ADJ
dpc-4805	30	19	existing	existing	ADJ
dpc-4805	30	20	conditions	condition	NOUN
dpc-4805	30	21	,	,	PUNCT
dpc-4805	30	22	exposure	exposure	NOUN
dpc-4805	30	23	to	to	ADP
dpc-4805	30	24	infectious	infectious	ADJ
dpc-4805	30	25	agents	agent	NOUN
dpc-4805	30	26	,	,	PUNCT
dpc-4805	30	27	as	as	ADV
dpc-4805	30	28	well	well	ADV
dpc-4805	30	29	as	as	ADP
dpc-4805	30	30	individual	individual	ADJ
dpc-4805	30	31	characteristics	characteristic	NOUN
dpc-4805	30	32	like	like	ADP
dpc-4805	30	33	skin	skin	NOUN
dpc-4805	30	34	microbes	microbe	NOUN
dpc-4805	30	35	,	,	PUNCT
dpc-4805	30	36	oxidative	oxidative	ADJ
dpc-4805	30	37	stress	stress	NOUN
dpc-4805	30	38	,	,	PUNCT
dpc-4805	30	39	and	and	CCONJ
dpc-4805	30	40	immune	immune	ADJ
dpc-4805	30	41	responses	response	NOUN
dpc-4805	30	42	,	,	PUNCT
dpc-4805	30	43	all	all	PRON
dpc-4805	30	44	contribute	contribute	VERB
dpc-4805	30	45	to	to	ADP
dpc-4805	30	46	the	the	DET
dpc-4805	30	47	development	development	NOUN
dpc-4805	30	48	and	and	CCONJ
dpc-4805	30	49	progression	progression	NOUN
dpc-4805	30	50	of	of	ADP
dpc-4805	30	51	psoriatic	psoriatic	ADJ
dpc-4805	30	52	lesions	lesion	NOUN
dpc-4805	30	53	in	in	ADP
dpc-4805	30	54	different	different	ADJ
dpc-4805	30	55	ways	way	NOUN
dpc-4805	30	56	[	[	X
dpc-4805	30	57	3	3	NUM
dpc-4805	30	58	]	]	PUNCT
dpc-4805	30	59	.	.	PUNCT
dpc-4805	31	1	research	research	NOUN
dpc-4805	31	2	has	have	AUX
dpc-4805	31	3	shown	show	VERB
dpc-4805	31	4	that	that	SCONJ
dpc-4805	31	5	psoriasis	psoriasis	NOUN
dpc-4805	31	6	may	may	AUX
dpc-4805	31	7	manifest	manifest	VERB
dpc-4805	31	8	differently	differently	ADV
dpc-4805	31	9	depending	depend	VERB
dpc-4805	31	10	on	on	ADP
dpc-4805	31	11	the	the	DET
dpc-4805	31	12	patient	patient	ADJ
dpc-4805	31	13	gender	gender	NOUN
dpc-4805	32	1	[	[	X
dpc-4805	32	2	4	4	NUM
dpc-4805	32	3	-	-	SYM
dpc-4805	32	4	5	5	NUM
dpc-4805	32	5	]	]	PUNCT
dpc-4805	32	6	.	.	PUNCT
dpc-4805	33	1	regarding	regard	VERB
dpc-4805	33	2	sex	sex	NOUN
dpc-4805	33	3	hormones	hormone	NOUN
dpc-4805	33	4	,	,	PUNCT
dpc-4805	33	5	estrogens	estrogen	NOUN
dpc-4805	33	6	inhibit	inhibit	VERB
dpc-4805	33	7	the	the	DET
dpc-4805	33	8	production	production	NOUN
dpc-4805	33	9	of	of	ADP
dpc-4805	33	10	psoriasis	psoriasis	NOUN
dpc-4805	33	11	-	-	PUNCT
dpc-4805	33	12	related	relate	VERB
dpc-4805	33	13	cytokines	cytokine	NOUN
dpc-4805	33	14	like	like	ADP
dpc-4805	33	15	il-1β	il-1β	NOUN
dpc-4805	33	16	and	and	CCONJ
dpc-4805	33	17	il-23	il-23	NOUN
dpc-4805	33	18	.	.	PUNCT
dpc-4805	34	1	for	for	ADP
dpc-4805	34	2	instance	instance	NOUN
dpc-4805	34	3	,	,	PUNCT
dpc-4805	34	4	men	man	NOUN
dpc-4805	34	5	are	be	AUX
dpc-4805	34	6	more	more	ADV
dpc-4805	34	7	likely	likely	ADJ
dpc-4805	34	8	to	to	PART
dpc-4805	34	9	develop	develop	VERB
dpc-4805	34	10	plaque	plaque	ADJ
dpc-4805	34	11	psoriasis	psoriasis	NOUN
dpc-4805	34	12	on	on	ADP
dpc-4805	34	13	the	the	DET
dpc-4805	34	14	scalp	scalp	NOUN
dpc-4805	34	15	and	and	CCONJ
dpc-4805	34	16	trunk	trunk	NOUN
dpc-4805	34	17	,	,	PUNCT
dpc-4805	34	18	while	while	SCONJ
dpc-4805	34	19	women	woman	NOUN
dpc-4805	34	20	are	be	AUX
dpc-4805	34	21	more	more	ADV
dpc-4805	34	22	prone	prone	ADJ
dpc-4805	34	23	to	to	ADP
dpc-4805	34	24	present	present	ADJ
dpc-4805	34	25	lesions	lesion	NOUN
dpc-4805	34	26	on	on	ADP
dpc-4805	34	27	the	the	DET
dpc-4805	34	28	face	face	NOUN
dpc-4805	34	29	and	and	CCONJ
dpc-4805	34	30	neck	neck	NOUN
dpc-4805	34	31	[	[	X
dpc-4805	34	32	6	6	NUM
dpc-4805	34	33	]	]	PUNCT
dpc-4805	34	34	.	.	PUNCT
dpc-4805	35	1	moreover	moreover	ADV
dpc-4805	35	2	,	,	PUNCT
dpc-4805	35	3	while	while	SCONJ
dpc-4805	35	4	men	man	NOUN
dpc-4805	35	5	tend	tend	VERB
dpc-4805	35	6	to	to	PART
dpc-4805	35	7	develop	develop	VERB
dpc-4805	35	8	psoriasis	psoriasis	NOUN
dpc-4805	35	9	at	at	ADP
dpc-4805	35	10	an	an	DET
dpc-4805	35	11	earlier	early	ADJ
dpc-4805	35	12	age	age	NOUN
dpc-4805	35	13	and	and	CCONJ
dpc-4805	35	14	have	have	VERB
dpc-4805	35	15	more	more	ADJ
dpc-4805	35	16	severe	severe	ADJ
dpc-4805	35	17	symptoms	symptom	NOUN
dpc-4805	35	18	,	,	PUNCT
dpc-4805	35	19	women	woman	NOUN
dpc-4805	35	20	are	be	AUX
dpc-4805	35	21	more	more	ADV
dpc-4805	35	22	likely	likely	ADJ
dpc-4805	35	23	to	to	PART
dpc-4805	35	24	experience	experience	VERB
dpc-4805	35	25	fluctuations	fluctuation	NOUN
dpc-4805	35	26	in	in	ADP
dpc-4805	35	27	disease	disease	NOUN
dpc-4805	35	28	activity	activity	NOUN
dpc-4805	35	29	associated	associate	VERB
dpc-4805	35	30	with	with	ADP
dpc-4805	35	31	hormonal	hormonal	ADJ
dpc-4805	35	32	changes	change	NOUN
dpc-4805	35	33	,	,	PUNCT
dpc-4805	35	34	such	such	ADJ
dpc-4805	35	35	as	as	ADP
dpc-4805	35	36	menstruations	menstruation	NOUN
dpc-4805	35	37	,	,	PUNCT
dpc-4805	35	38	pregnancy	pregnancy	NOUN
dpc-4805	35	39	or	or	CCONJ
dpc-4805	35	40	menopause	menopause	NOUN
dpc-4805	35	41	[	[	X
dpc-4805	35	42	7	7	NUM
dpc-4805	35	43	]	]	PUNCT
dpc-4805	35	44	.	.	PUNCT
dpc-4805	36	1	in	in	ADP
dpc-4805	36	2	fact	fact	NOUN
dpc-4805	36	3	,	,	PUNCT
dpc-4805	36	4	psoriasis	psoriasis	NOUN
dpc-4805	36	5	lesions	lesion	NOUN
dpc-4805	36	6	tend	tend	VERB
dpc-4805	36	7	to	to	PART
dpc-4805	36	8	appear	appear	VERB
dpc-4805	36	9	or	or	CCONJ
dpc-4805	36	10	worsen	worsen	VERB
dpc-4805	36	11	during	during	ADP
dpc-4805	36	12	puberty	puberty	NOUN
dpc-4805	36	13	and	and	CCONJ
dpc-4805	36	14	improve	improve	VERB
dpc-4805	36	15	during	during	ADP
dpc-4805	36	16	menopause	menopause	NOUN
dpc-4805	36	17	[	[	X
dpc-4805	36	18	8	8	NUM
dpc-4805	36	19	]	]	PUNCT
dpc-4805	36	20	.	.	PUNCT
dpc-4805	37	1	these	these	DET
dpc-4805	37	2	differences	difference	NOUN
dpc-4805	37	3	may	may	AUX
dpc-4805	37	4	be	be	AUX
dpc-4805	37	5	attributed	attribute	VERB
dpc-4805	37	6	to	to	ADP
dpc-4805	37	7	a	a	DET
dpc-4805	37	8	combination	combination	NOUN
dpc-4805	37	9	of	of	ADP
dpc-4805	37	10	genetic	genetic	ADJ
dpc-4805	37	11	,	,	PUNCT
dpc-4805	37	12	hormonal	hormonal	ADJ
dpc-4805	37	13	,	,	PUNCT
dpc-4805	37	14	and	and	CCONJ
dpc-4805	37	15	environmental	environmental	ADJ
dpc-4805	37	16	factors	factor	NOUN
dpc-4805	37	17	,	,	PUNCT
dpc-4805	37	18	requiring	require	VERB
dpc-4805	37	19	further	further	ADJ
dpc-4805	37	20	exploration	exploration	NOUN
dpc-4805	37	21	for	for	ADP
dpc-4805	37	22	full	full	ADJ
dpc-4805	37	23	understanding	understanding	NOUN
dpc-4805	37	24	.	.	PUNCT
dpc-4805	38	1	moreover	moreover	ADV
dpc-4805	38	2	,	,	PUNCT
dpc-4805	38	3	an	an	DET
dpc-4805	38	4	intriguing	intriguing	ADJ
dpc-4805	38	5	link	link	NOUN
dpc-4805	38	6	has	have	AUX
dpc-4805	38	7	emerged	emerge	VERB
dpc-4805	38	8	between	between	ADP
dpc-4805	38	9	psoriasis	psoriasis	NOUN
dpc-4805	38	10	and	and	CCONJ
dpc-4805	38	11	body	body	NOUN
dpc-4805	38	12	weight	weight	NOUN
dpc-4805	38	13	,	,	PUNCT
dpc-4805	38	14	considering	consider	VERB
dpc-4805	38	15	obesity	obesity	NOUN
dpc-4805	38	16	as	as	ADP
dpc-4805	38	17	a	a	DET
dpc-4805	38	18	part	part	NOUN
dpc-4805	38	19	of	of	ADP
dpc-4805	38	20	the	the	DET
dpc-4805	38	21	exposome	exposome	NOUN
dpc-4805	38	22	[	[	X
dpc-4805	38	23	9	9	NUM
dpc-4805	38	24	]	]	PUNCT
dpc-4805	38	25	.	.	PUNCT
dpc-4805	39	1	epidemiological	epidemiological	ADJ
dpc-4805	39	2	studies	study	NOUN
dpc-4805	39	3	have	have	AUX
dpc-4805	39	4	established	establish	VERB
dpc-4805	39	5	a	a	DET
dpc-4805	39	6	significant	significant	ADJ
dpc-4805	39	7	association	association	NOUN
dpc-4805	39	8	between	between	ADP
dpc-4805	39	9	obesity	obesity	NOUN
dpc-4805	39	10	and	and	CCONJ
dpc-4805	39	11	a	a	DET
dpc-4805	39	12	higher	high	ADJ
dpc-4805	39	13	risk	risk	NOUN
dpc-4805	39	14	of	of	ADP
dpc-4805	39	15	developing	develop	VERB
dpc-4805	39	16	psoriasis	psoriasis	NOUN
dpc-4805	39	17	,	,	PUNCT
dpc-4805	39	18	suggesting	suggest	VERB
dpc-4805	39	19	a	a	DET
dpc-4805	39	20	possible	possible	ADJ
dpc-4805	39	21	role	role	NOUN
dpc-4805	39	22	of	of	ADP
dpc-4805	39	23	systemic	systemic	ADJ
dpc-4805	39	24	chronic	chronic	ADJ
dpc-4805	39	25	low	low	ADJ
dpc-4805	39	26	-	-	PUNCT
dpc-4805	39	27	grade	grade	NOUN
dpc-4805	39	28	inflammation	inflammation	NOUN
dpc-4805	39	29	in	in	ADP
dpc-4805	39	30	the	the	DET
dpc-4805	39	31	disease	disease	NOUN
dpc-4805	39	32	pathogenetic	pathogenetic	ADJ
dpc-4805	39	33	process	process	NOUN
dpc-4805	39	34	[	[	X
dpc-4805	39	35	10	10	NUM
dpc-4805	39	36	]	]	PUNCT
dpc-4805	39	37	.	.	PUNCT
dpc-4805	40	1	the	the	DET
dpc-4805	40	2	relationship	relationship	NOUN
dpc-4805	40	3	between	between	ADP
dpc-4805	40	4	psoriasis	psoriasis	NOUN
dpc-4805	40	5	and	and	CCONJ
dpc-4805	40	6	obesity	obesity	NOUN
dpc-4805	40	7	is	be	AUX
dpc-4805	40	8	complex	complex	ADJ
dpc-4805	40	9	and	and	CCONJ
dpc-4805	40	10	bidirectional	bidirectional	NOUN
dpc-4805	40	11	.	.	PUNCT
dpc-4805	41	1	on	on	ADP
dpc-4805	41	2	one	one	NUM
dpc-4805	41	3	hand	hand	NOUN
dpc-4805	41	4	,	,	PUNCT
dpc-4805	41	5	obesity	obesity	NOUN
dpc-4805	41	6	may	may	AUX
dpc-4805	41	7	contribute	contribute	VERB
dpc-4805	41	8	to	to	ADP
dpc-4805	41	9	the	the	DET
dpc-4805	41	10	onset	onset	NOUN
dpc-4805	41	11	and	and	CCONJ
dpc-4805	41	12	severity	severity	NOUN
dpc-4805	41	13	of	of	ADP
dpc-4805	41	14	psoriasis	psoriasis	NOUN
dpc-4805	41	15	through	through	ADP
dpc-4805	41	16	mechanisms	mechanism	NOUN
dpc-4805	41	17	involving	involve	VERB
dpc-4805	41	18	adipose	adipose	ADP
dpc-4805	41	19	tissue	tissue	NOUN
dpc-4805	41	20	-	-	PUNCT
dpc-4805	41	21	derived	derive	VERB
dpc-4805	41	22	cytokines	cytokine	NOUN
dpc-4805	41	23	and	and	CCONJ
dpc-4805	41	24	insulin	insulin	NOUN
dpc-4805	41	25	resistance	resistance	NOUN
dpc-4805	41	26	,	,	PUNCT
dpc-4805	41	27	which	which	PRON
dpc-4805	41	28	promote	promote	VERB
dpc-4805	41	29	systemic	systemic	ADJ
dpc-4805	41	30	inflammation	inflammation	NOUN
dpc-4805	41	31	and	and	CCONJ
dpc-4805	41	32	exacerbate	exacerbate	VERB
dpc-4805	41	33	immune	immune	ADJ
dpc-4805	41	34	dysregulation	dysregulation	NOUN
dpc-4805	41	35	[	[	X
dpc-4805	41	36	11	11	NUM
dpc-4805	41	37	]	]	PUNCT
dpc-4805	41	38	.	.	PUNCT
dpc-4805	42	1	on	on	ADP
dpc-4805	42	2	the	the	DET
dpc-4805	42	3	other	other	ADJ
dpc-4805	42	4	hand	hand	NOUN
dpc-4805	42	5	,	,	PUNCT
dpc-4805	42	6	psoriasis	psoriasis	NOUN
dpc-4805	42	7	itself	itself	PRON
dpc-4805	42	8	can	can	AUX
dpc-4805	42	9	influence	influence	VERB
dpc-4805	42	10	body	body	NOUN
dpc-4805	42	11	weight	weight	NOUN
dpc-4805	42	12	,	,	PUNCT
dpc-4805	42	13	as	as	SCONJ
dpc-4805	42	14	the	the	DET
dpc-4805	42	15	physical	physical	ADJ
dpc-4805	42	16	discomfort	discomfort	NOUN
dpc-4805	42	17	and	and	CCONJ
dpc-4805	42	18	self	self	NOUN
dpc-4805	42	19	-	-	PUNCT
dpc-4805	42	20	consciousness	consciousness	NOUN
dpc-4805	42	21	associated	associate	VERB
dpc-4805	42	22	with	with	ADP
dpc-4805	42	23	skin	skin	NOUN
dpc-4805	42	24	lesions	lesion	NOUN
dpc-4805	42	25	may	may	AUX
dpc-4805	42	26	lead	lead	VERB
dpc-4805	42	27	to	to	ADP
dpc-4805	42	28	lifestyle	lifestyle	NOUN
dpc-4805	42	29	changes	change	NOUN
dpc-4805	42	30	,	,	PUNCT
dpc-4805	42	31	such	such	ADJ
dpc-4805	42	32	as	as	ADP
dpc-4805	42	33	adopting	adopt	VERB
dpc-4805	42	34	restrictive	restrictive	ADJ
dpc-4805	42	35	diets	diet	NOUN
dpc-4805	42	36	or	or	CCONJ
dpc-4805	42	37	avoiding	avoid	VERB
dpc-4805	42	38	physical	physical	ADJ
dpc-4805	42	39	activities	activity	NOUN
dpc-4805	42	40	[	[	X
dpc-4805	42	41	12	12	NUM
dpc-4805	42	42	]	]	PUNCT
dpc-4805	42	43	.	.	PUNCT
dpc-4805	43	1	adipocytes	adipocyte	NOUN
dpc-4805	43	2	release	release	VERB
dpc-4805	43	3	a	a	DET
dpc-4805	43	4	range	range	NOUN
dpc-4805	43	5	of	of	ADP
dpc-4805	43	6	cytokines	cytokine	NOUN
dpc-4805	43	7	associated	associate	VERB
dpc-4805	43	8	with	with	ADP
dpc-4805	43	9	inflammation	inflammation	NOUN
dpc-4805	43	10	,	,	PUNCT
dpc-4805	43	11	contributing	contribute	VERB
dpc-4805	43	12	to	to	ADP
dpc-4805	43	13	inflammatory	inflammatory	ADJ
dpc-4805	43	14	responses	response	NOUN
dpc-4805	43	15	,	,	PUNCT
dpc-4805	43	16	including	include	VERB
dpc-4805	43	17	in	in	ADP
dpc-4805	43	18	psoriasis	psoriasis	NOUN
dpc-4805	43	19	.	.	PUNCT
dpc-4805	44	1	in	in	ADP
dpc-4805	44	2	psoriatic	psoriatic	ADJ
dpc-4805	44	3	lesions	lesion	NOUN
dpc-4805	44	4	,	,	PUNCT
dpc-4805	44	5	unsaturated	unsaturate	VERB
dpc-4805	44	6	fatty	fatty	NOUN
dpc-4805	44	7	acids	acid	NOUN
dpc-4805	44	8	,	,	PUNCT
dpc-4805	44	9	some	some	PRON
dpc-4805	44	10	of	of	ADP
dpc-4805	44	11	which	which	PRON
dpc-4805	44	12	have	have	VERB
dpc-4805	44	13	antiinflammatory	antiinflammatory	NOUN
dpc-4805	44	14	and	and	CCONJ
dpc-4805	44	15	anti	anti	ADJ
dpc-4805	44	16	-	-	ADJ
dpc-4805	44	17	proliferative	proliferative	ADJ
dpc-4805	44	18	effects	effect	NOUN
dpc-4805	44	19	,	,	PUNCT
dpc-4805	44	20	show	show	VERB
dpc-4805	44	21	notable	notable	ADJ
dpc-4805	44	22	variations	variation	NOUN
dpc-4805	44	23	.	.	PUNCT
dpc-4805	45	1	disruptions	disruption	NOUN
dpc-4805	45	2	in	in	ADP
dpc-4805	45	3	the	the	DET
dpc-4805	45	4	urea	urea	NOUN
dpc-4805	45	5	cycle	cycle	NOUN
dpc-4805	45	6	and	and	CCONJ
dpc-4805	45	7	the	the	DET
dpc-4805	45	8	phenylalaninetyrosine	phenylalaninetyrosine	NOUN
dpc-4805	45	9	pathway	pathway	NOUN
dpc-4805	45	10	can	can	AUX
dpc-4805	45	11	result	result	VERB
dpc-4805	45	12	in	in	ADP
dpc-4805	45	13	higher	high	ADJ
dpc-4805	45	14	levels	level	NOUN
dpc-4805	45	15	of	of	ADP
dpc-4805	45	16	ornithine	ornithine	NOUN
dpc-4805	45	17	and	and	CCONJ
dpc-4805	45	18	phenylalanine	phenylalanine	NOUN
dpc-4805	45	19	in	in	ADP
dpc-4805	45	20	these	these	DET
dpc-4805	45	21	lesions	lesion	NOUN
dpc-4805	45	22	.	.	PUNCT
dpc-4805	46	1	the	the	DET
dpc-4805	46	2	rapid	rapid	ADJ
dpc-4805	46	3	skin	skin	NOUN
dpc-4805	46	4	cell	cell	NOUN
dpc-4805	46	5	turnover	turnover	NOUN
dpc-4805	46	6	in	in	ADP
dpc-4805	46	7	psoriasis	psoriasis	NOUN
dpc-4805	46	8	also	also	ADV
dpc-4805	46	9	affects	affect	VERB
dpc-4805	46	10	nucleotide	nucleotide	ADJ
dpc-4805	46	11	metabolism	metabolism	NOUN
dpc-4805	46	12	,	,	PUNCT
dpc-4805	46	13	leading	lead	VERB
dpc-4805	46	14	to	to	ADP
dpc-4805	46	15	reduced	reduced	ADJ
dpc-4805	46	16	levels	level	NOUN
dpc-4805	46	17	of	of	ADP
dpc-4805	46	18	certain	certain	ADJ
dpc-4805	46	19	metabolites	metabolite	NOUN
dpc-4805	46	20	due	due	ADP
dpc-4805	46	21	to	to	ADP
dpc-4805	46	22	increased	increase	VERB
dpc-4805	46	23	demand	demand	NOUN
dpc-4805	46	24	and	and	CCONJ
dpc-4805	46	25	accelerated	accelerate	VERB
dpc-4805	46	26	breakdown	breakdown	NOUN
dpc-4805	46	27	of	of	ADP
dpc-4805	46	28	purines	purine	NOUN
dpc-4805	46	29	and	and	CCONJ
dpc-4805	46	30	pyrimidines	pyrimidine	NOUN
dpc-4805	46	31	.	.	PUNCT
dpc-4805	47	1	studies	study	NOUN
dpc-4805	47	2	have	have	AUX
dpc-4805	47	3	found	find	VERB
dpc-4805	47	4	that	that	SCONJ
dpc-4805	47	5	elevated	elevated	ADJ
dpc-4805	47	6	levels	level	NOUN
dpc-4805	47	7	of	of	ADP
dpc-4805	47	8	proline	proline	NOUN
dpc-4805	47	9	and	and	CCONJ
dpc-4805	47	10	hydroxyproline	hydroxyproline	ADJ
dpc-4805	47	11	,	,	PUNCT
dpc-4805	47	12	amino	amino	ADJ
dpc-4805	47	13	acids	acid	NOUN
dpc-4805	47	14	involved	involve	VERB
dpc-4805	47	15	in	in	ADP
dpc-4805	47	16	the	the	DET
dpc-4805	47	17	urea	urea	NOUN
dpc-4805	47	18	cycle	cycle	NOUN
dpc-4805	47	19	and	and	CCONJ
dpc-4805	47	20	collagen	collagen	NOUN
dpc-4805	47	21	production	production	NOUN
dpc-4805	47	22	,	,	PUNCT
dpc-4805	47	23	may	may	AUX
dpc-4805	47	24	be	be	AUX
dpc-4805	47	25	linked	link	VERB
dpc-4805	47	26	to	to	ADP
dpc-4805	47	27	the	the	DET
dpc-4805	47	28	severity	severity	NOUN
dpc-4805	47	29	of	of	ADP
dpc-4805	47	30	psoriasis	psoriasis	NOUN
dpc-4805	47	31	[	[	X
dpc-4805	47	32	3	3	NUM
dpc-4805	47	33	]	]	PUNCT
dpc-4805	47	34	.	.	PUNCT
dpc-4805	48	1	this	this	DET
dpc-4805	48	2	psoriasisrelated	psoriasisrelate	VERB
dpc-4805	48	3	inflammation	inflammation	NOUN
dpc-4805	48	4	and	and	CCONJ
dpc-4805	48	5	psychosocial	psychosocial	ADJ
dpc-4805	48	6	stress	stress	NOUN
dpc-4805	48	7	can	can	AUX
dpc-4805	48	8	adversely	adversely	ADV
dpc-4805	48	9	affect	affect	VERB
dpc-4805	48	10	metabolic	metabolic	ADJ
dpc-4805	48	11	health	health	NOUN
dpc-4805	48	12	and	and	CCONJ
dpc-4805	48	13	contribute	contribute	VERB
dpc-4805	48	14	to	to	ADP
dpc-4805	48	15	weight	weight	NOUN
dpc-4805	48	16	gain	gain	NOUN
dpc-4805	48	17	,	,	PUNCT
dpc-4805	48	18	forming	form	VERB
dpc-4805	48	19	a	a	DET
dpc-4805	48	20	vicious	vicious	ADJ
dpc-4805	48	21	cycle	cycle	NOUN
dpc-4805	48	22	that	that	PRON
dpc-4805	48	23	further	far	ADV
dpc-4805	48	24	complicates	complicate	VERB
dpc-4805	48	25	disease	disease	NOUN
dpc-4805	48	26	management	management	NOUN
dpc-4805	48	27	[	[	X
dpc-4805	48	28	13	13	NUM
dpc-4805	48	29	]	]	PUNCT
dpc-4805	48	30	.	.	PUNCT
dpc-4805	49	1	gender	gender	NOUN
dpc-4805	49	2	-	-	PUNCT
dpc-4805	49	3	specific	specific	ADJ
dpc-4805	49	4	factors	factor	NOUN
dpc-4805	49	5	could	could	AUX
dpc-4805	49	6	allow	allow	VERB
dpc-4805	49	7	tailored	tailored	ADJ
dpc-4805	49	8	approaches	approach	NOUN
dpc-4805	49	9	for	for	ADP
dpc-4805	49	10	each	each	DET
dpc-4805	49	11	single	single	ADJ
dpc-4805	49	12	patient	patient	NOUN
dpc-4805	49	13	,	,	PUNCT
dpc-4805	49	14	taking	take	VERB
dpc-4805	49	15	in	in	ADP
dpc-4805	49	16	consideration	consideration	NOUN
dpc-4805	49	17	comorbidities	comorbiditie	NOUN
dpc-4805	49	18	,	,	PUNCT
dpc-4805	49	19	changes	change	NOUN
dpc-4805	49	20	in	in	ADP
dpc-4805	49	21	lifestyle	lifestyle	NOUN
dpc-4805	49	22	but	but	CCONJ
dpc-4805	49	23	above	above	ADP
dpc-4805	49	24	all	all	DET
dpc-4805	49	25	therapies	therapy	NOUN
dpc-4805	49	26	.	.	PUNCT
dpc-4805	50	1	at	at	ADP
dpc-4805	50	2	the	the	DET
dpc-4805	50	3	same	same	ADJ
dpc-4805	50	4	time	time	NOUN
dpc-4805	50	5	,	,	PUNCT
dpc-4805	50	6	managing	manage	VERB
dpc-4805	50	7	clinical	clinical	ADJ
dpc-4805	50	8	responses	response	NOUN
dpc-4805	50	9	becomes	become	VERB
dpc-4805	50	10	increasingly	increasingly	ADV
dpc-4805	50	11	complex	complex	ADJ
dpc-4805	50	12	in	in	ADP
dpc-4805	50	13	patients	patient	NOUN
dpc-4805	50	14	with	with	ADP
dpc-4805	50	15	multi	multi	ADJ
dpc-4805	50	16	-	-	ADJ
dpc-4805	50	17	failure	failure	ADJ
dpc-4805	50	18	psoriasis	psoriasis	NOUN
dpc-4805	50	19	,	,	PUNCT
dpc-4805	50	20	who	who	PRON
dpc-4805	50	21	have	have	AUX
dpc-4805	50	22	undergone	undergo	VERB
dpc-4805	50	23	multiple	multiple	ADJ
dpc-4805	50	24	biologic	biologic	NOUN
dpc-4805	50	25	treatments	treatment	NOUN
dpc-4805	50	26	,	,	PUNCT
dpc-4805	50	27	as	as	SCONJ
dpc-4805	50	28	their	their	PRON
dpc-4805	50	29	immune	immune	ADJ
dpc-4805	50	30	system	system	NOUN
dpc-4805	50	31	undergoes	undergo	VERB
dpc-4805	50	32	dynamic	dynamic	ADJ
dpc-4805	50	33	fluctuations	fluctuation	NOUN
dpc-4805	50	34	[	[	X
dpc-4805	50	35	14	14	NUM
dpc-4805	50	36	]	]	PUNCT
dpc-4805	50	37	.	.	PUNCT
dpc-4805	51	1	addressing	address	VERB
dpc-4805	51	2	their	their	PRON
dpc-4805	51	3	evolving	evolve	VERB
dpc-4805	51	4	immunologic	immunologic	ADJ
dpc-4805	51	5	landscape	landscape	NOUN
dpc-4805	51	6	presents	present	VERB
dpc-4805	51	7	significant	significant	ADJ
dpc-4805	51	8	challenges	challenge	NOUN
dpc-4805	51	9	,	,	PUNCT
dpc-4805	51	10	requiring	require	VERB
dpc-4805	51	11	individualized	individualized	ADJ
dpc-4805	51	12	results	result	NOUN
dpc-4805	51	13	:	:	PUNCT
dpc-4805	51	14	the	the	DET
dpc-4805	51	15	analysis	analysis	NOUN
dpc-4805	51	16	showed	show	VERB
dpc-4805	51	17	a	a	DET
dpc-4805	51	18	significant	significant	ADJ
dpc-4805	51	19	reduction	reduction	NOUN
dpc-4805	51	20	in	in	ADP
dpc-4805	51	21	body	body	NOUN
dpc-4805	51	22	weight	weight	NOUN
dpc-4805	51	23	in	in	ADP
dpc-4805	51	24	females	female	NOUN
dpc-4805	51	25	at	at	ADP
dpc-4805	51	26	w24	w24	PROPN
dpc-4805	51	27	and	and	CCONJ
dpc-4805	51	28	w48	w48	NOUN
dpc-4805	51	29	(	(	PUNCT
dpc-4805	51	30	p	p	X
dpc-4805	51	31	<	<	X
dpc-4805	51	32	0.001	0.001	NUM
dpc-4805	51	33	)	)	PUNCT
dpc-4805	51	34	,	,	PUNCT
dpc-4805	51	35	with	with	ADP
dpc-4805	51	36	a	a	DET
dpc-4805	51	37	mean	mean	ADJ
dpc-4805	51	38	difference	difference	NOUN
dpc-4805	51	39	of	of	ADP
dpc-4805	51	40	−2.6	−2.6	PROPN
dpc-4805	51	41	kg	kg	X
dpc-4805	51	42	at	at	ADP
dpc-4805	51	43	w24	w24	PROPN
dpc-4805	51	44	and	and	CCONJ
dpc-4805	51	45	of	of	ADP
dpc-4805	51	46	-5.7	-5.7	PRON
dpc-4805	51	47	kg	kg	NOUN
dpc-4805	51	48	at	at	ADP
dpc-4805	51	49	w48	w48	NOUN
dpc-4805	51	50	.	.	PUNCT
dpc-4805	52	1	we	we	PRON
dpc-4805	52	2	observed	observe	VERB
dpc-4805	52	3	a	a	DET
dpc-4805	52	4	reduction	reduction	NOUN
dpc-4805	52	5	of	of	ADP
dpc-4805	52	6	weight	weight	NOUN
dpc-4805	52	7	of	of	ADP
dpc-4805	52	8	3.6	3.6	NUM
dpc-4805	52	9	%	%	NOUN
dpc-4805	52	10	at	at	ADP
dpc-4805	52	11	w24	w24	PROPN
dpc-4805	52	12	,	,	PUNCT
dpc-4805	52	13	and	and	CCONJ
dpc-4805	52	14	7.9	7.9	NUM
dpc-4805	52	15	%	%	NOUN
dpc-4805	52	16	at	at	ADP
dpc-4805	52	17	w48	w48	NOUN
dpc-4805	52	18	.	.	PUNCT
dpc-4805	53	1	similar	similar	ADJ
dpc-4805	53	2	assessments	assessment	NOUN
dpc-4805	53	3	were	be	AUX
dpc-4805	53	4	also	also	ADV
dpc-4805	53	5	observed	observe	VERB
dpc-4805	53	6	for	for	ADP
dpc-4805	53	7	bmi	bmi	NOUN
dpc-4805	53	8	,	,	PUNCT
dpc-4805	53	9	which	which	PRON
dpc-4805	53	10	was	be	AUX
dpc-4805	53	11	reduced	reduce	VERB
dpc-4805	53	12	in	in	ADP
dpc-4805	53	13	women	woman	NOUN
dpc-4805	53	14	by	by	ADP
dpc-4805	53	15	3.6	3.6	NUM
dpc-4805	53	16	%	%	NOUN
dpc-4805	53	17	at	at	ADP
dpc-4805	53	18	w24	w24	PROPN
dpc-4805	53	19	and	and	CCONJ
dpc-4805	53	20	8	8	NUM
dpc-4805	53	21	%	%	NOUN
dpc-4805	53	22	at	at	ADP
dpc-4805	53	23	w48	w48	NOUN
dpc-4805	53	24	.	.	PUNCT
dpc-4805	54	1	in	in	ADP
dpc-4805	54	2	men	man	NOUN
dpc-4805	54	3	,	,	PUNCT
dpc-4805	54	4	no	no	DET
dpc-4805	54	5	changes	change	NOUN
dpc-4805	54	6	in	in	ADP
dpc-4805	54	7	weight	weight	NOUN
dpc-4805	54	8	and	and	CCONJ
dpc-4805	54	9	bmi	bmi	NOUN
dpc-4805	54	10	were	be	AUX
dpc-4805	54	11	observed	observe	VERB
dpc-4805	54	12	at	at	ADP
dpc-4805	54	13	w24	w24	PROPN
dpc-4805	54	14	and/or	and/or	CCONJ
dpc-4805	54	15	w48	w48	NOUN
dpc-4805	54	16	.	.	PUNCT
dpc-4805	55	1	conclusions	conclusion	NOUN
dpc-4805	55	2	:	:	PUNCT
dpc-4805	55	3	understanding	understand	VERB
dpc-4805	55	4	the	the	DET
dpc-4805	55	5	interplay	interplay	NOUN
dpc-4805	55	6	between	between	ADP
dpc-4805	55	7	psoriasis	psoriasis	NOUN
dpc-4805	55	8	,	,	PUNCT
dpc-4805	55	9	gender	gender	NOUN
dpc-4805	55	10	,	,	PUNCT
dpc-4805	55	11	and	and	CCONJ
dpc-4805	55	12	body	body	NOUN
dpc-4805	55	13	weight	weight	NOUN
dpc-4805	55	14	is	be	AUX
dpc-4805	55	15	essential	essential	ADJ
dpc-4805	55	16	for	for	ADP
dpc-4805	55	17	effective	effective	ADJ
dpc-4805	55	18	disease	disease	NOUN
dpc-4805	55	19	management	management	NOUN
dpc-4805	55	20	and	and	CCONJ
dpc-4805	55	21	improving	improve	VERB
dpc-4805	55	22	patient	patient	ADJ
dpc-4805	55	23	outcomes	outcome	NOUN
dpc-4805	55	24	.	.	PUNCT
dpc-4805	56	1	original	original	ADJ
dpc-4805	56	2	article	article	NOUN
dpc-4805	56	3	|	|	ADV
dpc-4805	56	4	dermatol	dermatol	ADJ
dpc-4805	56	5	pract	pract	NOUN
dpc-4805	56	6	concept	concept	NOUN
dpc-4805	56	7	.	.	PUNCT
dpc-4805	57	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	57	2	3	3	NUM
dpc-4805	57	3	approaches	approach	NOUN
dpc-4805	57	4	to	to	PART
dpc-4805	57	5	achieve	achieve	VERB
dpc-4805	57	6	therapeutic	therapeutic	ADJ
dpc-4805	57	7	efficacy	efficacy	NOUN
dpc-4805	57	8	among	among	ADP
dpc-4805	57	9	changing	change	VERB
dpc-4805	57	10	treatment	treatment	NOUN
dpc-4805	57	11	paradigms	paradigm	NOUN
dpc-4805	57	12	and	and	CCONJ
dpc-4805	57	13	individual	individual	ADJ
dpc-4805	57	14	patient	patient	NOUN
dpc-4805	57	15	responses	response	NOUN
dpc-4805	57	16	.	.	PUNCT
dpc-4805	58	1	objectives	objective	NOUN
dpc-4805	58	2	in	in	ADP
dpc-4805	58	3	last	last	ADJ
dpc-4805	58	4	years	year	NOUN
dpc-4805	58	5	,	,	PUNCT
dpc-4805	58	6	to	to	ADP
dpc-4805	58	7	the	the	DET
dpc-4805	58	8	already	already	ADV
dpc-4805	58	9	rich	rich	ADJ
dpc-4805	58	10	therapeutical	therapeutical	ADJ
dpc-4805	58	11	armamentarium	armamentarium	NOUN
dpc-4805	58	12	of	of	ADP
dpc-4805	58	13	monoclonal	monoclonal	NOUN
dpc-4805	58	14	antibodies	antibodie	VERB
dpc-4805	58	15	,	,	PUNCT
dpc-4805	58	16	the	the	DET
dpc-4805	58	17	small	small	ADJ
dpc-4805	58	18	molecules	molecule	NOUN
dpc-4805	58	19	have	have	AUX
dpc-4805	58	20	found	find	VERB
dpc-4805	58	21	a	a	DET
dpc-4805	58	22	unique	unique	ADJ
dpc-4805	58	23	position	position	NOUN
dpc-4805	58	24	[	[	X
dpc-4805	58	25	15	15	NUM
dpc-4805	58	26	]	]	PUNCT
dpc-4805	58	27	.	.	PUNCT
dpc-4805	59	1	among	among	ADP
dpc-4805	59	2	them	they	PRON
dpc-4805	59	3	,	,	PUNCT
dpc-4805	59	4	apremilast	apremilast	ADJ
dpc-4805	59	5	,	,	PUNCT
dpc-4805	59	6	a	a	DET
dpc-4805	59	7	phosphodiesterase-4	phosphodiesterase-4	NUM
dpc-4805	59	8	inhibitor	inhibitor	NOUN
dpc-4805	59	9	(	(	PUNCT
dpc-4805	59	10	pde4i	pde4i	NOUN
dpc-4805	59	11	)	)	PUNCT
dpc-4805	59	12	approved	approve	VERB
dpc-4805	59	13	for	for	ADP
dpc-4805	59	14	the	the	DET
dpc-4805	59	15	treatment	treatment	NOUN
dpc-4805	59	16	of	of	ADP
dpc-4805	59	17	moderate	moderate	ADJ
dpc-4805	59	18	-	-	PUNCT
dpc-4805	59	19	to	to	ADP
dpc-4805	59	20	-	-	PUNCT
dpc-4805	59	21	severe	severe	ADJ
dpc-4805	59	22	psoriasis	psoriasis	NOUN
dpc-4805	59	23	and	and	CCONJ
dpc-4805	59	24	psoriatic	psoriatic	ADJ
dpc-4805	59	25	arthritis	arthritis	NOUN
dpc-4805	59	26	(	(	PUNCT
dpc-4805	59	27	psa	psa	NOUN
dpc-4805	59	28	)	)	PUNCT
dpc-4805	59	29	,	,	PUNCT
dpc-4805	59	30	has	have	AUX
dpc-4805	59	31	been	be	AUX
dpc-4805	59	32	suggested	suggest	VERB
dpc-4805	59	33	to	to	PART
dpc-4805	59	34	have	have	VERB
dpc-4805	59	35	a	a	DET
dpc-4805	59	36	potential	potential	ADJ
dpc-4805	59	37	beneficial	beneficial	ADJ
dpc-4805	59	38	metabolic	metabolic	NOUN
dpc-4805	59	39	effect	effect	NOUN
dpc-4805	60	1	[	[	X
dpc-4805	60	2	16	16	NUM
dpc-4805	60	3	-	-	SYM
dpc-4805	60	4	17	17	NUM
dpc-4805	60	5	]	]	PUNCT
dpc-4805	60	6	.	.	PUNCT
dpc-4805	61	1	to	to	PART
dpc-4805	61	2	further	far	ADV
dpc-4805	61	3	confirm	confirm	VERB
dpc-4805	61	4	these	these	DET
dpc-4805	61	5	hypotheses	hypothesis	NOUN
dpc-4805	61	6	,	,	PUNCT
dpc-4805	61	7	a	a	DET
dpc-4805	61	8	multicenter	multicenter	NOUN
dpc-4805	61	9	retrospective	retrospective	ADJ
dpc-4805	61	10	study	study	NOUN
dpc-4805	61	11	was	be	AUX
dpc-4805	61	12	conducted	conduct	VERB
dpc-4805	61	13	among	among	ADP
dpc-4805	61	14	patients	patient	NOUN
dpc-4805	61	15	with	with	ADP
dpc-4805	61	16	moderate	moderate	ADJ
dpc-4805	61	17	-	-	PUNCT
dpc-4805	61	18	to	to	ADP
dpc-4805	61	19	-	-	PUNCT
dpc-4805	61	20	severe	severe	ADJ
dpc-4805	61	21	psoriasis	psoriasis	NOUN
dpc-4805	61	22	attending	attend	VERB
dpc-4805	61	23	the	the	DET
dpc-4805	61	24	outpatient	outpatient	NOUN
dpc-4805	61	25	clinic	clinic	NOUN
dpc-4805	61	26	of	of	ADP
dpc-4805	61	27	6	6	NUM
dpc-4805	61	28	university	university	NOUN
dpc-4805	61	29	hospital	hospital	NOUN
dpc-4805	61	30	in	in	ADP
dpc-4805	61	31	italy	italy	PROPN
dpc-4805	61	32	,	,	PUNCT
dpc-4805	61	33	considering	consider	VERB
dpc-4805	61	34	the	the	DET
dpc-4805	61	35	effects	effect	NOUN
dpc-4805	61	36	of	of	ADP
dpc-4805	61	37	apremilast	apremilast	NOUN
dpc-4805	61	38	on	on	ADP
dpc-4805	61	39	weight	weight	NOUN
dpc-4805	61	40	and	and	CCONJ
dpc-4805	61	41	body	body	NOUN
dpc-4805	61	42	mass	mass	NOUN
dpc-4805	61	43	index	index	NOUN
dpc-4805	61	44	(	(	PUNCT
dpc-4805	61	45	bmi	bmi	PROPN
dpc-4805	61	46	)	)	PUNCT
dpc-4805	61	47	according	accord	VERB
dpc-4805	61	48	to	to	ADP
dpc-4805	61	49	gender	gender	NOUN
dpc-4805	61	50	after	after	ADP
dpc-4805	61	51	24	24	NUM
dpc-4805	61	52	weeks	week	NOUN
dpc-4805	61	53	and	and	CCONJ
dpc-4805	61	54	48	48	NUM
dpc-4805	61	55	weeks	week	NOUN
dpc-4805	61	56	of	of	ADP
dpc-4805	61	57	therapy	therapy	NOUN
dpc-4805	61	58	.	.	PUNCT
dpc-4805	62	1	methods	method	NOUN
dpc-4805	62	2	we	we	PRON
dpc-4805	62	3	enrolled	enrol	VERB
dpc-4805	62	4	retrospectively	retrospectively	ADV
dpc-4805	62	5	adult	adult	NOUN
dpc-4805	62	6	patients	patient	NOUN
dpc-4805	62	7	(	(	PUNCT
dpc-4805	62	8	aged	aged	ADJ
dpc-4805	62	9	>	>	X
dpc-4805	62	10	18	18	NUM
dpc-4805	62	11	years	year	NOUN
dpc-4805	62	12	)	)	PUNCT
dpc-4805	62	13	with	with	ADP
dpc-4805	62	14	a	a	DET
dpc-4805	62	15	confirmed	confirm	VERB
dpc-4805	62	16	diagnosis	diagnosis	NOUN
dpc-4805	62	17	of	of	ADP
dpc-4805	62	18	moderate	moderate	ADJ
dpc-4805	62	19	-	-	PUNCT
dpc-4805	62	20	to	to	ADP
dpc-4805	62	21	-	-	PUNCT
dpc-4805	62	22	severe	severe	ADJ
dpc-4805	62	23	psoriasis	psoriasis	NOUN
dpc-4805	62	24	who	who	PRON
dpc-4805	62	25	underwent	undergo	VERB
dpc-4805	62	26	apremilast	apremilast	ADJ
dpc-4805	62	27	treatment	treatment	NOUN
dpc-4805	62	28	for	for	ADP
dpc-4805	62	29	at	at	ADV
dpc-4805	62	30	least	least	ADV
dpc-4805	62	31	24	24	NUM
dpc-4805	62	32	weeks	week	NOUN
dpc-4805	62	33	in	in	ADP
dpc-4805	62	34	the	the	DET
dpc-4805	62	35	period	period	NOUN
dpc-4805	62	36	from	from	ADP
dpc-4805	62	37	march	march	PROPN
dpc-4805	62	38	2018	2018	NUM
dpc-4805	62	39	to	to	ADP
dpc-4805	62	40	november	november	PROPN
dpc-4805	62	41	2023	2023	NUM
dpc-4805	62	42	.	.	PUNCT
dpc-4805	63	1	baseline	baseline	PROPN
dpc-4805	63	2	characteristics	characteristic	NOUN
dpc-4805	63	3	,	,	PUNCT
dpc-4805	63	4	including	include	VERB
dpc-4805	63	5	age	age	NOUN
dpc-4805	63	6	,	,	PUNCT
dpc-4805	63	7	gender	gender	NOUN
dpc-4805	63	8	,	,	PUNCT
dpc-4805	63	9	psoriasis	psoriasis	NOUN
dpc-4805	63	10	area	area	NOUN
dpc-4805	63	11	severity	severity	NOUN
dpc-4805	63	12	index	index	NOUN
dpc-4805	63	13	(	(	PUNCT
dpc-4805	63	14	pasi	pasi	NOUN
dpc-4805	63	15	)	)	PUNCT
dpc-4805	63	16	,	,	PUNCT
dpc-4805	63	17	comorbidities	comorbiditie	NOUN
dpc-4805	63	18	,	,	PUNCT
dpc-4805	63	19	smoking	smoking	NOUN
dpc-4805	63	20	and	and	CCONJ
dpc-4805	63	21	alcohol	alcohol	NOUN
dpc-4805	63	22	habits	habit	NOUN
dpc-4805	63	23	,	,	PUNCT
dpc-4805	63	24	relevant	relevant	ADJ
dpc-4805	63	25	medical	medical	ADJ
dpc-4805	63	26	history	history	NOUN
dpc-4805	63	27	and	and	CCONJ
dpc-4805	63	28	previous	previous	ADJ
dpc-4805	63	29	psoriasis	psoriasis	NOUN
dpc-4805	63	30	systemic	systemic	ADJ
dpc-4805	63	31	and	and	CCONJ
dpc-4805	63	32	biologic	biologic	NOUN
dpc-4805	63	33	treatments	treatment	NOUN
dpc-4805	63	34	were	be	AUX
dpc-4805	63	35	recorded	record	VERB
dpc-4805	63	36	.	.	PUNCT
dpc-4805	64	1	weight	weight	NOUN
dpc-4805	64	2	and	and	CCONJ
dpc-4805	64	3	body	body	NOUN
dpc-4805	64	4	mass	mass	NOUN
dpc-4805	64	5	index	index	NOUN
dpc-4805	64	6	(	(	PUNCT
dpc-4805	64	7	bmi	bmi	PROPN
dpc-4805	64	8	)	)	PUNCT
dpc-4805	64	9	were	be	AUX
dpc-4805	64	10	evaluated	evaluate	VERB
dpc-4805	64	11	at	at	ADP
dpc-4805	64	12	baseline	baseline	PROPN
dpc-4805	64	13	(	(	PUNCT
dpc-4805	64	14	t0	t0	NOUN
dpc-4805	64	15	)	)	PUNCT
dpc-4805	64	16	and	and	CCONJ
dpc-4805	64	17	at	at	ADP
dpc-4805	64	18	24	24	NUM
dpc-4805	64	19	(	(	PUNCT
dpc-4805	64	20	w24	w24	PROPN
dpc-4805	64	21	)	)	PUNCT
dpc-4805	64	22	and	and	CCONJ
dpc-4805	64	23	48	48	NUM
dpc-4805	64	24	weeks	week	NOUN
dpc-4805	64	25	(	(	PUNCT
dpc-4805	64	26	w48	w48	NOUN
dpc-4805	64	27	)	)	PUNCT
dpc-4805	64	28	.	.	PUNCT
dpc-4805	65	1	a	a	DET
dpc-4805	65	2	descriptive	descriptive	ADJ
dpc-4805	65	3	statistical	statistical	ADJ
dpc-4805	65	4	analysis	analysis	NOUN
dpc-4805	65	5	has	have	AUX
dpc-4805	65	6	been	be	AUX
dpc-4805	65	7	performed	perform	VERB
dpc-4805	65	8	.	.	PUNCT
dpc-4805	66	1	one	one	NUM
dpc-4805	66	2	-	-	PUNCT
dpc-4805	66	3	way	way	NOUN
dpc-4805	66	4	or	or	CCONJ
dpc-4805	66	5	mixed	mixed	ADJ
dpc-4805	66	6	paired	pair	VERB
dpc-4805	66	7	anova	anova	PROPN
dpc-4805	66	8	were	be	AUX
dpc-4805	66	9	used	use	VERB
dpc-4805	66	10	to	to	PART
dpc-4805	66	11	evaluate	evaluate	VERB
dpc-4805	66	12	the	the	DET
dpc-4805	66	13	change	change	NOUN
dpc-4805	66	14	of	of	ADP
dpc-4805	66	15	weight	weight	NOUN
dpc-4805	66	16	and	and	CCONJ
dpc-4805	66	17	bmi	bmi	NOUN
dpc-4805	66	18	among	among	ADP
dpc-4805	66	19	different	different	ADJ
dpc-4805	66	20	follow	follow	NOUN
dpc-4805	66	21	-	-	PUNCT
dpc-4805	66	22	up	up	ADP
dpc-4805	66	23	visits	visit	NOUN
dpc-4805	66	24	.	.	PUNCT
dpc-4805	67	1	a	a	DET
dpc-4805	67	2	p	p	NOUN
dpc-4805	67	3	value	value	NOUN
dpc-4805	67	4	less	less	ADJ
dpc-4805	67	5	than	than	ADP
dpc-4805	67	6	0.05	0.05	NUM
dpc-4805	67	7	was	be	AUX
dpc-4805	67	8	considered	consider	VERB
dpc-4805	67	9	statistically	statistically	ADV
dpc-4805	67	10	significant	significant	ADJ
dpc-4805	67	11	.	.	PUNCT
dpc-4805	68	1	results	result	VERB
dpc-4805	68	2	a	a	DET
dpc-4805	68	3	total	total	NOUN
dpc-4805	68	4	of	of	ADP
dpc-4805	68	5	120	120	NUM
dpc-4805	68	6	patients	patient	NOUN
dpc-4805	68	7	(	(	PUNCT
dpc-4805	68	8	63	63	NUM
dpc-4805	68	9	male	male	NOUN
dpc-4805	69	1	[	[	X
dpc-4805	69	2	m	m	X
dpc-4805	69	3	]	]	X
dpc-4805	69	4	:	:	PUNCT
dpc-4805	69	5	63	63	NUM
dpc-4805	70	1	[	[	SYM
dpc-4805	70	2	52.5	52.5	NUM
dpc-4805	70	3	%	%	NOUN
dpc-4805	70	4	]	]	PUNCT
dpc-4805	70	5	)	)	PUNCT
dpc-4805	70	6	and	and	CCONJ
dpc-4805	70	7	57	57	NUM
dpc-4805	70	8	 	 	SPACE
dpc-4805	70	9	female	female	ADJ
dpc-4805	70	10	[	[	X
dpc-4805	70	11	f	f	X
dpc-4805	70	12	]	]	X
dpc-4805	70	13	[	[	X
dpc-4805	70	14	47.5	47.5	NUM
dpc-4805	70	15	%	%	NOUN
dpc-4805	70	16	]	]	PUNCT
dpc-4805	70	17	)	)	PUNCT
dpc-4805	70	18	with	with	ADP
dpc-4805	70	19	psoriasis	psoriasis	NOUN
dpc-4805	70	20	treated	treat	VERB
dpc-4805	70	21	with	with	ADP
dpc-4805	70	22	apremilast	apremilast	NOUN
dpc-4805	70	23	for	for	ADP
dpc-4805	70	24	at	at	ADV
dpc-4805	70	25	least	least	ADJ
dpc-4805	70	26	w24	w24	PROPN
dpc-4805	70	27	and	and	CCONJ
dpc-4805	70	28	with	with	SCONJ
dpc-4805	70	29	a	a	DET
dpc-4805	70	30	follow	follow	VERB
dpc-4805	70	31	-	-	PUNCT
dpc-4805	70	32	up	up	ADP
dpc-4805	70	33	visit	visit	NOUN
dpc-4805	70	34	at	at	ADP
dpc-4805	70	35	w48	w48	NOUN
dpc-4805	70	36	were	be	AUX
dpc-4805	70	37	enrolled	enrol	VERB
dpc-4805	70	38	.	.	PUNCT
dpc-4805	71	1	twenty	twenty	NUM
dpc-4805	71	2	-	-	PUNCT
dpc-4805	71	3	eight	eight	NUM
dpc-4805	71	4	patients	patient	NOUN
dpc-4805	71	5	(	(	PUNCT
dpc-4805	71	6	11	11	NUM
dpc-4805	71	7	m	m	NOUN
dpc-4805	71	8	[	[	X
dpc-4805	71	9	17.5	17.5	NUM
dpc-4805	71	10	%	%	NOUN
dpc-4805	71	11	]	]	PUNCT
dpc-4805	71	12	)	)	PUNCT
dpc-4805	71	13	and	and	CCONJ
dpc-4805	71	14	14	14	NUM
dpc-4805	71	15	f	f	NOUN
dpc-4805	72	1	[	[	X
dpc-4805	72	2	24.5	24.5	NUM
dpc-4805	72	3	%	%	NOUN
dpc-4805	72	4	]	]	PUNCT
dpc-4805	72	5	)	)	PUNCT
dpc-4805	72	6	discontinued	discontinue	VERB
dpc-4805	72	7	apremilast	apremilast	ADJ
dpc-4805	72	8	before	before	ADP
dpc-4805	72	9	w48	w48	NOUN
dpc-4805	72	10	;	;	PUNCT
dpc-4805	72	11	among	among	ADP
dpc-4805	72	12	them	they	PRON
dpc-4805	72	13	,	,	PUNCT
dpc-4805	72	14	5	5	NUM
dpc-4805	72	15	dropped	drop	VERB
dpc-4805	72	16	-	-	PUNCT
dpc-4805	72	17	out	out	NOUN
dpc-4805	72	18	at	at	ADP
dpc-4805	72	19	follow	follow	NOUN
dpc-4805	72	20	-	-	PUNCT
dpc-4805	72	21	up	up	ADP
dpc-4805	72	22	visit	visit	NOUN
dpc-4805	72	23	,	,	PUNCT
dpc-4805	72	24	16	16	NUM
dpc-4805	72	25	patients	patient	NOUN
dpc-4805	72	26	reported	report	VERB
dpc-4805	72	27	adverse	adverse	ADJ
dpc-4805	72	28	events	event	NOUN
dpc-4805	72	29	(	(	PUNCT
dpc-4805	72	30	gastrointestinal	gastrointestinal	ADJ
dpc-4805	72	31	symptoms	symptom	NOUN
dpc-4805	72	32	,	,	PUNCT
dpc-4805	72	33	diarrhea	diarrhea	NOUN
dpc-4805	72	34	)	)	PUNCT
dpc-4805	72	35	,	,	PUNCT
dpc-4805	72	36	and	and	CCONJ
dpc-4805	72	37	7	7	NUM
dpc-4805	72	38	 	 	SPACE
dpc-4805	72	39	patients	patient	NOUN
dpc-4805	72	40	had	have	VERB
dpc-4805	72	41	primary	primary	ADJ
dpc-4805	72	42	failure	failure	NOUN
dpc-4805	72	43	.	.	PUNCT
dpc-4805	73	1	the	the	DET
dpc-4805	73	2	mean	mean	ADJ
dpc-4805	73	3	age	age	NOUN
dpc-4805	73	4	of	of	ADP
dpc-4805	73	5	the	the	DET
dpc-4805	73	6	patients	patient	NOUN
dpc-4805	73	7	was	be	AUX
dpc-4805	73	8	63.5	63.5	NUM
dpc-4805	73	9	±	±	NUM
dpc-4805	73	10	6.3	6.3	NUM
dpc-4805	73	11	years	year	NOUN
dpc-4805	73	12	(	(	PUNCT
dpc-4805	73	13	64.4	64.4	NUM
dpc-4805	73	14	±	±	NUM
dpc-4805	73	15	13.2	13.2	NUM
dpc-4805	73	16	in	in	ADP
dpc-4805	73	17	the	the	DET
dpc-4805	73	18	male	male	ADJ
dpc-4805	73	19	group	group	NOUN
dpc-4805	73	20	and	and	CCONJ
dpc-4805	73	21	62.6	62.6	NUM
dpc-4805	73	22	±	±	NUM
dpc-4805	73	23	11.7	11.7	NUM
dpc-4805	73	24	in	in	ADP
dpc-4805	73	25	the	the	DET
dpc-4805	73	26	female	female	ADJ
dpc-4805	73	27	group	group	NOUN
dpc-4805	73	28	)	)	PUNCT
dpc-4805	73	29	.	.	PUNCT
dpc-4805	74	1	mean	mean	VERB
dpc-4805	74	2	duration	duration	NOUN
dpc-4805	74	3	of	of	ADP
dpc-4805	74	4	psoriasis	psoriasis	NOUN
dpc-4805	74	5	was	be	AUX
dpc-4805	74	6	about	about	ADV
dpc-4805	74	7	21.9	21.9	NUM
dpc-4805	74	8	±	±	NUM
dpc-4805	74	9	0.7	0.7	NUM
dpc-4805	74	10	years	year	NOUN
dpc-4805	74	11	in	in	ADP
dpc-4805	74	12	all	all	DET
dpc-4805	74	13	patients	patient	NOUN
dpc-4805	74	14	(	(	PUNCT
dpc-4805	74	15	23.2	23.2	NUM
dpc-4805	74	16	±14.9	±14.9	X
dpc-4805	74	17	in	in	ADP
dpc-4805	74	18	male	male	NOUN
dpc-4805	74	19	and	and	CCONJ
dpc-4805	74	20	20.2	20.2	NUM
dpc-4805	74	21	±	±	NUM
dpc-4805	74	22	13.7	13.7	NUM
dpc-4805	74	23	in	in	ADP
dpc-4805	74	24	female	female	NOUN
dpc-4805	74	25	)	)	PUNCT
dpc-4805	74	26	.	.	PUNCT
dpc-4805	75	1	data	datum	NOUN
dpc-4805	75	2	about	about	ADP
dpc-4805	75	3	smoking	smoking	NOUN
dpc-4805	75	4	,	,	PUNCT
dpc-4805	75	5	alcohol	alcohol	NOUN
dpc-4805	75	6	habits	habit	NOUN
dpc-4805	75	7	and	and	CCONJ
dpc-4805	75	8	comorbidities	comorbiditie	NOUN
dpc-4805	75	9	are	be	AUX
dpc-4805	75	10	reported	report	VERB
dpc-4805	75	11	in	in	ADP
dpc-4805	75	12	table	table	NOUN
dpc-4805	75	13	1	1	NUM
dpc-4805	75	14	.	.	PUNCT
dpc-4805	75	15	considering	consider	VERB
dpc-4805	75	16	special	special	ADJ
dpc-4805	75	17	sites	site	NOUN
dpc-4805	75	18	of	of	ADP
dpc-4805	75	19	psoriasis	psoriasis	NOUN
dpc-4805	75	20	,	,	PUNCT
dpc-4805	75	21	30	30	NUM
dpc-4805	75	22	patients	patient	NOUN
dpc-4805	75	23	(	(	PUNCT
dpc-4805	75	24	25	25	NUM
dpc-4805	75	25	%	%	NOUN
dpc-4805	75	26	)	)	PUNCT
dpc-4805	75	27	had	have	VERB
dpc-4805	75	28	nail	nail	NOUN
dpc-4805	75	29	involvement	involvement	NOUN
dpc-4805	75	30	(	(	PUNCT
dpc-4805	75	31	15	15	NUM
dpc-4805	75	32	m	m	NOUN
dpc-4805	75	33	–	–	PUNCT
dpc-4805	75	34	23.8	23.8	NUM
dpc-4805	75	35	%	%	NOUN
dpc-4805	75	36	and	and	CCONJ
dpc-4805	75	37	15	15	NUM
dpc-4805	75	38	f	f	NOUN
dpc-4805	75	39	–	–	PUNCT
dpc-4805	75	40	26.3	26.3	NUM
dpc-4805	75	41	%	%	NOUN
dpc-4805	75	42	)	)	PUNCT
dpc-4805	75	43	,	,	PUNCT
dpc-4805	75	44	30	30	NUM
dpc-4805	75	45	patients	patient	NOUN
dpc-4805	75	46	(	(	PUNCT
dpc-4805	75	47	25	25	NUM
dpc-4805	75	48	%	%	NOUN
dpc-4805	75	49	)	)	PUNCT
dpc-4805	75	50	reported	report	VERB
dpc-4805	75	51	involvement	involvement	NOUN
dpc-4805	75	52	of	of	ADP
dpc-4805	75	53	palms	palm	NOUN
dpc-4805	75	54	and	and	CCONJ
dpc-4805	75	55	soles	sol	NOUN
dpc-4805	75	56	(	(	PUNCT
dpc-4805	75	57	11	11	NUM
dpc-4805	75	58	m	m	NOUN
dpc-4805	75	59	–	–	PUNCT
dpc-4805	75	60	17.5	17.5	NUM
dpc-4805	75	61	%	%	NOUN
dpc-4805	75	62	and	and	CCONJ
dpc-4805	75	63	19	19	NUM
dpc-4805	75	64	f	f	NOUN
dpc-4805	75	65	–	–	PUNCT
dpc-4805	75	66	33.3	33.3	NUM
dpc-4805	75	67	%	%	NOUN
dpc-4805	75	68	)	)	PUNCT
dpc-4805	75	69	,	,	PUNCT
dpc-4805	75	70	55	55	NUM
dpc-4805	75	71	patients	patient	NOUN
dpc-4805	75	72	(	(	PUNCT
dpc-4805	75	73	45.8	45.8	NUM
dpc-4805	75	74	%	%	NOUN
dpc-4805	75	75	)	)	PUNCT
dpc-4805	75	76	on	on	ADP
dpc-4805	75	77	the	the	DET
dpc-4805	75	78	scalp	scalp	NOUN
dpc-4805	75	79	(	(	PUNCT
dpc-4805	75	80	23	23	NUM
dpc-4805	75	81	m	m	NOUN
dpc-4805	75	82	–	–	PUNCT
dpc-4805	75	83	36.5	36.5	NUM
dpc-4805	75	84	%	%	NOUN
dpc-4805	75	85	and	and	CCONJ
dpc-4805	75	86	32	32	NUM
dpc-4805	75	87	f	f	NOUN
dpc-4805	75	88	–	–	PUNCT
dpc-4805	75	89	56.1	56.1	NUM
dpc-4805	75	90	%	%	NOUN
dpc-4805	75	91	)	)	PUNCT
dpc-4805	75	92	,	,	PUNCT
dpc-4805	75	93	and	and	CCONJ
dpc-4805	75	94	16	16	NUM
dpc-4805	75	95	(	(	PUNCT
dpc-4805	75	96	13.3	13.3	NUM
dpc-4805	75	97	%	%	NOUN
dpc-4805	75	98	)	)	PUNCT
dpc-4805	75	99	on	on	ADP
dpc-4805	75	100	genitalia	genitalia	NOUN
dpc-4805	75	101	(	(	PUNCT
dpc-4805	75	102	7	7	NUM
dpc-4805	75	103	m	m	PROPN
dpc-4805	75	104	–	–	PUNCT
dpc-4805	75	105	11.1	11.1	NUM
dpc-4805	75	106	%	%	NOUN
dpc-4805	75	107	and	and	CCONJ
dpc-4805	75	108	9	9	NUM
dpc-4805	75	109	f	f	X
dpc-4805	75	110	–	–	PUNCT
dpc-4805	75	111	15.8	15.8	NUM
dpc-4805	75	112	%	%	NOUN
dpc-4805	75	113	)	)	PUNCT
dpc-4805	75	114	.	.	PUNCT
dpc-4805	76	1	forty	forty	NUM
dpc-4805	76	2	-	-	PUNCT
dpc-4805	76	3	one	one	NUM
dpc-4805	76	4	patients	patient	NOUN
dpc-4805	76	5	(	(	PUNCT
dpc-4805	76	6	34.2	34.2	NUM
dpc-4805	76	7	%	%	NOUN
dpc-4805	76	8	;	;	PUNCT
dpc-4805	76	9	19	19	NUM
dpc-4805	76	10	m	m	NOUN
dpc-4805	76	11	–	–	PUNCT
dpc-4805	76	12	30.1	30.1	NUM
dpc-4805	76	13	%	%	NOUN
dpc-4805	76	14	and	and	CCONJ
dpc-4805	76	15	22	22	NUM
dpc-4805	76	16	f	f	PROPN
dpc-4805	76	17	–	–	PUNCT
dpc-4805	76	18	38.6	38.6	NUM
dpc-4805	76	19	%	%	NOUN
dpc-4805	76	20	)	)	PUNCT
dpc-4805	76	21	had	have	VERB
dpc-4805	76	22	concomitant	concomitant	ADJ
dpc-4805	76	23	psa	psa	NOUN
dpc-4805	76	24	.	.	PROPN
dpc-4805	76	25	out	out	ADP
dpc-4805	76	26	of	of	ADP
dpc-4805	76	27	120	120	NUM
dpc-4805	76	28	patients	patient	NOUN
dpc-4805	76	29	,	,	PUNCT
dpc-4805	76	30	31.7	31.7	NUM
dpc-4805	76	31	%	%	NOUN
dpc-4805	76	32	(	(	PUNCT
dpc-4805	76	33	n=	n=	ADJ
dpc-4805	76	34	38	38	NUM
dpc-4805	76	35	,	,	PUNCT
dpc-4805	76	36	17	17	NUM
dpc-4805	76	37	m	m	NOUN
dpc-4805	76	38	–	–	PUNCT
dpc-4805	76	39	27	27	NUM
dpc-4805	76	40	%	%	NOUN
dpc-4805	76	41	and	and	CCONJ
dpc-4805	76	42	31	31	NUM
dpc-4805	76	43	f	f	PROPN
dpc-4805	76	44	–	–	PUNCT
dpc-4805	76	45	36.9	36.9	NUM
dpc-4805	76	46	%	%	NOUN
dpc-4805	76	47	)	)	PUNCT
dpc-4805	76	48	were	be	AUX
dpc-4805	76	49	naïve	naïve	ADJ
dpc-4805	76	50	to	to	ADP
dpc-4805	76	51	systemic	systemic	ADJ
dpc-4805	76	52	therapies	therapy	NOUN
dpc-4805	76	53	and	and	CCONJ
dpc-4805	76	54	67.5	67.5	NUM
dpc-4805	76	55	%	%	NOUN
dpc-4805	76	56	(	(	PUNCT
dpc-4805	76	57	n	n	NOUN
dpc-4805	76	58	=	=	SYM
dpc-4805	76	59	81	81	NUM
dpc-4805	76	60	,	,	PUNCT
dpc-4805	76	61	45	45	NUM
dpc-4805	76	62	m	m	NUM
dpc-4805	76	63	–	–	PUNCT
dpc-4805	76	64	71.4	71.4	NUM
dpc-4805	76	65	%	%	NOUN
dpc-4805	76	66	and	and	CCONJ
dpc-4805	76	67	36	36	NUM
dpc-4805	76	68	f	f	NOUN
dpc-4805	76	69	–	–	PUNCT
dpc-4805	76	70	63.2	63.2	NUM
dpc-4805	76	71	%	%	NOUN
dpc-4805	76	72	)	)	PUNCT
dpc-4805	76	73	were	be	AUX
dpc-4805	76	74	bio	bio	ADJ
dpc-4805	76	75	-	-	ADJ
dpc-4805	76	76	naïve	naïve	ADJ
dpc-4805	76	77	.	.	PUNCT
dpc-4805	77	1	data	datum	NOUN
dpc-4805	77	2	about	about	ADP
dpc-4805	77	3	previous	previous	ADJ
dpc-4805	77	4	systemic	systemic	ADJ
dpc-4805	77	5	or	or	CCONJ
dpc-4805	77	6	biologic	biologic	NOUN
dpc-4805	77	7	therapies	therapy	NOUN
dpc-4805	77	8	are	be	AUX
dpc-4805	77	9	reported	report	VERB
dpc-4805	77	10	in	in	ADP
dpc-4805	77	11	table	table	NOUN
dpc-4805	77	12	1	1	NUM
dpc-4805	77	13	.	.	PUNCT
dpc-4805	78	1	the	the	DET
dpc-4805	78	2	mean	mean	ADJ
dpc-4805	78	3	duration	duration	NOUN
dpc-4805	78	4	of	of	ADP
dpc-4805	78	5	therapy	therapy	NOUN
dpc-4805	78	6	with	with	ADP
dpc-4805	78	7	apremilast	apremilast	PROPN
dpc-4805	78	8	expressed	express	VERB
dpc-4805	78	9	in	in	ADP
dpc-4805	78	10	months	month	NOUN
dpc-4805	78	11	was	be	AUX
dpc-4805	78	12	25.2	25.2	NUM
dpc-4805	78	13	±	±	NUM
dpc-4805	78	14	19.4	19.4	NUM
dpc-4805	78	15	(	(	PUNCT
dpc-4805	78	16	28.4	28.4	NUM
dpc-4805	78	17	±	±	NUM
dpc-4805	78	18	20.9	20.9	NUM
dpc-4805	78	19	in	in	ADP
dpc-4805	78	20	males	male	NOUN
dpc-4805	78	21	and	and	CCONJ
dpc-4805	78	22	21.5	21.5	NUM
dpc-4805	78	23	±	±	NUM
dpc-4805	78	24	17.1	17.1	NUM
dpc-4805	78	25	in	in	ADP
dpc-4805	78	26	females	female	NOUN
dpc-4805	78	27	)	)	PUNCT
dpc-4805	78	28	.	.	PUNCT
dpc-4805	79	1	the	the	DET
dpc-4805	79	2	mean	mean	ADJ
dpc-4805	79	3	baseline	baseline	PROPN
dpc-4805	79	4	pasi	pasi	NOUN
dpc-4805	79	5	score	score	NOUN
dpc-4805	79	6	for	for	ADP
dpc-4805	79	7	all	all	DET
dpc-4805	79	8	patients	patient	NOUN
dpc-4805	79	9	was	be	AUX
dpc-4805	79	10	10.1	10.1	NUM
dpc-4805	79	11	±	±	NUM
dpc-4805	79	12	3.39	3.39	NUM
dpc-4805	79	13	with	with	ADP
dpc-4805	79	14	higher	high	ADJ
dpc-4805	79	15	values	value	NOUN
dpc-4805	79	16	in	in	ADP
dpc-4805	79	17	males	male	NOUN
dpc-4805	79	18	(	(	PUNCT
dpc-4805	79	19	10.7	10.7	NUM
dpc-4805	79	20	±	±	NUM
dpc-4805	79	21	4.8	4.8	NUM
dpc-4805	79	22	)	)	PUNCT
dpc-4805	79	23	than	than	ADP
dpc-4805	79	24	females	female	NOUN
dpc-4805	79	25	(	(	PUNCT
dpc-4805	79	26	9.75	9.75	NUM
dpc-4805	79	27	±	±	NUM
dpc-4805	79	28	1.17	1.17	NUM
dpc-4805	79	29	)	)	PUNCT
dpc-4805	79	30	.	.	PUNCT
dpc-4805	80	1	because	because	SCONJ
dpc-4805	80	2	the	the	DET
dpc-4805	80	3	focus	focus	NOUN
dpc-4805	80	4	of	of	ADP
dpc-4805	80	5	the	the	DET
dpc-4805	80	6	study	study	NOUN
dpc-4805	80	7	was	be	AUX
dpc-4805	80	8	to	to	PART
dpc-4805	80	9	assess	assess	VERB
dpc-4805	80	10	changes	change	NOUN
dpc-4805	80	11	in	in	ADP
dpc-4805	80	12	weight	weight	NOUN
dpc-4805	80	13	and	and	CCONJ
dpc-4805	80	14	bmi	bmi	NOUN
dpc-4805	80	15	according	accord	VERB
dpc-4805	80	16	to	to	ADP
dpc-4805	80	17	the	the	DET
dpc-4805	80	18	gender	gender	NOUN
dpc-4805	80	19	of	of	ADP
dpc-4805	80	20	enrolled	enrol	VERB
dpc-4805	80	21	patients	patient	NOUN
dpc-4805	80	22	,	,	PUNCT
dpc-4805	80	23	pasi	pasi	NOUN
dpc-4805	80	24	values	value	NOUN
dpc-4805	80	25	were	be	AUX
dpc-4805	80	26	not	not	PART
dpc-4805	80	27	analyzed	analyze	VERB
dpc-4805	80	28	at	at	ADP
dpc-4805	80	29	w24	w24	PROPN
dpc-4805	80	30	and	and	CCONJ
dpc-4805	80	31	w48	w48	NOUN
dpc-4805	80	32	.	.	PUNCT
dpc-4805	81	1	patients	patient	NOUN
dpc-4805	81	2	baseline	baseline	VERB
dpc-4805	81	3	characteristics	characteristic	NOUN
dpc-4805	81	4	are	be	AUX
dpc-4805	81	5	reported	report	VERB
dpc-4805	81	6	in	in	ADP
dpc-4805	81	7	table	table	NOUN
dpc-4805	81	8	1	1	NUM
dpc-4805	81	9	.	.	PUNCT
dpc-4805	82	1	in	in	ADP
dpc-4805	82	2	male	male	ADJ
dpc-4805	82	3	patients	patient	NOUN
dpc-4805	82	4	,	,	PUNCT
dpc-4805	82	5	the	the	DET
dpc-4805	82	6	average	average	ADJ
dpc-4805	82	7	weight	weight	NOUN
dpc-4805	82	8	was	be	AUX
dpc-4805	82	9	87.1	87.1	NUM
dpc-4805	82	10	±	±	NUM
dpc-4805	82	11	19.7	19.7	NUM
dpc-4805	82	12	kg	kg	NOUN
dpc-4805	82	13	at	at	ADP
dpc-4805	82	14	baseline	baseline	NOUN
dpc-4805	82	15	,	,	PUNCT
dpc-4805	82	16	86.8	86.8	NUM
dpc-4805	82	17	±	±	NUM
dpc-4805	82	18	19.5	19.5	NUM
dpc-4805	82	19	kg	kg	NOUN
dpc-4805	82	20	at	at	ADP
dpc-4805	82	21	week	week	NOUN
dpc-4805	82	22	24	24	NUM
dpc-4805	82	23	,	,	PUNCT
dpc-4805	82	24	and	and	CCONJ
dpc-4805	82	25	87	87	NUM
dpc-4805	82	26	 	 	SPACE
dpc-4805	82	27	±	±	NUM
dpc-4805	82	28	20.1	20.1	NUM
dpc-4805	82	29	kg	kg	NOUN
dpc-4805	82	30	at	at	ADP
dpc-4805	82	31	week	week	NOUN
dpc-4805	82	32	48	48	NUM
dpc-4805	82	33	,	,	PUNCT
dpc-4805	82	34	with	with	ADP
dpc-4805	82	35	a	a	DET
dpc-4805	82	36	corresponding	corresponding	ADJ
dpc-4805	82	37	bmi	bmi	NOUN
dpc-4805	82	38	of	of	ADP
dpc-4805	82	39	24.8	24.8	NUM
dpc-4805	82	40	±	±	NUM
dpc-4805	82	41	5.1	5.1	NUM
dpc-4805	82	42	at	at	ADP
dpc-4805	82	43	baseline	baseline	NOUN
dpc-4805	82	44	,	,	PUNCT
dpc-4805	82	45	24.7	24.7	NUM
dpc-4805	82	46	±	±	NUM
dpc-4805	82	47	5.1	5.1	NUM
dpc-4805	82	48	at	at	ADP
dpc-4805	82	49	week	week	NOUN
dpc-4805	82	50	24	24	NUM
dpc-4805	82	51	,	,	PUNCT
dpc-4805	82	52	and	and	CCONJ
dpc-4805	82	53	24.6	24.6	NUM
dpc-4805	82	54	±	±	NUM
dpc-4805	82	55	5.3	5.3	NUM
dpc-4805	82	56	at	at	ADP
dpc-4805	82	57	week	week	NOUN
dpc-4805	82	58	  	  	SPACE
dpc-4805	82	59	48	48	NUM
dpc-4805	82	60	.	.	PUNCT
dpc-4805	83	1	for	for	ADP
dpc-4805	83	2	women	woman	NOUN
dpc-4805	83	3	,	,	PUNCT
dpc-4805	83	4	the	the	DET
dpc-4805	83	5	average	average	ADJ
dpc-4805	83	6	weight	weight	NOUN
dpc-4805	83	7	decreased	decrease	VERB
dpc-4805	83	8	from	from	ADP
dpc-4805	83	9	72.1	72.1	NUM
dpc-4805	83	10	±	±	NUM
dpc-4805	83	11	15.6	15.6	NUM
dpc-4805	83	12	kg	kg	NOUN
dpc-4805	83	13	at	at	ADP
dpc-4805	83	14	baseline	baseline	NOUN
dpc-4805	83	15	to	to	ADP
dpc-4805	83	16	69.6	69.6	NUM
dpc-4805	83	17	±	±	NUM
dpc-4805	83	18	15.3	15.3	NUM
dpc-4805	83	19	kg	kg	NOUN
dpc-4805	83	20	at	at	ADP
dpc-4805	83	21	week	week	NOUN
dpc-4805	83	22	24	24	NUM
dpc-4805	83	23	,	,	PUNCT
dpc-4805	83	24	and	and	CCONJ
dpc-4805	83	25	further	far	ADV
dpc-4805	83	26	to	to	ADP
dpc-4805	83	27	66.4	66.4	NUM
dpc-4805	83	28	±	±	NUM
dpc-4805	83	29	15.7	15.7	NUM
dpc-4805	83	30	kg	kg	NOUN
dpc-4805	83	31	at	at	ADP
dpc-4805	83	32	week	week	NOUN
dpc-4805	83	33	48	48	NUM
dpc-4805	83	34	.	.	PUNCT
dpc-4805	84	1	their	their	PRON
dpc-4805	84	2	mean	mean	ADJ
dpc-4805	84	3	bmi	bmi	NOUN
dpc-4805	84	4	followed	follow	VERB
dpc-4805	84	5	a	a	DET
dpc-4805	84	6	similar	similar	ADJ
dpc-4805	84	7	trend	trend	NOUN
dpc-4805	84	8	,	,	PUNCT
dpc-4805	84	9	starting	start	VERB
dpc-4805	84	10	at	at	ADP
dpc-4805	84	11	22.3	22.3	NUM
dpc-4805	84	12	±	±	NUM
dpc-4805	84	13	4.9	4.9	NUM
dpc-4805	84	14	at	at	ADP
dpc-4805	84	15	baseline	baseline	NOUN
dpc-4805	84	16	,	,	PUNCT
dpc-4805	84	17	dropping	drop	VERB
dpc-4805	84	18	to	to	ADP
dpc-4805	84	19	21.5	21.5	NUM
dpc-4805	84	20	±	±	NUM
dpc-4805	84	21	4.8	4.8	NUM
dpc-4805	84	22	at	at	ADP
dpc-4805	84	23	week	week	NOUN
dpc-4805	84	24	24	24	NUM
dpc-4805	84	25	,	,	PUNCT
dpc-4805	84	26	and	and	CCONJ
dpc-4805	84	27	reaching	reach	VERB
dpc-4805	84	28	20.5	20.5	NUM
dpc-4805	84	29	±	±	NUM
dpc-4805	84	30	5.1	5.1	NUM
dpc-4805	84	31	at	at	ADP
dpc-4805	84	32	week	week	NOUN
dpc-4805	84	33	48	48	NUM
dpc-4805	84	34	.	.	PUNCT
dpc-4805	85	1	the	the	DET
dpc-4805	85	2	most	most	ADV
dpc-4805	85	3	notable	notable	ADJ
dpc-4805	85	4	changes	change	NOUN
dpc-4805	85	5	were	be	AUX
dpc-4805	85	6	observed	observe	VERB
dpc-4805	85	7	in	in	ADP
dpc-4805	85	8	women	woman	NOUN
dpc-4805	85	9	,	,	PUNCT
dpc-4805	85	10	with	with	ADP
dpc-4805	85	11	a	a	DET
dpc-4805	85	12	more	more	ADV
dpc-4805	85	13	significant	significant	ADJ
dpc-4805	85	14	reduction	reduction	NOUN
dpc-4805	85	15	in	in	ADP
dpc-4805	85	16	both	both	DET
dpc-4805	85	17	weight	weight	NOUN
dpc-4805	85	18	and	and	CCONJ
dpc-4805	85	19	bmi	bmi	NOUN
dpc-4805	85	20	over	over	ADP
dpc-4805	85	21	time	time	NOUN
dpc-4805	85	22	.	.	PUNCT
dpc-4805	86	1	values	value	NOUN
dpc-4805	86	2	about	about	ADP
dpc-4805	86	3	weight	weight	NOUN
dpc-4805	86	4	and	and	CCONJ
dpc-4805	86	5	bmi	bmi	NOUN
dpc-4805	86	6	are	be	AUX
dpc-4805	86	7	reported	report	VERB
dpc-4805	86	8	in	in	ADP
dpc-4805	86	9	table	table	NOUN
dpc-4805	86	10	2	2	NUM
dpc-4805	86	11	.	.	PUNCT
dpc-4805	87	1	the	the	DET
dpc-4805	87	2	analysis	analysis	NOUN
dpc-4805	87	3	showed	show	VERB
dpc-4805	87	4	a	a	DET
dpc-4805	87	5	significant	significant	ADJ
dpc-4805	87	6	reduction	reduction	NOUN
dpc-4805	87	7	in	in	ADP
dpc-4805	87	8	body	body	NOUN
dpc-4805	87	9	weight	weight	NOUN
dpc-4805	87	10	in	in	ADP
dpc-4805	87	11	females	female	NOUN
dpc-4805	87	12	at	at	ADP
dpc-4805	87	13	w24	w24	PROPN
dpc-4805	87	14	and	and	CCONJ
dpc-4805	87	15	w48	w48	NOUN
dpc-4805	87	16	(	(	PUNCT
dpc-4805	87	17	p	p	X
dpc-4805	87	18	<	<	X
dpc-4805	87	19	0.001	0.001	NUM
dpc-4805	87	20	)	)	PUNCT
dpc-4805	87	21	,	,	PUNCT
dpc-4805	87	22	with	with	ADP
dpc-4805	87	23	a	a	DET
dpc-4805	87	24	mean	mean	ADJ
dpc-4805	87	25	difference	difference	NOUN
dpc-4805	87	26	of	of	ADP
dpc-4805	87	27	−2.6	−2.6	PROPN
dpc-4805	87	28	kg	kg	X
dpc-4805	87	29	(	(	PUNCT
dpc-4805	87	30	95	95	NUM
dpc-4805	87	31	%	%	NOUN
dpc-4805	87	32	confidence	confidence	NOUN
dpc-4805	87	33	interval	interval	NOUN
dpc-4805	87	34	[	[	X
dpc-4805	87	35	ci	ci	X
dpc-4805	87	36	]	]	X
dpc-4805	87	37	−15	−15	NOUN
dpc-4805	87	38	;	;	PUNCT
dpc-4805	87	39	−0.2	−0.2	PROPN
dpc-4805	87	40	)	)	PUNCT
dpc-4805	87	41	at	at	ADP
dpc-4805	87	42	w24	w24	PROPN
dpc-4805	87	43	and	and	CCONJ
dpc-4805	87	44	of	of	ADP
dpc-4805	87	45	-5.7	-5.7	NOUN
dpc-4805	87	46	kg	kg	NOUN
dpc-4805	87	47	;	;	PUNCT
dpc-4805	87	48	(	(	PUNCT
dpc-4805	87	49	95	95	NUM
dpc-4805	87	50	%	%	NOUN
dpc-4805	87	51	ci	ci	PROPN
dpc-4805	87	52	−15	−15	NOUN
dpc-4805	87	53	;	;	PUNCT
dpc-4805	87	54	−3	−3	X
dpc-4805	87	55	)	)	PUNCT
dpc-4805	87	56	at	at	ADP
dpc-4805	87	57	w48	w48	NOUN
dpc-4805	87	58	.	.	PUNCT
dpc-4805	88	1	we	we	PRON
dpc-4805	88	2	observed	observe	VERB
dpc-4805	88	3	a	a	DET
dpc-4805	88	4	reduction	reduction	NOUN
dpc-4805	88	5	of	of	ADP
dpc-4805	88	6	weight	weight	NOUN
dpc-4805	88	7	of	of	ADP
dpc-4805	88	8	3.6	3.6	NUM
dpc-4805	88	9	%	%	NOUN
dpc-4805	88	10	at	at	ADP
dpc-4805	88	11	w24	w24	PROPN
dpc-4805	88	12	(	(	PUNCT
dpc-4805	88	13	p	p	X
dpc-4805	88	14	<	<	X
dpc-4805	88	15	0.001	0.001	NUM
dpc-4805	88	16	)	)	PUNCT
dpc-4805	88	17	,	,	PUNCT
dpc-4805	88	18	and	and	CCONJ
dpc-4805	88	19	7.9	7.9	NUM
dpc-4805	88	20	%	%	NOUN
dpc-4805	88	21	at	at	ADP
dpc-4805	88	22	w48	w48	NOUN
dpc-4805	88	23	(	(	PUNCT
dpc-4805	88	24	p	p	X
dpc-4805	88	25	<	<	X
dpc-4805	88	26	0.001	0.001	NUM
dpc-4805	88	27	)	)	PUNCT
dpc-4805	88	28	.	.	PUNCT
dpc-4805	89	1	similar	similar	ADJ
dpc-4805	89	2	assessments	assessment	NOUN
dpc-4805	89	3	were	be	AUX
dpc-4805	89	4	also	also	ADV
dpc-4805	89	5	observed	observe	VERB
dpc-4805	89	6	for	for	ADP
dpc-4805	89	7	bmi	bmi	NOUN
dpc-4805	89	8	,	,	PUNCT
dpc-4805	89	9	which	which	PRON
dpc-4805	89	10	was	be	AUX
dpc-4805	89	11	reduced	reduce	VERB
dpc-4805	89	12	in	in	ADP
dpc-4805	89	13	women	woman	NOUN
dpc-4805	89	14	by	by	ADP
dpc-4805	89	15	3.6	3.6	NUM
dpc-4805	89	16	%	%	NOUN
dpc-4805	89	17	at	at	ADP
dpc-4805	89	18	w24	w24	PROPN
dpc-4805	89	19	and	and	CCONJ
dpc-4805	89	20	8	8	NUM
dpc-4805	89	21	%	%	NOUN
dpc-4805	89	22	at	at	ADP
dpc-4805	89	23	w48	w48	NOUN
dpc-4805	89	24	(	(	PUNCT
dpc-4805	89	25	p	p	X
dpc-4805	89	26	<	<	X
dpc-4805	89	27	0.001	0.001	NUM
dpc-4805	89	28	)	)	PUNCT
dpc-4805	89	29	(	(	PUNCT
dpc-4805	89	30	figure	figure	NOUN
dpc-4805	89	31	2	2	NUM
dpc-4805	89	32	)	)	PUNCT
dpc-4805	89	33	.	.	PUNCT
dpc-4805	90	1	in	in	ADP
dpc-4805	90	2	men	man	NOUN
dpc-4805	90	3	,	,	PUNCT
dpc-4805	90	4	no	no	DET
dpc-4805	90	5	changes	change	NOUN
dpc-4805	90	6	in	in	ADP
dpc-4805	90	7	weight	weight	NOUN
dpc-4805	90	8	and	and	CCONJ
dpc-4805	90	9	bmi	bmi	NOUN
dpc-4805	90	10	were	be	AUX
dpc-4805	90	11	observed	observe	VERB
dpc-4805	90	12	at	at	ADP
dpc-4805	90	13	w24	w24	PROPN
dpc-4805	90	14	and/or	and/or	CCONJ
dpc-4805	90	15	w48	w48	NOUN
dpc-4805	90	16	,	,	PUNCT
dpc-4805	90	17	and	and	CCONJ
dpc-4805	90	18	the	the	DET
dpc-4805	90	19	values	value	NOUN
dpc-4805	90	20	remained	remain	VERB
dpc-4805	90	21	almost	almost	ADV
dpc-4805	90	22	unchanged	unchanged	ADJ
dpc-4805	90	23	(	(	PUNCT
dpc-4805	90	24	figures	figure	NOUN
dpc-4805	90	25	1	1	NUM
dpc-4805	90	26	and	and	CCONJ
dpc-4805	90	27	2	2	NUM
dpc-4805	90	28	)	)	PUNCT
dpc-4805	90	29	.	.	PUNCT
dpc-4805	91	1	conclusions	conclusion	NOUN
dpc-4805	91	2	in	in	ADP
dpc-4805	91	3	our	our	PRON
dpc-4805	91	4	research	research	NOUN
dpc-4805	91	5	,	,	PUNCT
dpc-4805	91	6	we	we	PRON
dpc-4805	91	7	detected	detect	VERB
dpc-4805	91	8	a	a	DET
dpc-4805	91	9	notable	notable	ADJ
dpc-4805	91	10	decrease	decrease	NOUN
dpc-4805	91	11	in	in	ADP
dpc-4805	91	12	both	both	DET
dpc-4805	91	13	mean	mean	VERB
dpc-4805	91	14	weight	weight	NOUN
dpc-4805	91	15	and	and	CCONJ
dpc-4805	91	16	bmi	bmi	NOUN
dpc-4805	91	17	in	in	ADP
dpc-4805	91	18	women	woman	NOUN
dpc-4805	91	19	treated	treat	VERB
dpc-4805	91	20	with	with	ADP
dpc-4805	91	21	apremilast	apremilast	NOUN
dpc-4805	91	22	.	.	PUNCT
dpc-4805	92	1	we	we	PRON
dpc-4805	92	2	observed	observe	VERB
dpc-4805	92	3	a	a	DET
dpc-4805	92	4	steady	steady	ADJ
dpc-4805	92	5	trend	trend	NOUN
dpc-4805	92	6	of	of	ADP
dpc-4805	92	7	weight	weight	NOUN
dpc-4805	92	8	reduction	reduction	NOUN
dpc-4805	92	9	as	as	ADV
dpc-4805	92	10	early	early	ADV
dpc-4805	92	11	as	as	ADP
dpc-4805	92	12	w24	w24	NUM
dpc-4805	92	13	and	and	CCONJ
dpc-4805	92	14	almost	almost	ADV
dpc-4805	92	15	doubled	double	VERB
dpc-4805	92	16	at	at	ADP
dpc-4805	92	17	w48	w48	NOUN
dpc-4805	92	18	.	.	PUNCT
dpc-4805	93	1	weight	weight	NOUN
dpc-4805	93	2	loss	loss	NOUN
dpc-4805	93	3	was	be	AUX
dpc-4805	93	4	higher	high	ADJ
dpc-4805	93	5	in	in	ADP
dpc-4805	93	6	overweight	overweight	ADJ
dpc-4805	93	7	patients	patient	NOUN
dpc-4805	93	8	who	who	PRON
dpc-4805	93	9	reported	report	VERB
dpc-4805	93	10	mean	mean	ADJ
dpc-4805	93	11	changes	change	NOUN
dpc-4805	93	12	of	of	ADP
dpc-4805	93	13	about	about	ADV
dpc-4805	93	14	12	12	NUM
dpc-4805	93	15	 	 	SPACE
dpc-4805	93	16	kg	kg	NOUN
dpc-4805	93	17	at	at	ADP
dpc-4805	93	18	both	both	DET
dpc-4805	93	19	w24	w24	PROPN
dpc-4805	93	20	and	and	CCONJ
dpc-4805	93	21	w48	w48	NOUN
dpc-4805	93	22	.	.	PUNCT
dpc-4805	94	1	however	however	ADV
dpc-4805	94	2	,	,	PUNCT
dpc-4805	94	3	given	give	VERB
dpc-4805	94	4	the	the	DET
dpc-4805	94	5	documented	document	VERB
dpc-4805	94	6	correlation	correlation	NOUN
dpc-4805	94	7	between	between	ADP
dpc-4805	94	8	weight	weight	NOUN
dpc-4805	94	9	loss	loss	NOUN
dpc-4805	94	10	and	and	CCONJ
dpc-4805	94	11	apremilast	apremilast	ADJ
dpc-4805	94	12	use	use	NOUN
dpc-4805	94	13	and	and	CCONJ
dpc-4805	94	14	the	the	DET
dpc-4805	94	15	potential	potential	ADJ
dpc-4805	94	16	risks	risk	NOUN
dpc-4805	94	17	associated	associate	VERB
dpc-4805	94	18	with	with	ADP
dpc-4805	94	19	substantial	substantial	ADJ
dpc-4805	94	20	weight	weight	NOUN
dpc-4805	94	21	reduction	reduction	NOUN
dpc-4805	94	22	,	,	PUNCT
dpc-4805	94	23	4	4	NUM
dpc-4805	94	24	original	original	ADJ
dpc-4805	94	25	article	article	NOUN
dpc-4805	94	26	|	|	ADV
dpc-4805	94	27	dermatol	dermatol	ADJ
dpc-4805	94	28	pract	pract	NOUN
dpc-4805	94	29	concept	concept	NOUN
dpc-4805	94	30	.	.	PUNCT
dpc-4805	95	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	95	2	table	table	NOUN
dpc-4805	95	3	1	1	NUM
dpc-4805	95	4	.	.	PUNCT
dpc-4805	95	5	demographic	demographic	ADJ
dpc-4805	95	6	and	and	CCONJ
dpc-4805	95	7	medical	medical	ADJ
dpc-4805	95	8	history	history	NOUN
dpc-4805	95	9	data	datum	NOUN
dpc-4805	95	10	at	at	ADP
dpc-4805	95	11	baseline	baseline	NOUN
dpc-4805	95	12	of	of	ADP
dpc-4805	95	13	patients	patient	NOUN
dpc-4805	95	14	enrolled	enrol	VERB
dpc-4805	95	15	all	all	DET
dpc-4805	95	16	patients	patient	NOUN
dpc-4805	95	17	(	(	PUNCT
dpc-4805	95	18	100	100	NUM
dpc-4805	95	19	%	%	NOUN
dpc-4805	95	20	n	n	NOUN
dpc-4805	95	21	=	=	SYM
dpc-4805	95	22	120	120	NUM
dpc-4805	95	23	)	)	PUNCT
dpc-4805	95	24	males	male	NOUN
dpc-4805	95	25	(	(	PUNCT
dpc-4805	95	26	52.5	52.5	NUM
dpc-4805	95	27	%	%	NOUN
dpc-4805	95	28	n	n	NOUN
dpc-4805	95	29	=	=	SYM
dpc-4805	95	30	63	63	NUM
dpc-4805	95	31	)	)	PUNCT
dpc-4805	95	32	females	female	NOUN
dpc-4805	95	33	(	(	PUNCT
dpc-4805	95	34	47.5	47.5	NUM
dpc-4805	95	35	%	%	NOUN
dpc-4805	95	36	n	n	NOUN
dpc-4805	95	37	=	=	SYM
dpc-4805	95	38	57	57	NUM
dpc-4805	95	39	)	)	PUNCT
dpc-4805	95	40	age	age	NOUN
dpc-4805	95	41	(	(	PUNCT
dpc-4805	95	42	years	year	NOUN
dpc-4805	95	43	)	)	PUNCT
dpc-4805	95	44	63.5	63.5	NUM
dpc-4805	95	45	±	±	NUM
dpc-4805	95	46	6.3	6.3	NUM
dpc-4805	95	47	64.4	64.4	NUM
dpc-4805	95	48	±	±	NUM
dpc-4805	95	49	13.2	13.2	NUM
dpc-4805	95	50	62.6	62.6	NUM
dpc-4805	95	51	±	±	NUM
dpc-4805	95	52	11.7	11.7	NUM
dpc-4805	95	53	weight	weight	NOUN
dpc-4805	95	54	(	(	PUNCT
dpc-4805	95	55	kg	kg	NOUN
dpc-4805	95	56	)	)	PUNCT
dpc-4805	95	57	79.9	79.9	NUM
dpc-4805	95	58	±	±	NUM
dpc-4805	95	59	19.3	19.3	NUM
dpc-4805	95	60	kg	kg	PROPN
dpc-4805	95	61	87.1	87.1	NUM
dpc-4805	95	62	±	±	NUM
dpc-4805	95	63	19.7	19.7	NUM
dpc-4805	95	64	kg	kg	NOUN
dpc-4805	95	65	72.1	72.1	NUM
dpc-4805	95	66	±	±	NUM
dpc-4805	95	67	15.6	15.6	NUM
dpc-4805	95	68	bmi	bmi	NOUN
dpc-4805	95	69	23.6	23.6	NUM
dpc-4805	95	70	±	±	NUM
dpc-4805	95	71	4.9	4.9	NUM
dpc-4805	95	72	24.8	24.8	NUM
dpc-4805	95	73	±	±	NUM
dpc-4805	95	74	5.1	5.1	NUM
dpc-4805	95	75	22.3	22.3	NUM
dpc-4805	95	76	±	±	NUM
dpc-4805	95	77	4.9	4.9	NUM
dpc-4805	95	78	duration	duration	NOUN
dpc-4805	95	79	of	of	ADP
dpc-4805	95	80	disease	disease	NOUN
dpc-4805	95	81	(	(	PUNCT
dpc-4805	95	82	years	year	NOUN
dpc-4805	95	83	)	)	PUNCT
dpc-4805	95	84	21.9	21.9	NUM
dpc-4805	95	85	±	±	NUM
dpc-4805	95	86	0.7	0.7	NUM
dpc-4805	95	87	23.2	23.2	NUM
dpc-4805	95	88	±14.9	±14.9	NUM
dpc-4805	95	89	20.2	20.2	NUM
dpc-4805	95	90	±	±	NUM
dpc-4805	95	91	13.7	13.7	NUM
dpc-4805	95	92	mean	mean	NOUN
dpc-4805	95	93	pasi	pasi	NOUN
dpc-4805	95	94	10.1	10.1	NUM
dpc-4805	95	95	±	±	NUM
dpc-4805	95	96	3.39	3.39	NUM
dpc-4805	95	97	10.7	10.7	NUM
dpc-4805	95	98	±	±	NUM
dpc-4805	95	99	4.8	4.8	NUM
dpc-4805	95	100	9.75	9.75	NUM
dpc-4805	95	101	±	±	NUM
dpc-4805	95	102	1.17	1.17	NUM
dpc-4805	95	103	smoke	smoke	NOUN
dpc-4805	95	104	•	•	ADP
dpc-4805	95	105	current	current	ADJ
dpc-4805	95	106	•	•	ADV
dpc-4805	95	107	former	former	ADJ
dpc-4805	95	108	•	•	NOUN
dpc-4805	95	109	no	no	DET
dpc-4805	95	110	24.2	24.2	NUM
dpc-4805	95	111	%	%	NOUN
dpc-4805	95	112	(	(	PUNCT
dpc-4805	95	113	29	29	NUM
dpc-4805	95	114	)	)	PUNCT
dpc-4805	95	115	20.8	20.8	NUM
dpc-4805	95	116	%	%	NOUN
dpc-4805	95	117	(	(	PUNCT
dpc-4805	95	118	25	25	NUM
dpc-4805	95	119	)	)	PUNCT
dpc-4805	95	120	55	55	NUM
dpc-4805	95	121	%	%	NOUN
dpc-4805	95	122	(	(	PUNCT
dpc-4805	95	123	66	66	NUM
dpc-4805	95	124	)	)	PUNCT
dpc-4805	95	125	25.4	25.4	NUM
dpc-4805	95	126	%	%	NOUN
dpc-4805	95	127	(	(	PUNCT
dpc-4805	95	128	16	16	NUM
dpc-4805	95	129	)	)	PUNCT
dpc-4805	95	130	30.1	30.1	NUM
dpc-4805	95	131	%	%	NOUN
dpc-4805	95	132	(	(	PUNCT
dpc-4805	95	133	19	19	NUM
dpc-4805	95	134	)	)	PUNCT
dpc-4805	95	135	44.4	44.4	NUM
dpc-4805	95	136	%	%	NOUN
dpc-4805	95	137	(	(	PUNCT
dpc-4805	95	138	28	28	NUM
dpc-4805	95	139	)	)	PUNCT
dpc-4805	95	140	22.8	22.8	NUM
dpc-4805	95	141	%	%	NOUN
dpc-4805	95	142	(	(	PUNCT
dpc-4805	95	143	13	13	NUM
dpc-4805	95	144	)	)	PUNCT
dpc-4805	95	145	10.5	10.5	NUM
dpc-4805	95	146	%	%	NOUN
dpc-4805	95	147	(	(	PUNCT
dpc-4805	95	148	6	6	NUM
dpc-4805	95	149	)	)	PUNCT
dpc-4805	95	150	66.6	66.6	NUM
dpc-4805	95	151	%	%	NOUN
dpc-4805	95	152	(	(	PUNCT
dpc-4805	95	153	38	38	NUM
dpc-4805	95	154	)	)	PUNCT
dpc-4805	95	155	alcohol	alcohol	NOUN
dpc-4805	95	156	•	•	NOUN
dpc-4805	96	1	yes	yes	INTJ
dpc-4805	96	2	(	(	PUNCT
dpc-4805	96	3	occasional	occasional	ADJ
dpc-4805	96	4	)	)	PUNCT
dpc-4805	96	5	•	•	NOUN
dpc-4805	96	6	no	no	DET
dpc-4805	96	7	30	30	NUM
dpc-4805	96	8	%	%	NOUN
dpc-4805	96	9	(	(	PUNCT
dpc-4805	96	10	36	36	NUM
dpc-4805	96	11	)	)	PUNCT
dpc-4805	96	12	70	70	NUM
dpc-4805	96	13	%	%	NOUN
dpc-4805	96	14	(	(	PUNCT
dpc-4805	96	15	84	84	NUM
dpc-4805	96	16	)	)	PUNCT
dpc-4805	96	17	36.5	36.5	NUM
dpc-4805	96	18	%	%	NOUN
dpc-4805	96	19	(	(	PUNCT
dpc-4805	96	20	23	23	NUM
dpc-4805	96	21	)	)	PUNCT
dpc-4805	96	22	63.5	63.5	NUM
dpc-4805	96	23	%	%	NOUN
dpc-4805	96	24	(	(	PUNCT
dpc-4805	96	25	40	40	NUM
dpc-4805	96	26	)	)	PUNCT
dpc-4805	96	27	22.8	22.8	NUM
dpc-4805	96	28	%	%	NOUN
dpc-4805	96	29	(	(	PUNCT
dpc-4805	96	30	13	13	NUM
dpc-4805	96	31	)	)	PUNCT
dpc-4805	96	32	77.2	77.2	NUM
dpc-4805	96	33	%	%	NOUN
dpc-4805	96	34	(	(	PUNCT
dpc-4805	96	35	44	44	NUM
dpc-4805	96	36	)	)	PUNCT
dpc-4805	96	37	special	special	ADJ
dpc-4805	96	38	sites	site	NOUN
dpc-4805	96	39	•	•	NUM
dpc-4805	96	40	scalp	scalp	NOUN
dpc-4805	96	41	•	•	NUM
dpc-4805	96	42	palms	palm	NOUN
dpc-4805	96	43	/	/	SYM
dpc-4805	96	44	soles	sol	NOUN
dpc-4805	96	45	•	•	NOUN
dpc-4805	96	46	nails	nail	NOUN
dpc-4805	96	47	•	•	NOUN
dpc-4805	96	48	genitalia	genitalia	NOUN
dpc-4805	96	49	45.8	45.8	NUM
dpc-4805	96	50	%	%	NOUN
dpc-4805	96	51	(	(	PUNCT
dpc-4805	96	52	55	55	NUM
dpc-4805	96	53	)	)	PUNCT
dpc-4805	96	54	25	25	NUM
dpc-4805	96	55	%	%	NOUN
dpc-4805	96	56	(	(	PUNCT
dpc-4805	96	57	30	30	NUM
dpc-4805	96	58	)	)	PUNCT
dpc-4805	96	59	25	25	NUM
dpc-4805	96	60	%	%	NOUN
dpc-4805	96	61	(	(	PUNCT
dpc-4805	96	62	30	30	NUM
dpc-4805	96	63	)	)	PUNCT
dpc-4805	96	64	13.3	13.3	NUM
dpc-4805	96	65	%	%	NOUN
dpc-4805	96	66	(	(	PUNCT
dpc-4805	96	67	16	16	NUM
dpc-4805	96	68	)	)	PUNCT
dpc-4805	96	69	36.5	36.5	NUM
dpc-4805	96	70	%	%	NOUN
dpc-4805	96	71	(	(	PUNCT
dpc-4805	96	72	23	23	NUM
dpc-4805	96	73	)	)	PUNCT
dpc-4805	96	74	17.5	17.5	NUM
dpc-4805	96	75	%	%	NOUN
dpc-4805	96	76	(	(	PUNCT
dpc-4805	96	77	11	11	NUM
dpc-4805	96	78	)	)	PUNCT
dpc-4805	96	79	23.8	23.8	NUM
dpc-4805	96	80	%	%	NOUN
dpc-4805	96	81	(	(	PUNCT
dpc-4805	96	82	15	15	NUM
dpc-4805	96	83	)	)	PUNCT
dpc-4805	96	84	11.1	11.1	NUM
dpc-4805	96	85	%	%	NOUN
dpc-4805	96	86	(	(	PUNCT
dpc-4805	96	87	7	7	NUM
dpc-4805	96	88	)	)	PUNCT
dpc-4805	96	89	56.1	56.1	NUM
dpc-4805	96	90	%	%	NOUN
dpc-4805	96	91	(	(	PUNCT
dpc-4805	96	92	32	32	NUM
dpc-4805	96	93	)	)	PUNCT
dpc-4805	96	94	33.3	33.3	NUM
dpc-4805	96	95	%	%	NOUN
dpc-4805	96	96	(	(	PUNCT
dpc-4805	96	97	19	19	NUM
dpc-4805	96	98	)	)	PUNCT
dpc-4805	96	99	26.3	26.3	NUM
dpc-4805	96	100	(	(	PUNCT
dpc-4805	96	101	15	15	NUM
dpc-4805	96	102	)	)	PUNCT
dpc-4805	96	103	15.8	15.8	NUM
dpc-4805	96	104	%	%	NOUN
dpc-4805	96	105	(	(	PUNCT
dpc-4805	96	106	9	9	NUM
dpc-4805	96	107	)	)	PUNCT
dpc-4805	96	108	psoriatic	psoriatic	ADJ
dpc-4805	96	109	arthritis	arthritis	NOUN
dpc-4805	96	110	(	(	PUNCT
dpc-4805	96	111	psa	psa	NOUN
dpc-4805	96	112	)	)	PUNCT
dpc-4805	96	113	34.2	34.2	NUM
dpc-4805	96	114	%	%	NOUN
dpc-4805	96	115	(	(	PUNCT
dpc-4805	96	116	41	41	NUM
dpc-4805	96	117	)	)	PUNCT
dpc-4805	96	118	30.1	30.1	NUM
dpc-4805	96	119	%	%	NOUN
dpc-4805	96	120	(	(	PUNCT
dpc-4805	96	121	19	19	NUM
dpc-4805	96	122	)	)	PUNCT
dpc-4805	96	123	38.6	38.6	NUM
dpc-4805	96	124	%	%	NOUN
dpc-4805	96	125	(	(	PUNCT
dpc-4805	96	126	22	22	NUM
dpc-4805	96	127	)	)	PUNCT
dpc-4805	96	128	comorbidities	comorbiditie	NOUN
dpc-4805	96	129	•	•	PRON
dpc-4805	96	130	diabetes	diabetes	NOUN
dpc-4805	96	131	•	•	NUM
dpc-4805	96	132	cvds	cvds	PROPN
dpc-4805	96	133	•	•	NUM
dpc-4805	96	134	hcv	hcv	PROPN
dpc-4805	96	135	•	•	NUM
dpc-4805	96	136	dyslipidemia	dyslipidemia	NOUN
dpc-4805	96	137	•	•	NOUN
dpc-4805	96	138	hypertension	hypertension	NOUN
dpc-4805	96	139	•	•	NOUN
dpc-4805	96	140	glaucoma	glaucoma	NOUN
dpc-4805	96	141	•	•	NOUN
dpc-4805	96	142	cancer	cancer	NOUN
dpc-4805	96	143	•	•	NOUN
dpc-4805	96	144	depression	depression	NOUN
dpc-4805	96	145	•	•	ADP
dpc-4805	96	146	thyroidopathy	thyroidopathy	PROPN
dpc-4805	96	147	•	•	NUM
dpc-4805	96	148	hs	hs	PROPN
dpc-4805	96	149	•	•	PROPN
dpc-4805	96	150	vitiligo	vitiligo	ADJ
dpc-4805	97	1	•	•	NOUN
dpc-4805	97	2	latent	latent	NOUN
dpc-4805	97	3	tb	tb	ADP
dpc-4805	97	4	95	95	NUM
dpc-4805	97	5	%	%	NOUN
dpc-4805	97	6	(	(	PUNCT
dpc-4805	97	7	114	114	NUM
dpc-4805	97	8	)	)	PUNCT
dpc-4805	97	9	11.7	11.7	NUM
dpc-4805	97	10	%	%	NOUN
dpc-4805	97	11	(	(	PUNCT
dpc-4805	97	12	14	14	NUM
dpc-4805	97	13	)	)	PUNCT
dpc-4805	97	14	5	5	NUM
dpc-4805	97	15	%	%	NOUN
dpc-4805	97	16	(	(	PUNCT
dpc-4805	97	17	6	6	NUM
dpc-4805	97	18	)	)	PUNCT
dpc-4805	97	19	0.8	0.8	NUM
dpc-4805	97	20	%	%	NOUN
dpc-4805	97	21	(	(	PUNCT
dpc-4805	97	22	1	1	NUM
dpc-4805	97	23	)	)	PUNCT
dpc-4805	97	24	9.2	9.2	NUM
dpc-4805	97	25	%	%	NOUN
dpc-4805	97	26	(	(	PUNCT
dpc-4805	97	27	11	11	NUM
dpc-4805	97	28	)	)	PUNCT
dpc-4805	97	29	24.2	24.2	NUM
dpc-4805	97	30	%	%	NOUN
dpc-4805	97	31	(	(	PUNCT
dpc-4805	97	32	29	29	NUM
dpc-4805	97	33	)	)	PUNCT
dpc-4805	97	34	0.8	0.8	NUM
dpc-4805	97	35	%	%	NOUN
dpc-4805	97	36	(	(	PUNCT
dpc-4805	97	37	1	1	NUM
dpc-4805	97	38	)	)	PUNCT
dpc-4805	97	39	36.7	36.7	NUM
dpc-4805	97	40	%	%	NOUN
dpc-4805	97	41	(	(	PUNCT
dpc-4805	97	42	44	44	NUM
dpc-4805	97	43	)	)	PUNCT
dpc-4805	97	44	1.7	1.7	NUM
dpc-4805	97	45	%	%	NOUN
dpc-4805	97	46	(	(	PUNCT
dpc-4805	97	47	2	2	NUM
dpc-4805	97	48	)	)	PUNCT
dpc-4805	97	49	2.5	2.5	NUM
dpc-4805	97	50	%	%	NOUN
dpc-4805	97	51	(	(	PUNCT
dpc-4805	97	52	3	3	NUM
dpc-4805	97	53	)	)	PUNCT
dpc-4805	97	54	0.8	0.8	NUM
dpc-4805	97	55	%	%	NOUN
dpc-4805	97	56	(	(	PUNCT
dpc-4805	97	57	1	1	NUM
dpc-4805	97	58	)	)	PUNCT
dpc-4805	97	59	0.8	0.8	NUM
dpc-4805	97	60	%	%	NOUN
dpc-4805	97	61	(	(	PUNCT
dpc-4805	97	62	1	1	NUM
dpc-4805	97	63	)	)	PUNCT
dpc-4805	97	64	0.8	0.8	NUM
dpc-4805	97	65	%	%	NOUN
dpc-4805	97	66	(	(	PUNCT
dpc-4805	97	67	1	1	NUM
dpc-4805	97	68	)	)	PUNCT
dpc-4805	97	69	92.1	92.1	NUM
dpc-4805	97	70	%	%	NOUN
dpc-4805	97	71	(	(	PUNCT
dpc-4805	97	72	58	58	NUM
dpc-4805	97	73	)	)	PUNCT
dpc-4805	97	74	11.1	11.1	NUM
dpc-4805	97	75	%	%	NOUN
dpc-4805	97	76	(	(	PUNCT
dpc-4805	97	77	7	7	NUM
dpc-4805	97	78	)	)	PUNCT
dpc-4805	97	79	6.3	6.3	NUM
dpc-4805	97	80	%	%	NOUN
dpc-4805	97	81	(	(	PUNCT
dpc-4805	97	82	4	4	NUM
dpc-4805	97	83	)	)	PUNCT
dpc-4805	97	84	7.9	7.9	NUM
dpc-4805	97	85	%	%	NOUN
dpc-4805	97	86	(	(	PUNCT
dpc-4805	97	87	5	5	NUM
dpc-4805	97	88	)	)	PUNCT
dpc-4805	97	89	20.6	20.6	NUM
dpc-4805	97	90	%	%	NOUN
dpc-4805	97	91	(	(	PUNCT
dpc-4805	97	92	13	13	NUM
dpc-4805	97	93	)	)	PUNCT
dpc-4805	97	94	36.5	36.5	NUM
dpc-4805	97	95	%	%	NOUN
dpc-4805	97	96	(	(	PUNCT
dpc-4805	97	97	23	23	NUM
dpc-4805	97	98	)	)	PUNCT
dpc-4805	97	99	4.8	4.8	NUM
dpc-4805	97	100	%	%	NOUN
dpc-4805	97	101	(	(	PUNCT
dpc-4805	97	102	3	3	NUM
dpc-4805	97	103	)	)	PUNCT
dpc-4805	97	104	1.6	1.6	NUM
dpc-4805	97	105	%	%	NOUN
dpc-4805	97	106	(	(	PUNCT
dpc-4805	97	107	1	1	NUM
dpc-4805	97	108	)	)	PUNCT
dpc-4805	97	109	1.6	1.6	NUM
dpc-4805	97	110	%	%	NOUN
dpc-4805	97	111	(	(	PUNCT
dpc-4805	97	112	1	1	NUM
dpc-4805	97	113	)	)	PUNCT
dpc-4805	97	114	1.6	1.6	NUM
dpc-4805	97	115	%	%	NOUN
dpc-4805	97	116	(	(	PUNCT
dpc-4805	97	117	1	1	NUM
dpc-4805	97	118	)	)	PUNCT
dpc-4805	97	119	98.3	98.3	NUM
dpc-4805	97	120	%	%	NOUN
dpc-4805	97	121	(	(	PUNCT
dpc-4805	97	122	56	56	NUM
dpc-4805	97	123	)	)	PUNCT
dpc-4805	97	124	12.3	12.3	NUM
dpc-4805	97	125	%	%	NOUN
dpc-4805	97	126	(	(	PUNCT
dpc-4805	97	127	7	7	NUM
dpc-4805	97	128	)	)	PUNCT
dpc-4805	97	129	3.5	3.5	NUM
dpc-4805	97	130	%	%	NOUN
dpc-4805	97	131	(	(	PUNCT
dpc-4805	97	132	2	2	NUM
dpc-4805	97	133	)	)	PUNCT
dpc-4805	97	134	1.8	1.8	NUM
dpc-4805	97	135	%	%	NOUN
dpc-4805	97	136	(	(	PUNCT
dpc-4805	97	137	1	1	NUM
dpc-4805	97	138	)	)	PUNCT
dpc-4805	97	139	10.5	10.5	NUM
dpc-4805	97	140	%	%	NOUN
dpc-4805	97	141	(	(	PUNCT
dpc-4805	97	142	6	6	NUM
dpc-4805	97	143	)	)	PUNCT
dpc-4805	97	144	28.1	28.1	NUM
dpc-4805	97	145	%	%	NOUN
dpc-4805	97	146	(	(	PUNCT
dpc-4805	97	147	16	16	NUM
dpc-4805	97	148	)	)	PUNCT
dpc-4805	97	149	1.8	1.8	NUM
dpc-4805	97	150	%	%	NOUN
dpc-4805	97	151	(	(	PUNCT
dpc-4805	97	152	1	1	NUM
dpc-4805	97	153	)	)	PUNCT
dpc-4805	97	154	36.8	36.8	NUM
dpc-4805	97	155	%	%	NOUN
dpc-4805	97	156	(	(	PUNCT
dpc-4805	97	157	21	21	NUM
dpc-4805	97	158	)	)	PUNCT
dpc-4805	97	159	3.5	3.5	NUM
dpc-4805	97	160	%	%	NOUN
dpc-4805	97	161	(	(	PUNCT
dpc-4805	97	162	2	2	NUM
dpc-4805	97	163	)	)	PUNCT
dpc-4805	97	164	previous	previous	ADJ
dpc-4805	97	165	systemic	systemic	ADJ
dpc-4805	97	166	therapies	therapy	NOUN
dpc-4805	97	167	(	(	PUNCT
dpc-4805	97	168	phototherapy	phototherapy	NOUN
dpc-4805	97	169	or	or	CCONJ
dpc-4805	97	170	cdmards	cdmard	NOUN
dpc-4805	97	171	)	)	PUNCT
dpc-4805	97	172	naïve	naïve	ADJ
dpc-4805	97	173	31.7	31.7	NUM
dpc-4805	97	174	%	%	NOUN
dpc-4805	97	175	(	(	PUNCT
dpc-4805	97	176	38	38	NUM
dpc-4805	97	177	)	)	PUNCT
dpc-4805	97	178	cya	cya	NOUN
dpc-4805	97	179	36.7	36.7	NUM
dpc-4805	97	180	%	%	NOUN
dpc-4805	97	181	(	(	PUNCT
dpc-4805	97	182	44	44	NUM
dpc-4805	97	183	)	)	PUNCT
dpc-4805	97	184	mtx	mtx	NOUN
dpc-4805	97	185	37.5	37.5	NUM
dpc-4805	97	186	%	%	NOUN
dpc-4805	97	187	(	(	PUNCT
dpc-4805	97	188	45	45	NUM
dpc-4805	97	189	)	)	PUNCT
dpc-4805	97	190	aci	aci	NOUN
dpc-4805	97	191	13.3	13.3	NUM
dpc-4805	97	192	%	%	NOUN
dpc-4805	97	193	(	(	PUNCT
dpc-4805	97	194	16	16	NUM
dpc-4805	97	195	)	)	PUNCT
dpc-4805	97	196	dmf	dmf	PROPN
dpc-4805	97	197	22.5	22.5	NUM
dpc-4805	97	198	%	%	NOUN
dpc-4805	97	199	(	(	PUNCT
dpc-4805	97	200	27	27	NUM
dpc-4805	97	201	)	)	PUNCT
dpc-4805	97	202	nbuvb	nbuvb	NOUN
dpc-4805	97	203	37.5	37.5	NUM
dpc-4805	97	204	%	%	NOUN
dpc-4805	97	205	(	(	PUNCT
dpc-4805	97	206	45	45	NUM
dpc-4805	97	207	)	)	PUNCT
dpc-4805	97	208	naïve	naïve	ADJ
dpc-4805	97	209	27	27	NUM
dpc-4805	97	210	%	%	NOUN
dpc-4805	97	211	(	(	PUNCT
dpc-4805	97	212	17	17	NUM
dpc-4805	97	213	)	)	PUNCT
dpc-4805	97	214	cya	cya	NOUN
dpc-4805	97	215	38.1	38.1	NUM
dpc-4805	97	216	%	%	NOUN
dpc-4805	97	217	(	(	PUNCT
dpc-4805	97	218	24	24	NUM
dpc-4805	97	219	)	)	PUNCT
dpc-4805	97	220	mtx	mtx	NOUN
dpc-4805	97	221	31.7	31.7	NUM
dpc-4805	97	222	%	%	NOUN
dpc-4805	97	223	(	(	PUNCT
dpc-4805	97	224	20	20	NUM
dpc-4805	97	225	)	)	PUNCT
dpc-4805	97	226	aci	aci	NOUN
dpc-4805	97	227	15.9	15.9	NUM
dpc-4805	97	228	%	%	NOUN
dpc-4805	97	229	(	(	PUNCT
dpc-4805	97	230	10	10	NUM
dpc-4805	97	231	)	)	PUNCT
dpc-4805	97	232	dmf	dmf	PROPN
dpc-4805	97	233	25.4	25.4	NUM
dpc-4805	97	234	%	%	NOUN
dpc-4805	97	235	(	(	PUNCT
dpc-4805	97	236	16	16	NUM
dpc-4805	97	237	)	)	PUNCT
dpc-4805	97	238	nbuvb	nbuvb	ADJ
dpc-4805	97	239	39.7	39.7	NUM
dpc-4805	97	240	%	%	NOUN
dpc-4805	97	241	(	(	PUNCT
dpc-4805	97	242	25	25	NUM
dpc-4805	97	243	)	)	PUNCT
dpc-4805	97	244	naïve	naïve	ADJ
dpc-4805	97	245	36.8	36.8	NUM
dpc-4805	97	246	%	%	NOUN
dpc-4805	97	247	(	(	PUNCT
dpc-4805	97	248	21	21	NUM
dpc-4805	97	249	)	)	PUNCT
dpc-4805	97	250	cya	cya	NOUN
dpc-4805	97	251	35.1	35.1	NUM
dpc-4805	97	252	%	%	NOUN
dpc-4805	97	253	(	(	PUNCT
dpc-4805	97	254	20	20	NUM
dpc-4805	97	255	)	)	PUNCT
dpc-4805	97	256	mtx	mtx	NOUN
dpc-4805	97	257	43.9	43.9	NUM
dpc-4805	97	258	%	%	NOUN
dpc-4805	97	259	(	(	PUNCT
dpc-4805	97	260	25	25	NUM
dpc-4805	97	261	)	)	PUNCT
dpc-4805	97	262	aci	aci	NOUN
dpc-4805	97	263	19.3	19.3	NUM
dpc-4805	97	264	%	%	NOUN
dpc-4805	97	265	(	(	PUNCT
dpc-4805	97	266	11	11	NUM
dpc-4805	97	267	)	)	PUNCT
dpc-4805	97	268	dmf	dmf	NOUN
dpc-4805	97	269	10.5	10.5	NUM
dpc-4805	97	270	%	%	NOUN
dpc-4805	97	271	(	(	PUNCT
dpc-4805	97	272	6	6	NUM
dpc-4805	97	273	)	)	PUNCT
dpc-4805	97	274	nbuvb	nbuvb	ADJ
dpc-4805	97	275	35.1	35.1	NUM
dpc-4805	97	276	%	%	NOUN
dpc-4805	97	277	(	(	PUNCT
dpc-4805	97	278	20	20	NUM
dpc-4805	97	279	)	)	PUNCT
dpc-4805	97	280	bionaïve	bionaïve	NOUN
dpc-4805	97	281	67.5	67.5	NUM
dpc-4805	97	282	%	%	NOUN
dpc-4805	97	283	(	(	PUNCT
dpc-4805	97	284	81	81	NUM
dpc-4805	97	285	)	)	PUNCT
dpc-4805	97	286	71.4	71.4	NUM
dpc-4805	97	287	%	%	NOUN
dpc-4805	97	288	(	(	PUNCT
dpc-4805	97	289	45	45	NUM
dpc-4805	97	290	)	)	PUNCT
dpc-4805	97	291	63.2	63.2	NUM
dpc-4805	97	292	%	%	NOUN
dpc-4805	97	293	(	(	PUNCT
dpc-4805	97	294	36	36	NUM
dpc-4805	97	295	)	)	PUNCT
dpc-4805	98	1	previous	previous	ADJ
dpc-4805	98	2	mabs	mab	NOUN
dpc-4805	98	3	(	(	PUNCT
dpc-4805	98	4	number	number	NOUN
dpc-4805	98	5	)	)	PUNCT
dpc-4805	98	6	1	1	NUM
dpc-4805	98	7	)	)	PUNCT
dpc-4805	98	8	14.2	14.2	NUM
dpc-4805	98	9	%	%	NOUN
dpc-4805	98	10	(	(	PUNCT
dpc-4805	98	11	17	17	NUM
dpc-4805	98	12	)	)	PUNCT
dpc-4805	98	13	2	2	NUM
dpc-4805	98	14	)	)	PUNCT
dpc-4805	98	15	8.3	8.3	NUM
dpc-4805	98	16	%	%	NOUN
dpc-4805	98	17	(	(	PUNCT
dpc-4805	98	18	10	10	NUM
dpc-4805	98	19	)	)	PUNCT
dpc-4805	98	20	3	3	NUM
dpc-4805	98	21	)	)	PUNCT
dpc-4805	98	22	0.8	0.8	NUM
dpc-4805	98	23	%	%	NOUN
dpc-4805	98	24	(	(	PUNCT
dpc-4805	98	25	1	1	NUM
dpc-4805	98	26	)	)	PUNCT
dpc-4805	98	27	4	4	NUM
dpc-4805	98	28	)	)	PUNCT
dpc-4805	98	29	2.5	2.5	NUM
dpc-4805	98	30	%	%	NOUN
dpc-4805	98	31	(	(	PUNCT
dpc-4805	98	32	4	4	NUM
dpc-4805	98	33	)	)	PUNCT
dpc-4805	98	34	5	5	NUM
dpc-4805	98	35	)	)	PUNCT
dpc-4805	98	36	1.7	1.7	NUM
dpc-4805	98	37	%	%	NOUN
dpc-4805	98	38	(	(	PUNCT
dpc-4805	98	39	2	2	NUM
dpc-4805	98	40	)	)	PUNCT
dpc-4805	98	41	6	6	NUM
dpc-4805	98	42	)	)	PUNCT
dpc-4805	98	43	0.8	0.8	NUM
dpc-4805	98	44	%	%	NOUN
dpc-4805	98	45	(	(	PUNCT
dpc-4805	98	46	1	1	NUM
dpc-4805	98	47	)	)	PUNCT
dpc-4805	98	48	11.1	11.1	NUM
dpc-4805	98	49	%	%	NOUN
dpc-4805	98	50	(	(	PUNCT
dpc-4805	98	51	7	7	NUM
dpc-4805	98	52	)	)	PUNCT
dpc-4805	98	53	6.3	6.3	NUM
dpc-4805	98	54	%	%	NOUN
dpc-4805	98	55	(	(	PUNCT
dpc-4805	98	56	4	4	NUM
dpc-4805	98	57	)	)	PUNCT
dpc-4805	98	58	1.6	1.6	NUM
dpc-4805	98	59	%	%	NOUN
dpc-4805	98	60	(	(	PUNCT
dpc-4805	98	61	1	1	NUM
dpc-4805	98	62	)	)	PUNCT
dpc-4805	98	63	1.6	1.6	NUM
dpc-4805	98	64	%	%	NOUN
dpc-4805	98	65	(	(	PUNCT
dpc-4805	98	66	1	1	NUM
dpc-4805	98	67	)	)	PUNCT
dpc-4805	98	68	17.5	17.5	NUM
dpc-4805	98	69	%	%	NOUN
dpc-4805	98	70	(	(	PUNCT
dpc-4805	98	71	10	10	NUM
dpc-4805	98	72	)	)	PUNCT
dpc-4805	98	73	10.5	10.5	NUM
dpc-4805	98	74	%	%	NOUN
dpc-4805	98	75	(	(	PUNCT
dpc-4805	98	76	6	6	NUM
dpc-4805	98	77	)	)	PUNCT
dpc-4805	98	78	3.5	3.5	NUM
dpc-4805	98	79	%	%	NOUN
dpc-4805	98	80	(	(	PUNCT
dpc-4805	98	81	2	2	NUM
dpc-4805	98	82	)	)	PUNCT
dpc-4805	98	83	3.5	3.5	NUM
dpc-4805	98	84	%	%	NOUN
dpc-4805	98	85	(	(	PUNCT
dpc-4805	98	86	2	2	NUM
dpc-4805	98	87	)	)	PUNCT
dpc-4805	98	88	1.8	1.8	NUM
dpc-4805	98	89	%	%	NOUN
dpc-4805	98	90	(	(	PUNCT
dpc-4805	98	91	1	1	NUM
dpc-4805	98	92	)	)	PUNCT
dpc-4805	98	93	duration	duration	NOUN
dpc-4805	98	94	of	of	ADP
dpc-4805	98	95	therapy	therapy	NOUN
dpc-4805	98	96	with	with	ADP
dpc-4805	98	97	apremilast	apremilast	ADJ
dpc-4805	98	98	(	(	PUNCT
dpc-4805	98	99	months	month	NOUN
dpc-4805	98	100	)	)	PUNCT
dpc-4805	98	101	25.2	25.2	NUM
dpc-4805	98	102	±	±	NUM
dpc-4805	98	103	19.4	19.4	NUM
dpc-4805	98	104	28.4	28.4	NUM
dpc-4805	98	105	±	±	NUM
dpc-4805	98	106	20.9	20.9	NUM
dpc-4805	98	107	21.5	21.5	NUM
dpc-4805	98	108	±	±	NUM
dpc-4805	98	109	17.1	17.1	NUM
dpc-4805	98	110	aci	aci	NOUN
dpc-4805	98	111	=	=	PROPN
dpc-4805	98	112	acitretin	acitretin	PROPN
dpc-4805	98	113	;	;	PUNCT
dpc-4805	98	114	bmi	bmi	NOUN
dpc-4805	98	115	=	=	SYM
dpc-4805	98	116	body	body	PROPN
dpc-4805	98	117	mass	mass	PROPN
dpc-4805	98	118	index	index	NOUN
dpc-4805	98	119	;	;	PUNCT
dpc-4805	98	120	cvds	cvds	NOUN
dpc-4805	98	121	=	=	PUNCT
dpc-4805	98	122	cardiovascular	cardiovascular	ADJ
dpc-4805	98	123	diseases	disease	NOUN
dpc-4805	98	124	;	;	PUNCT
dpc-4805	98	125	cya	cya	NOUN
dpc-4805	98	126	=	=	SYM
dpc-4805	98	127	cyclosporin	cyclosporin	NOUN
dpc-4805	98	128	a	a	NOUN
dpc-4805	98	129	;	;	PUNCT
dpc-4805	98	130	dmf	dmf	PROPN
dpc-4805	98	131	=	=	PROPN
dpc-4805	98	132	dimethylfumarate	dimethylfumarate	PROPN
dpc-4805	98	133	;	;	PUNCT
dpc-4805	98	134	cdmards	cdmard	NOUN
dpc-4805	98	135	=	=	SYM
dpc-4805	98	136	conventional	conventional	ADJ
dpc-4805	98	137	disease	disease	NOUN
dpc-4805	98	138	modifying	modify	VERB
dpc-4805	98	139	anti	anti	ADJ
dpc-4805	98	140	-	-	ADJ
dpc-4805	98	141	rheumatic	rheumatic	ADJ
dpc-4805	98	142	drugs	drug	NOUN
dpc-4805	98	143	;	;	PUNCT
dpc-4805	98	144	hs	hs	PROPN
dpc-4805	98	145	=	=	PROPN
dpc-4805	98	146	hidradenitis	hidradenitis	PROPN
dpc-4805	98	147	suppurativa	suppurativa	PROPN
dpc-4805	98	148	;	;	PUNCT
dpc-4805	98	149	mabs	mab	NOUN
dpc-4805	98	150	=	=	SYM
dpc-4805	98	151	monoclonal	monoclonal	NOUN
dpc-4805	98	152	antibodies	antibodie	VERB
dpc-4805	98	153	;	;	PUNCT
dpc-4805	98	154	mtx	mtx	NOUN
dpc-4805	98	155	=	=	PUNCT
dpc-4805	98	156	methotrexate	methotrexate	NOUN
dpc-4805	98	157	;	;	PUNCT
dpc-4805	98	158	nbuvb	nbuvb	ADJ
dpc-4805	98	159	=	=	SYM
dpc-4805	98	160	narrowband	narrowband	NOUN
dpc-4805	98	161	uvb	uvb	NOUN
dpc-4805	98	162	;	;	PUNCT
dpc-4805	98	163	pasi	pasi	NOUN
dpc-4805	98	164	=	=	SYM
dpc-4805	98	165	psoriasis	psoriasis	NOUN
dpc-4805	98	166	area	area	NOUN
dpc-4805	98	167	and	and	CCONJ
dpc-4805	98	168	severity	severity	NOUN
dpc-4805	98	169	index	index	NOUN
dpc-4805	98	170	;	;	PUNCT
dpc-4805	98	171	tb	tb	NOUN
dpc-4805	98	172	=	=	PUNCT
dpc-4805	98	173	tuberculosis	tuberculosis	NOUN
dpc-4805	98	174	.	.	PUNCT
dpc-4805	99	1	original	original	ADJ
dpc-4805	99	2	article	article	NOUN
dpc-4805	99	3	|	|	ADV
dpc-4805	99	4	dermatol	dermatol	ADJ
dpc-4805	99	5	pract	pract	NOUN
dpc-4805	99	6	concept	concept	NOUN
dpc-4805	99	7	.	.	PUNCT
dpc-4805	100	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	100	2	5	5	NUM
dpc-4805	100	3	percentage	percentage	NOUN
dpc-4805	100	4	change	change	NOUN
dpc-4805	100	5	in	in	ADP
dpc-4805	100	6	weight	weight	NOUN
dpc-4805	100	7	of	of	ADP
dpc-4805	100	8	1.53	1.53	NUM
dpc-4805	100	9	%	%	NOUN
dpc-4805	100	10	over	over	ADP
dpc-4805	100	11	the	the	DET
dpc-4805	100	12	156	156	NUM
dpc-4805	100	13	-	-	PUNCT
dpc-4805	100	14	week	week	NOUN
dpc-4805	100	15	treatment	treatment	NOUN
dpc-4805	100	16	period	period	NOUN
dpc-4805	100	17	with	with	ADP
dpc-4805	100	18	apremilast	apremilast	NOUN
dpc-4805	100	19	[	[	X
dpc-4805	100	20	20	20	NUM
dpc-4805	100	21	]	]	PUNCT
dpc-4805	100	22	.	.	PUNCT
dpc-4805	101	1	notably	notably	ADV
dpc-4805	101	2	,	,	PUNCT
dpc-4805	101	3	a	a	DET
dpc-4805	101	4	higher	high	ADJ
dpc-4805	101	5	baseline	baseline	NOUN
dpc-4805	101	6	bmi	bmi	NOUN
dpc-4805	101	7	was	be	AUX
dpc-4805	101	8	associated	associate	VERB
dpc-4805	101	9	with	with	ADP
dpc-4805	101	10	a	a	DET
dpc-4805	101	11	greater	great	ADJ
dpc-4805	101	12	proportion	proportion	NOUN
dpc-4805	101	13	of	of	ADP
dpc-4805	101	14	patients	patient	NOUN
dpc-4805	101	15	experiencing	experience	VERB
dpc-4805	101	16	weight	weight	NOUN
dpc-4805	101	17	loss	loss	NOUN
dpc-4805	101	18	,	,	PUNCT
dpc-4805	101	19	primarily	primarily	ADV
dpc-4805	101	20	observed	observe	VERB
dpc-4805	101	21	within	within	ADP
dpc-4805	101	22	the	the	DET
dpc-4805	101	23	initial	initial	ADJ
dpc-4805	101	24	year	year	NOUN
dpc-4805	101	25	of	of	ADP
dpc-4805	101	26	treatment	treatment	NOUN
dpc-4805	101	27	.	.	PUNCT
dpc-4805	102	1	moreover	moreover	ADV
dpc-4805	102	2	,	,	PUNCT
dpc-4805	102	3	no	no	DET
dpc-4805	102	4	discernible	discernible	ADJ
dpc-4805	102	5	correlation	correlation	NOUN
dpc-4805	102	6	was	be	AUX
dpc-4805	102	7	established	establish	VERB
dpc-4805	102	8	between	between	ADP
dpc-4805	102	9	gastrointestinal	gastrointestinal	ADJ
dpc-4805	102	10	adverse	adverse	ADJ
dpc-4805	102	11	events	event	NOUN
dpc-4805	102	12	,	,	PUNCT
dpc-4805	102	13	such	such	ADJ
dpc-4805	102	14	careful	careful	ADJ
dpc-4805	102	15	monitoring	monitoring	NOUN
dpc-4805	102	16	is	be	AUX
dpc-4805	102	17	imperative	imperative	ADJ
dpc-4805	102	18	,	,	PUNCT
dpc-4805	102	19	particularly	particularly	ADV
dpc-4805	102	20	for	for	ADP
dpc-4805	102	21	individuals	individual	NOUN
dpc-4805	102	22	with	with	ADP
dpc-4805	102	23	below	below	ADP
dpc-4805	102	24	-	-	PUNCT
dpc-4805	102	25	average	average	NOUN
dpc-4805	102	26	body	body	NOUN
dpc-4805	102	27	weight	weight	NOUN
dpc-4805	102	28	[	[	X
dpc-4805	102	29	18	18	NUM
dpc-4805	102	30	-	-	SYM
dpc-4805	102	31	19	19	NUM
dpc-4805	102	32	]	]	PUNCT
dpc-4805	102	33	.	.	PUNCT
dpc-4805	103	1	in	in	ADP
dpc-4805	103	2	accordance	accordance	NOUN
dpc-4805	103	3	with	with	ADP
dpc-4805	103	4	our	our	PRON
dpc-4805	103	5	study	study	NOUN
dpc-4805	103	6	findings	finding	NOUN
dpc-4805	103	7	,	,	PUNCT
dpc-4805	103	8	pivotal	pivotal	ADJ
dpc-4805	103	9	trials	trial	NOUN
dpc-4805	103	10	have	have	AUX
dpc-4805	103	11	underscored	underscore	VERB
dpc-4805	103	12	weight	weight	NOUN
dpc-4805	103	13	loss	loss	NOUN
dpc-4805	103	14	as	as	ADP
dpc-4805	103	15	a	a	DET
dpc-4805	103	16	significant	significant	ADJ
dpc-4805	103	17	adverse	adverse	ADJ
dpc-4805	103	18	event	event	NOUN
dpc-4805	103	19	in	in	ADP
dpc-4805	103	20	patients	patient	NOUN
dpc-4805	103	21	in	in	ADP
dpc-4805	103	22	treatment	treatment	NOUN
dpc-4805	103	23	with	with	ADP
dpc-4805	103	24	apremilast	apremilast	NOUN
dpc-4805	103	25	.	.	PUNCT
dpc-4805	104	1	an	an	DET
dpc-4805	104	2	amalgamated	amalgamated	ADJ
dpc-4805	104	3	analysis	analysis	NOUN
dpc-4805	104	4	of	of	ADP
dpc-4805	104	5	phase	phase	NOUN
dpc-4805	104	6	3	3	NUM
dpc-4805	104	7	trials	trial	NOUN
dpc-4805	104	8	esteem	esteem	VERB
dpc-4805	104	9	1	1	NUM
dpc-4805	104	10	and	and	CCONJ
dpc-4805	104	11	esteem	esteem	VERB
dpc-4805	104	12	2	2	NUM
dpc-4805	104	13	revealed	reveal	VERB
dpc-4805	104	14	a	a	DET
dpc-4805	104	15	mean	mean	ADJ
dpc-4805	104	16	figure	figure	NOUN
dpc-4805	104	17	1	1	NUM
dpc-4805	104	18	.	.	X
dpc-4805	104	19	boxplot	boxplot	NOUN
dpc-4805	104	20	of	of	ADP
dpc-4805	104	21	weight	weight	NOUN
dpc-4805	104	22	.	.	PUNCT
dpc-4805	105	1	males	male	NOUN
dpc-4805	105	2	(	(	PUNCT
dpc-4805	105	3	light	light	NOUN
dpc-4805	105	4	gray	gray	NOUN
dpc-4805	105	5	)	)	PUNCT
dpc-4805	105	6	at	at	ADP
dpc-4805	105	7	baseline	baseline	PROPN
dpc-4805	105	8	,	,	PUNCT
dpc-4805	105	9	w24	w24	PROPN
dpc-4805	105	10	and	and	CCONJ
dpc-4805	105	11	w48	w48	NOUN
dpc-4805	105	12	and	and	CCONJ
dpc-4805	105	13	females	female	NOUN
dpc-4805	105	14	(	(	PUNCT
dpc-4805	105	15	dark	dark	ADJ
dpc-4805	105	16	gray	gray	NOUN
dpc-4805	105	17	)	)	PUNCT
dpc-4805	105	18	at	at	ADP
dpc-4805	105	19	baseline	baseline	PROPN
dpc-4805	105	20	,	,	PUNCT
dpc-4805	105	21	w24	w24	PROPN
dpc-4805	105	22	and	and	CCONJ
dpc-4805	105	23	w48	w48	NOUN
dpc-4805	105	24	.	.	PUNCT
dpc-4805	105	25	table	table	NOUN
dpc-4805	105	26	2	2	NUM
dpc-4805	105	27	.	.	PUNCT
dpc-4805	105	28	weight	weight	NOUN
dpc-4805	105	29	and	and	CCONJ
dpc-4805	105	30	body	body	NOUN
dpc-4805	105	31	mass	mass	NOUN
dpc-4805	105	32	index	index	NOUN
dpc-4805	105	33	according	accord	VERB
dpc-4805	105	34	to	to	ADP
dpc-4805	105	35	gender	gender	NOUN
dpc-4805	105	36	at	at	ADP
dpc-4805	105	37	baseline	baseline	NOUN
dpc-4805	105	38	and	and	CCONJ
dpc-4805	105	39	after	after	ADP
dpc-4805	105	40	24	24	NUM
dpc-4805	105	41	and	and	CCONJ
dpc-4805	105	42	48	48	NUM
dpc-4805	105	43	weeks	week	NOUN
dpc-4805	105	44	of	of	ADP
dpc-4805	105	45	therapy	therapy	NOUN
dpc-4805	105	46	with	with	ADP
dpc-4805	105	47	apremilast	apremilast	ADJ
dpc-4805	105	48	weight	weight	NOUN
dpc-4805	105	49	bmi	bmi	PROPN
dpc-4805	105	50	baseline	baseline	PROPN
dpc-4805	105	51	week	week	NOUN
dpc-4805	105	52	24	24	NUM
dpc-4805	105	53	week	week	NOUN
dpc-4805	105	54	48	48	NUM
dpc-4805	105	55	(	(	PUNCT
dpc-4805	105	56	p	p	X
dpc-4805	105	57	<	<	X
dpc-4805	105	58	0.001	0.001	NUM
dpc-4805	105	59	)	)	PUNCT
dpc-4805	105	60	baseline	baseline	NOUN
dpc-4805	105	61	week	week	NOUN
dpc-4805	105	62	24	24	NUM
dpc-4805	105	63	week	week	NOUN
dpc-4805	105	64	48	48	NUM
dpc-4805	105	65	(	(	PUNCT
dpc-4805	105	66	p	p	X
dpc-4805	105	67	<	<	X
dpc-4805	105	68	0.001	0.001	NUM
dpc-4805	105	69	)	)	PUNCT
dpc-4805	105	70	males	male	NOUN
dpc-4805	105	71	87.1	87.1	NUM
dpc-4805	105	72	±	±	NUM
dpc-4805	105	73	19.7	19.7	NUM
dpc-4805	105	74	86.8	86.8	NUM
dpc-4805	105	75	±	±	NUM
dpc-4805	105	76	19.5	19.5	NUM
dpc-4805	105	77	87	87	NUM
dpc-4805	105	78	±	±	NUM
dpc-4805	105	79	20.1	20.1	NUM
dpc-4805	105	80	24.8	24.8	NUM
dpc-4805	105	81	±	±	NUM
dpc-4805	105	82	5.1	5.1	NUM
dpc-4805	105	83	24.7	24.7	NUM
dpc-4805	105	84	±	±	NUM
dpc-4805	105	85	5.1	5.1	NUM
dpc-4805	105	86	24.6	24.6	NUM
dpc-4805	105	87	±	±	NUM
dpc-4805	105	88	5.3	5.3	NUM
dpc-4805	105	89	females	female	NOUN
dpc-4805	105	90	72.1	72.1	NUM
dpc-4805	105	91	±	±	NUM
dpc-4805	105	92	15.6	15.6	NUM
dpc-4805	105	93	69.6	69.6	NUM
dpc-4805	105	94	±	±	NUM
dpc-4805	105	95	15.3	15.3	NUM
dpc-4805	105	96	66.4	66.4	NUM
dpc-4805	105	97	±	±	NUM
dpc-4805	105	98	15.7	15.7	NUM
dpc-4805	105	99	22.3	22.3	NUM
dpc-4805	105	100	±	±	NUM
dpc-4805	105	101	4.9	4.9	NUM
dpc-4805	105	102	21.5	21.5	NUM
dpc-4805	106	1	±4.8	±4.8	PROPN
dpc-4805	106	2	20.5	20.5	NUM
dpc-4805	106	3	±	±	NUM
dpc-4805	106	4	5.1	5.1	NUM
dpc-4805	106	5	bmi	bmi	NOUN
dpc-4805	106	6	=	=	SYM
dpc-4805	106	7	body	body	NOUN
dpc-4805	106	8	mass	mass	PROPN
dpc-4805	106	9	index	index	NOUN
dpc-4805	106	10	.	.	PUNCT
dpc-4805	107	1	figure	figure	NOUN
dpc-4805	107	2	2	2	NUM
dpc-4805	107	3	.	.	X
dpc-4805	108	1	boxplot	boxplot	NOUN
dpc-4805	108	2	of	of	ADP
dpc-4805	108	3	body	body	NOUN
dpc-4805	108	4	mass	mass	PROPN
dpc-4805	108	5	index	index	NOUN
dpc-4805	108	6	.	.	PUNCT
dpc-4805	109	1	males	male	NOUN
dpc-4805	109	2	(	(	PUNCT
dpc-4805	109	3	light	light	NOUN
dpc-4805	109	4	gray	gray	NOUN
dpc-4805	109	5	)	)	PUNCT
dpc-4805	109	6	at	at	ADP
dpc-4805	109	7	baseline	baseline	PROPN
dpc-4805	109	8	,	,	PUNCT
dpc-4805	109	9	w24	w24	PROPN
dpc-4805	109	10	and	and	CCONJ
dpc-4805	109	11	w48	w48	NOUN
dpc-4805	109	12	and	and	CCONJ
dpc-4805	109	13	females	female	NOUN
dpc-4805	109	14	(	(	PUNCT
dpc-4805	109	15	dark	dark	ADJ
dpc-4805	109	16	gray	gray	NOUN
dpc-4805	109	17	)	)	PUNCT
dpc-4805	109	18	at	at	ADP
dpc-4805	109	19	baseline	baseline	PROPN
dpc-4805	109	20	,	,	PUNCT
dpc-4805	109	21	w24	w24	PROPN
dpc-4805	109	22	and	and	CCONJ
dpc-4805	109	23	w48	w48	NOUN
dpc-4805	109	24	.	.	PUNCT
dpc-4805	110	1	6	6	NUM
dpc-4805	110	2	original	original	ADJ
dpc-4805	110	3	article	article	NOUN
dpc-4805	110	4	|	|	ADV
dpc-4805	110	5	dermatol	dermatol	ADJ
dpc-4805	110	6	pract	pract	NOUN
dpc-4805	110	7	concept	concept	NOUN
dpc-4805	110	8	.	.	PUNCT
dpc-4805	111	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	111	2	patient	patient	NOUN
dpc-4805	111	3	is	be	AUX
dpc-4805	111	4	essential	essential	ADJ
dpc-4805	111	5	,	,	PUNCT
dpc-4805	111	6	allowing	allow	VERB
dpc-4805	111	7	for	for	ADP
dpc-4805	111	8	targeted	target	VERB
dpc-4805	111	9	action	action	NOUN
dpc-4805	111	10	on	on	ADP
dpc-4805	111	11	both	both	DET
dpc-4805	111	12	skin	skin	NOUN
dpc-4805	111	13	disease	disease	NOUN
dpc-4805	111	14	and	and	CCONJ
dpc-4805	111	15	comorbidities	comorbiditie	NOUN
dpc-4805	111	16	and	and	CCONJ
dpc-4805	111	17	aiming	aim	VERB
dpc-4805	111	18	to	to	PART
dpc-4805	111	19	restore	restore	VERB
dpc-4805	111	20	well	well	ADV
dpc-4805	111	21	-	-	PUNCT
dpc-4805	111	22	being	be	AUX
dpc-4805	111	23	[	[	X
dpc-4805	111	24	27	27	NUM
dpc-4805	111	25	]	]	PUNCT
dpc-4805	111	26	.	.	PUNCT
dpc-4805	112	1	from	from	ADP
dpc-4805	112	2	the	the	DET
dpc-4805	112	3	result	result	NOUN
dpc-4805	112	4	of	of	ADP
dpc-4805	112	5	our	our	PRON
dpc-4805	112	6	study	study	NOUN
dpc-4805	112	7	,	,	PUNCT
dpc-4805	112	8	however	however	ADV
dpc-4805	112	9	,	,	PUNCT
dpc-4805	112	10	weight	weight	NOUN
dpc-4805	112	11	loss	loss	NOUN
dpc-4805	112	12	and	and	CCONJ
dpc-4805	112	13	bmi	bmi	NOUN
dpc-4805	112	14	reduction	reduction	NOUN
dpc-4805	112	15	appear	appear	VERB
dpc-4805	112	16	to	to	PART
dpc-4805	112	17	be	be	AUX
dpc-4805	112	18	the	the	DET
dpc-4805	112	19	exclusive	exclusive	ADJ
dpc-4805	112	20	preserve	preserve	NOUN
dpc-4805	112	21	of	of	ADP
dpc-4805	112	22	women	woman	NOUN
dpc-4805	112	23	while	while	SCONJ
dpc-4805	112	24	men	man	NOUN
dpc-4805	112	25	are	be	AUX
dpc-4805	112	26	less	less	ADV
dpc-4805	112	27	affected	affect	VERB
dpc-4805	112	28	by	by	ADP
dpc-4805	112	29	these	these	DET
dpc-4805	112	30	changes	change	NOUN
dpc-4805	112	31	(	(	PUNCT
dpc-4805	112	32	figure	figure	NOUN
dpc-4805	112	33	3	3	NUM
dpc-4805	112	34	)	)	PUNCT
dpc-4805	112	35	.	.	PUNCT
dpc-4805	113	1	to	to	ADP
dpc-4805	113	2	date	date	NOUN
dpc-4805	113	3	,	,	PUNCT
dpc-4805	113	4	gender	gender	NOUN
dpc-4805	113	5	dermatology	dermatology	NOUN
dpc-4805	113	6	has	have	AUX
dpc-4805	113	7	focused	focus	VERB
dpc-4805	113	8	almost	almost	ADV
dpc-4805	113	9	exclusively	exclusively	ADV
dpc-4805	113	10	on	on	ADP
dpc-4805	113	11	possible	possible	ADJ
dpc-4805	113	12	differences	difference	NOUN
dpc-4805	113	13	in	in	ADP
dpc-4805	113	14	the	the	DET
dpc-4805	113	15	therapeutic	therapeutic	ADJ
dpc-4805	113	16	efficacy	efficacy	NOUN
dpc-4805	113	17	of	of	ADP
dpc-4805	113	18	systemic	systemic	ADJ
dpc-4805	113	19	drugs	drug	NOUN
dpc-4805	113	20	or	or	CCONJ
dpc-4805	113	21	mabs	mab	NOUN
dpc-4805	114	1	[	[	X
dpc-4805	114	2	28	28	NUM
dpc-4805	114	3	]	]	PUNCT
dpc-4805	114	4	.	.	PUNCT
dpc-4805	115	1	the	the	DET
dpc-4805	115	2	mechanism	mechanism	NOUN
dpc-4805	115	3	underlying	underlie	VERB
dpc-4805	115	4	the	the	DET
dpc-4805	115	5	results	result	NOUN
dpc-4805	115	6	of	of	ADP
dpc-4805	115	7	our	our	PRON
dpc-4805	115	8	study	study	NOUN
dpc-4805	115	9	is	be	AUX
dpc-4805	115	10	not	not	PART
dpc-4805	115	11	fully	fully	ADV
dpc-4805	115	12	elucidated	elucidated	ADJ
dpc-4805	115	13	.	.	PUNCT
dpc-4805	116	1	there	there	PRON
dpc-4805	116	2	is	be	VERB
dpc-4805	116	3	a	a	DET
dpc-4805	116	4	morphological	morphological	ADJ
dpc-4805	116	5	difference	difference	NOUN
dpc-4805	116	6	between	between	ADP
dpc-4805	116	7	fat	fat	ADJ
dpc-4805	116	8	accumulation	accumulation	NOUN
dpc-4805	116	9	in	in	ADP
dpc-4805	116	10	women	woman	NOUN
dpc-4805	116	11	and	and	CCONJ
dpc-4805	116	12	that	that	SCONJ
dpc-4805	116	13	in	in	ADP
dpc-4805	116	14	men	man	NOUN
dpc-4805	116	15	,	,	PUNCT
dpc-4805	116	16	which	which	PRON
dpc-4805	116	17	gender	gender	NOUN
dpc-4805	116	18	hormones	hormone	NOUN
dpc-4805	116	19	related	relate	VERB
dpc-4805	116	20	,	,	PUNCT
dpc-4805	116	21	along	along	ADP
dpc-4805	116	22	with	with	ADP
dpc-4805	116	23	the	the	DET
dpc-4805	116	24	density	density	NOUN
dpc-4805	116	25	of	of	ADP
dpc-4805	116	26	their	their	PRON
dpc-4805	116	27	respective	respective	ADJ
dpc-4805	116	28	receptors	receptor	NOUN
dpc-4805	116	29	[	[	X
dpc-4805	116	30	29	29	NUM
dpc-4805	116	31	]	]	PUNCT
dpc-4805	116	32	.	.	PUNCT
dpc-4805	117	1	in	in	ADP
dpc-4805	117	2	fact	fact	NOUN
dpc-4805	117	3	,	,	PUNCT
dpc-4805	117	4	adipocytes	adipocyte	NOUN
dpc-4805	117	5	have	have	VERB
dpc-4805	117	6	specific	specific	ADJ
dpc-4805	117	7	receptors	receptor	NOUN
dpc-4805	117	8	for	for	ADP
dpc-4805	117	9	androgens	androgen	NOUN
dpc-4805	117	10	with	with	ADP
dpc-4805	117	11	a	a	DET
dpc-4805	117	12	higher	high	ADJ
dpc-4805	117	13	density	density	NOUN
dpc-4805	117	14	in	in	ADP
dpc-4805	117	15	visceral	visceral	ADJ
dpc-4805	117	16	fat	fat	ADJ
dpc-4805	117	17	cells	cell	NOUN
dpc-4805	117	18	than	than	ADP
dpc-4805	117	19	in	in	ADP
dpc-4805	117	20	adipocytes	adipocyte	NOUN
dpc-4805	117	21	isolated	isolate	VERB
dpc-4805	117	22	from	from	ADP
dpc-4805	117	23	subcutaneous	subcutaneous	ADJ
dpc-4805	117	24	fat	fat	NOUN
dpc-4805	117	25	[	[	X
dpc-4805	117	26	30	30	NUM
dpc-4805	117	27	]	]	PUNCT
dpc-4805	117	28	.	.	PUNCT
dpc-4805	118	1	in	in	ADP
dpc-4805	118	2	particular	particular	ADJ
dpc-4805	118	3	,	,	PUNCT
dpc-4805	118	4	alpha1	alpha1	NOUN
dpc-4805	118	5	-	-	PUNCT
dpc-4805	118	6	adrenergic	adrenergic	NOUN
dpc-4805	118	7	receptors	receptor	NOUN
dpc-4805	118	8	play	play	VERB
dpc-4805	118	9	a	a	DET
dpc-4805	118	10	significant	significant	ADJ
dpc-4805	118	11	inhibitory	inhibitory	ADJ
dpc-4805	118	12	role	role	NOUN
dpc-4805	118	13	in	in	ADP
dpc-4805	118	14	lipogenesis	lipogenesis	NOUN
dpc-4805	118	15	,	,	PUNCT
dpc-4805	118	16	while	while	SCONJ
dpc-4805	118	17	alpha2	alpha2	NOUN
dpc-4805	118	18	-	-	PUNCT
dpc-4805	118	19	adrenergic	adrenergic	ADJ
dpc-4805	118	20	receptors	receptor	NOUN
dpc-4805	118	21	inhibit	inhibit	VERB
dpc-4805	118	22	lipolysis	lipolysis	NOUN
dpc-4805	118	23	[	[	X
dpc-4805	118	24	31	31	NUM
dpc-4805	118	25	]	]	PUNCT
dpc-4805	118	26	.	.	PUNCT
dpc-4805	119	1	alpha2s	alpha2s	NOUN
dpc-4805	119	2	are	be	AUX
dpc-4805	119	3	17	17	NUM
dpc-4805	119	4	times	time	NOUN
dpc-4805	119	5	more	more	ADV
dpc-4805	119	6	numerous	numerous	ADJ
dpc-4805	119	7	in	in	ADP
dpc-4805	119	8	women	woman	NOUN
dpc-4805	119	9	than	than	ADP
dpc-4805	119	10	in	in	ADP
dpc-4805	119	11	men	man	NOUN
dpc-4805	119	12	[	[	X
dpc-4805	119	13	32	32	NUM
dpc-4805	119	14	]	]	PUNCT
dpc-4805	119	15	.	.	PUNCT
dpc-4805	120	1	thus	thus	ADV
dpc-4805	120	2	,	,	PUNCT
dpc-4805	120	3	a	a	DET
dpc-4805	120	4	role	role	NOUN
dpc-4805	120	5	of	of	ADP
dpc-4805	120	6	apremilast	apremilast	NOUN
dpc-4805	120	7	on	on	ADP
dpc-4805	120	8	alpha2	alpha2	NOUN
dpc-4805	120	9	inhibition	inhibition	NOUN
dpc-4805	120	10	and	and	CCONJ
dpc-4805	120	11	alpha1	alpha1	NOUN
dpc-4805	120	12	overactivation	overactivation	NOUN
dpc-4805	120	13	could	could	AUX
dpc-4805	120	14	be	be	AUX
dpc-4805	120	15	hypothesized	hypothesize	VERB
dpc-4805	120	16	,	,	PUNCT
dpc-4805	120	17	which	which	PRON
dpc-4805	120	18	would	would	AUX
dpc-4805	120	19	explain	explain	VERB
dpc-4805	120	20	the	the	DET
dpc-4805	120	21	greater	great	ADJ
dpc-4805	120	22	weight	weight	NOUN
dpc-4805	120	23	loss	loss	NOUN
dpc-4805	120	24	in	in	ADP
dpc-4805	120	25	women	woman	NOUN
dpc-4805	120	26	than	than	ADP
dpc-4805	120	27	in	in	ADP
dpc-4805	120	28	men	man	NOUN
dpc-4805	120	29	.	.	PUNCT
dpc-4805	121	1	however	however	ADV
dpc-4805	121	2	,	,	PUNCT
dpc-4805	121	3	further	further	ADJ
dpc-4805	121	4	studies	study	NOUN
dpc-4805	121	5	are	be	AUX
dpc-4805	121	6	needed	need	VERB
dpc-4805	121	7	to	to	PART
dpc-4805	121	8	substantiate	substantiate	VERB
dpc-4805	121	9	this	this	DET
dpc-4805	121	10	hypothesis	hypothesis	NOUN
dpc-4805	121	11	.	.	PUNCT
dpc-4805	122	1	considering	consider	VERB
dpc-4805	122	2	these	these	DET
dpc-4805	122	3	intricate	intricate	ADJ
dpc-4805	122	4	connections	connection	NOUN
dpc-4805	122	5	,	,	PUNCT
dpc-4805	122	6	a	a	DET
dpc-4805	122	7	multidisciplinary	multidisciplinary	ADJ
dpc-4805	122	8	approach	approach	NOUN
dpc-4805	122	9	involving	involve	VERB
dpc-4805	122	10	dermatologists	dermatologist	NOUN
dpc-4805	122	11	and	and	CCONJ
dpc-4805	122	12	endocrinologists	endocrinologist	NOUN
dpc-4805	122	13	is	be	AUX
dpc-4805	122	14	essential	essential	ADJ
dpc-4805	122	15	for	for	ADP
dpc-4805	122	16	comprehensive	comprehensive	ADJ
dpc-4805	122	17	psoriasis	psoriasis	NOUN
dpc-4805	122	18	care	care	NOUN
dpc-4805	122	19	.	.	PUNCT
dpc-4805	123	1	collaborative	collaborative	ADJ
dpc-4805	123	2	efforts	effort	NOUN
dpc-4805	123	3	aimed	aim	VERB
dpc-4805	123	4	at	at	ADP
dpc-4805	123	5	addressing	address	VERB
dpc-4805	123	6	both	both	CCONJ
dpc-4805	123	7	the	the	DET
dpc-4805	123	8	dermatological	dermatological	ADJ
dpc-4805	123	9	and	and	CCONJ
dpc-4805	123	10	systemic	systemic	ADJ
dpc-4805	123	11	aspects	aspect	NOUN
dpc-4805	123	12	of	of	ADP
dpc-4805	123	13	the	the	DET
dpc-4805	123	14	disease	disease	NOUN
dpc-4805	123	15	,	,	PUNCT
dpc-4805	123	16	while	while	SCONJ
dpc-4805	123	17	considering	consider	VERB
dpc-4805	123	18	the	the	DET
dpc-4805	123	19	unique	unique	ADJ
dpc-4805	123	20	characteristics	characteristic	NOUN
dpc-4805	123	21	of	of	ADP
dpc-4805	123	22	each	each	DET
dpc-4805	123	23	patient	patient	NOUN
dpc-4805	123	24	,	,	PUNCT
dpc-4805	123	25	are	be	AUX
dpc-4805	123	26	crucial	crucial	ADJ
dpc-4805	123	27	for	for	ADP
dpc-4805	123	28	achieving	achieve	VERB
dpc-4805	123	29	optimal	optimal	ADJ
dpc-4805	123	30	outcomes	outcome	NOUN
dpc-4805	123	31	and	and	CCONJ
dpc-4805	123	32	enhancing	enhance	VERB
dpc-4805	123	33	quality	quality	NOUN
dpc-4805	123	34	of	of	ADP
dpc-4805	123	35	life	life	NOUN
dpc-4805	123	36	.	.	PUNCT
dpc-4805	124	1	in	in	ADP
dpc-4805	124	2	conclusion	conclusion	NOUN
dpc-4805	124	3	,	,	PUNCT
dpc-4805	124	4	understanding	understand	VERB
dpc-4805	124	5	the	the	DET
dpc-4805	124	6	interplay	interplay	NOUN
dpc-4805	124	7	between	between	ADP
dpc-4805	124	8	psoriasis	psoriasis	NOUN
dpc-4805	124	9	,	,	PUNCT
dpc-4805	124	10	gender	gender	NOUN
dpc-4805	124	11	,	,	PUNCT
dpc-4805	124	12	and	and	CCONJ
dpc-4805	124	13	body	body	NOUN
dpc-4805	124	14	weight	weight	NOUN
dpc-4805	124	15	is	be	AUX
dpc-4805	124	16	essential	essential	ADJ
dpc-4805	124	17	for	for	ADP
dpc-4805	124	18	effective	effective	ADJ
dpc-4805	124	19	disease	disease	NOUN
dpc-4805	124	20	management	management	NOUN
dpc-4805	124	21	and	and	CCONJ
dpc-4805	124	22	improving	improve	VERB
dpc-4805	124	23	patient	patient	ADJ
dpc-4805	124	24	outcomes	outcome	NOUN
dpc-4805	124	25	.	.	PUNCT
dpc-4805	125	1	by	by	ADP
dpc-4805	125	2	being	be	AUX
dpc-4805	125	3	able	able	ADJ
dpc-4805	125	4	to	to	PART
dpc-4805	125	5	understand	understand	VERB
dpc-4805	125	6	the	the	DET
dpc-4805	125	7	complexities	complexity	NOUN
dpc-4805	125	8	of	of	ADP
dpc-4805	125	9	these	these	DET
dpc-4805	125	10	relationships	relationship	NOUN
dpc-4805	125	11	as	as	ADP
dpc-4805	125	12	diarrhea	diarrhea	NOUN
dpc-4805	125	13	,	,	PUNCT
dpc-4805	125	14	nausea	nausea	NOUN
dpc-4805	125	15	,	,	PUNCT
dpc-4805	125	16	or	or	CCONJ
dpc-4805	125	17	vomiting	vomiting	NOUN
dpc-4805	125	18	,	,	PUNCT
dpc-4805	125	19	and	and	CCONJ
dpc-4805	125	20	weight	weight	NOUN
dpc-4805	125	21	loss	loss	NOUN
dpc-4805	125	22	in	in	ADP
dpc-4805	125	23	patients	patient	NOUN
dpc-4805	125	24	treated	treat	VERB
dpc-4805	125	25	with	with	ADP
dpc-4805	125	26	apremilast	apremilast	NOUN
dpc-4805	125	27	[	[	X
dpc-4805	125	28	17	17	NUM
dpc-4805	125	29	]	]	PUNCT
dpc-4805	125	30	.	.	PUNCT
dpc-4805	126	1	other	other	ADJ
dpc-4805	126	2	studies	study	NOUN
dpc-4805	126	3	have	have	AUX
dpc-4805	126	4	evaluated	evaluate	VERB
dpc-4805	126	5	the	the	DET
dpc-4805	126	6	reduction	reduction	NOUN
dpc-4805	126	7	in	in	ADP
dpc-4805	126	8	weight	weight	NOUN
dpc-4805	126	9	and/or	and/or	CCONJ
dpc-4805	126	10	bmi	bmi	VERB
dpc-4805	126	11	during	during	ADP
dpc-4805	126	12	apremilast	apremilast	NOUN
dpc-4805	126	13	therapy	therapy	NOUN
dpc-4805	126	14	.	.	PUNCT
dpc-4805	127	1	in	in	ADP
dpc-4805	127	2	a	a	DET
dpc-4805	127	3	6	6	NUM
dpc-4805	127	4	-	-	PUNCT
dpc-4805	127	5	month	month	NOUN
dpc-4805	127	6	prospective	prospective	ADJ
dpc-4805	127	7	open	open	ADJ
dpc-4805	127	8	-	-	PUNCT
dpc-4805	127	9	label	label	NOUN
dpc-4805	127	10	study	study	NOUN
dpc-4805	127	11	involving	involve	VERB
dpc-4805	127	12	patients	patient	NOUN
dpc-4805	127	13	with	with	ADP
dpc-4805	127	14	psa	psa	NOUN
dpc-4805	127	15	and	and	CCONJ
dpc-4805	127	16	psoriasis	psoriasis	NOUN
dpc-4805	127	17	treated	treat	VERB
dpc-4805	127	18	with	with	ADP
dpc-4805	127	19	apremilast	apremilast	ADJ
dpc-4805	127	20	,	,	PUNCT
dpc-4805	127	21	consistent	consistent	ADJ
dpc-4805	127	22	reductions	reduction	NOUN
dpc-4805	127	23	in	in	ADP
dpc-4805	127	24	weight	weight	NOUN
dpc-4805	127	25	and	and	CCONJ
dpc-4805	127	26	bmi	bmi	NOUN
dpc-4805	127	27	were	be	AUX
dpc-4805	127	28	reported	report	VERB
dpc-4805	127	29	.	.	PUNCT
dpc-4805	128	1	the	the	DET
dpc-4805	128	2	study	study	NOUN
dpc-4805	128	3	demonstrated	demonstrate	VERB
dpc-4805	128	4	an	an	DET
dpc-4805	128	5	average	average	ADJ
dpc-4805	128	6	weight	weight	NOUN
dpc-4805	128	7	loss	loss	NOUN
dpc-4805	128	8	of	of	ADP
dpc-4805	128	9	2.2	2.2	NUM
dpc-4805	128	10	kg	kg	NOUN
dpc-4805	128	11	,	,	PUNCT
dpc-4805	128	12	a	a	DET
dpc-4805	128	13	significant	significant	ADJ
dpc-4805	128	14	decrease	decrease	NOUN
dpc-4805	128	15	in	in	ADP
dpc-4805	128	16	waist	waist	NOUN
dpc-4805	128	17	circumference	circumference	NOUN
dpc-4805	128	18	at	at	ADP
dpc-4805	128	19	week	week	NOUN
dpc-4805	128	20	4	4	NUM
dpc-4805	128	21	,	,	PUNCT
dpc-4805	128	22	and	and	CCONJ
dpc-4805	128	23	a	a	DET
dpc-4805	128	24	reduction	reduction	NOUN
dpc-4805	128	25	in	in	ADP
dpc-4805	128	26	hip	hip	NOUN
dpc-4805	128	27	circumference	circumference	NOUN
dpc-4805	128	28	at	at	ADP
dpc-4805	128	29	week	week	NOUN
dpc-4805	128	30	12	12	NUM
dpc-4805	129	1	[	[	X
dpc-4805	129	2	21	21	NUM
dpc-4805	129	3	]	]	PUNCT
dpc-4805	129	4	.	.	PUNCT
dpc-4805	130	1	further	further	ADJ
dpc-4805	130	2	consideration	consideration	NOUN
dpc-4805	130	3	would	would	AUX
dpc-4805	130	4	be	be	AUX
dpc-4805	130	5	needed	need	VERB
dpc-4805	130	6	regarding	regard	VERB
dpc-4805	130	7	the	the	DET
dpc-4805	130	8	possible	possible	ADJ
dpc-4805	130	9	role	role	NOUN
dpc-4805	130	10	of	of	ADP
dpc-4805	130	11	the	the	DET
dpc-4805	130	12	molecule	molecule	NOUN
dpc-4805	130	13	on	on	ADP
dpc-4805	130	14	visceral	visceral	ADJ
dpc-4805	130	15	fat	fat	NOUN
dpc-4805	130	16	.	.	PUNCT
dpc-4805	131	1	the	the	DET
dpc-4805	131	2	differentiation	differentiation	NOUN
dpc-4805	131	3	between	between	ADP
dpc-4805	131	4	visceral	visceral	ADJ
dpc-4805	131	5	and	and	CCONJ
dpc-4805	131	6	subcutaneous	subcutaneous	ADJ
dpc-4805	131	7	fat	fat	NOUN
dpc-4805	131	8	assumes	assume	NOUN
dpc-4805	131	9	significance	significance	NOUN
dpc-4805	131	10	in	in	ADP
dpc-4805	131	11	the	the	DET
dpc-4805	131	12	assessment	assessment	NOUN
dpc-4805	131	13	of	of	ADP
dpc-4805	131	14	cardiovascular	cardiovascular	ADJ
dpc-4805	131	15	disease	disease	NOUN
dpc-4805	131	16	(	(	PUNCT
dpc-4805	131	17	cvd	cvd	NOUN
dpc-4805	131	18	)	)	PUNCT
dpc-4805	131	19	risk	risk	NOUN
dpc-4805	131	20	,	,	PUNCT
dpc-4805	131	21	given	give	VERB
dpc-4805	131	22	the	the	DET
dpc-4805	131	23	metabolic	metabolic	NOUN
dpc-4805	131	24	activity	activity	NOUN
dpc-4805	131	25	of	of	ADP
dpc-4805	131	26	the	the	DET
dpc-4805	131	27	former	former	ADJ
dpc-4805	131	28	and	and	CCONJ
dpc-4805	131	29	its	its	PRON
dpc-4805	131	30	impact	impact	NOUN
dpc-4805	131	31	on	on	ADP
dpc-4805	131	32	cardiovascular	cardiovascular	ADJ
dpc-4805	131	33	homeostasis	homeostasis	NOUN
dpc-4805	131	34	[	[	X
dpc-4805	131	35	22	22	NUM
dpc-4805	131	36	]	]	PUNCT
dpc-4805	131	37	.	.	PUNCT
dpc-4805	132	1	dysregulated	dysregulated	ADJ
dpc-4805	132	2	inflammation	inflammation	NOUN
dpc-4805	132	3	in	in	ADP
dpc-4805	132	4	visceral	visceral	ADJ
dpc-4805	132	5	adipose	adipose	ADJ
dpc-4805	132	6	tissue	tissue	NOUN
dpc-4805	132	7	exacerbates	exacerbate	VERB
dpc-4805	132	8	endothelial	endothelial	ADJ
dpc-4805	132	9	dysfunction	dysfunction	NOUN
dpc-4805	132	10	,	,	PUNCT
dpc-4805	132	11	altering	alter	VERB
dpc-4805	132	12	immune	immune	ADJ
dpc-4805	132	13	cell	cell	NOUN
dpc-4805	132	14	and	and	CCONJ
dpc-4805	132	15	adipokine	adipokine	ADJ
dpc-4805	132	16	profiles	profile	NOUN
dpc-4805	132	17	[	[	X
dpc-4805	132	18	23	23	NUM
dpc-4805	132	19	]	]	PUNCT
dpc-4805	132	20	.	.	PUNCT
dpc-4805	133	1	a	a	DET
dpc-4805	133	2	study	study	NOUN
dpc-4805	133	3	highlighted	highlight	VERB
dpc-4805	133	4	a	a	DET
dpc-4805	133	5	6	6	NUM
dpc-4805	133	6	%	%	NOUN
dpc-4805	133	7	reduction	reduction	NOUN
dpc-4805	133	8	in	in	ADP
dpc-4805	133	9	both	both	CCONJ
dpc-4805	133	10	subcutaneous	subcutaneous	ADJ
dpc-4805	133	11	and	and	CCONJ
dpc-4805	133	12	visceral	visceral	ADJ
dpc-4805	133	13	fat	fat	NOUN
dpc-4805	133	14	in	in	ADP
dpc-4805	133	15	patients	patient	NOUN
dpc-4805	133	16	treated	treat	VERB
dpc-4805	133	17	with	with	ADP
dpc-4805	133	18	apremilast	apremilast	ADJ
dpc-4805	133	19	,	,	PUNCT
dpc-4805	133	20	with	with	ADP
dpc-4805	133	21	a	a	DET
dpc-4805	133	22	steady	steady	ADJ
dpc-4805	133	23	downward	downward	ADJ
dpc-4805	133	24	trend	trend	NOUN
dpc-4805	133	25	from	from	ADP
dpc-4805	133	26	week	week	NOUN
dpc-4805	133	27	16	16	NUM
dpc-4805	133	28	to	to	ADP
dpc-4805	133	29	52	52	NUM
dpc-4805	133	30	[	[	X
dpc-4805	133	31	24	24	NUM
dpc-4805	133	32	]	]	PUNCT
dpc-4805	133	33	.	.	PUNCT
dpc-4805	134	1	consequently	consequently	ADV
dpc-4805	134	2	,	,	PUNCT
dpc-4805	134	3	the	the	DET
dpc-4805	134	4	observed	observed	ADJ
dpc-4805	134	5	decline	decline	NOUN
dpc-4805	134	6	in	in	ADP
dpc-4805	134	7	both	both	CCONJ
dpc-4805	134	8	subcutaneous	subcutaneous	ADJ
dpc-4805	134	9	and	and	CCONJ
dpc-4805	134	10	visceral	visceral	ADJ
dpc-4805	134	11	fat	fat	NOUN
dpc-4805	134	12	in	in	ADP
dpc-4805	134	13	patients	patient	NOUN
dpc-4805	134	14	receiving	receive	VERB
dpc-4805	134	15	apremilast	apremilast	ADJ
dpc-4805	134	16	treatment	treatment	NOUN
dpc-4805	134	17	suggests	suggest	VERB
dpc-4805	134	18	a	a	DET
dpc-4805	134	19	potential	potential	ADJ
dpc-4805	134	20	protective	protective	ADJ
dpc-4805	134	21	effect	effect	NOUN
dpc-4805	134	22	against	against	ADP
dpc-4805	134	23	cvds	cvds	PROPN
dpc-4805	134	24	.	.	PUNCT
dpc-4805	135	1	additionally	additionally	ADV
dpc-4805	135	2	,	,	PUNCT
dpc-4805	135	3	interventions	intervention	NOUN
dpc-4805	135	4	targeting	target	VERB
dpc-4805	135	5	weight	weight	NOUN
dpc-4805	135	6	loss	loss	NOUN
dpc-4805	135	7	have	have	AUX
dpc-4805	135	8	demonstrated	demonstrate	VERB
dpc-4805	135	9	efficacy	efficacy	NOUN
dpc-4805	135	10	in	in	ADP
dpc-4805	135	11	reducing	reduce	VERB
dpc-4805	135	12	psoriasis	psoriasis	NOUN
dpc-4805	135	13	severity	severity	NOUN
dpc-4805	135	14	among	among	ADP
dpc-4805	135	15	overweight	overweight	NOUN
dpc-4805	135	16	or	or	CCONJ
dpc-4805	135	17	obese	obese	ADJ
dpc-4805	135	18	individuals	individual	NOUN
dpc-4805	135	19	[	[	X
dpc-4805	135	20	25	25	NUM
dpc-4805	135	21	]	]	PUNCT
dpc-4805	135	22	.	.	PUNCT
dpc-4805	136	1	obesity	obesity	NOUN
dpc-4805	136	2	and	and	CCONJ
dpc-4805	136	3	elevated	elevated	ADJ
dpc-4805	136	4	bmi	bmi	NOUN
dpc-4805	136	5	,	,	PUNCT
dpc-4805	136	6	recognized	recognize	VERB
dpc-4805	136	7	as	as	ADP
dpc-4805	136	8	cvds	cvds	PROPN
dpc-4805	136	9	risk	risk	NOUN
dpc-4805	136	10	factors	factor	NOUN
dpc-4805	136	11	,	,	PUNCT
dpc-4805	136	12	have	have	AUX
dpc-4805	136	13	also	also	ADV
dpc-4805	136	14	been	be	AUX
dpc-4805	136	15	associated	associate	VERB
dpc-4805	136	16	with	with	ADP
dpc-4805	136	17	diminished	diminished	ADJ
dpc-4805	136	18	short	short	ADJ
dpc-4805	136	19	-	-	PUNCT
dpc-4805	136	20	term	term	NOUN
dpc-4805	136	21	clinical	clinical	ADJ
dpc-4805	136	22	responses	response	NOUN
dpc-4805	136	23	to	to	ADP
dpc-4805	136	24	various	various	ADJ
dpc-4805	136	25	systemic	systemic	ADJ
dpc-4805	136	26	treatments	treatment	NOUN
dpc-4805	136	27	,	,	PUNCT
dpc-4805	136	28	particularly	particularly	ADV
dpc-4805	136	29	biologics	biologic	NOUN
dpc-4805	136	30	[	[	X
dpc-4805	136	31	26	26	NUM
dpc-4805	136	32	]	]	PUNCT
dpc-4805	136	33	.	.	PUNCT
dpc-4805	137	1	therefore	therefore	ADV
dpc-4805	137	2	,	,	PUNCT
dpc-4805	137	3	the	the	DET
dpc-4805	137	4	documented	document	VERB
dpc-4805	137	5	influence	influence	NOUN
dpc-4805	137	6	of	of	ADP
dpc-4805	137	7	apremilast	apremilast	NOUN
dpc-4805	137	8	on	on	ADP
dpc-4805	137	9	weight	weight	NOUN
dpc-4805	137	10	loss	loss	NOUN
dpc-4805	137	11	and	and	CCONJ
dpc-4805	137	12	adiposity	adiposity	NOUN
dpc-4805	137	13	reduction	reduction	NOUN
dpc-4805	137	14	holds	hold	VERB
dpc-4805	137	15	promise	promise	NOUN
dpc-4805	137	16	for	for	ADP
dpc-4805	137	17	improving	improve	VERB
dpc-4805	137	18	metabolic	metabolic	ADJ
dpc-4805	137	19	profiles	profile	NOUN
dpc-4805	137	20	and	and	CCONJ
dpc-4805	137	21	treatment	treatment	NOUN
dpc-4805	137	22	responses	response	NOUN
dpc-4805	137	23	within	within	ADP
dpc-4805	137	24	this	this	DET
dpc-4805	137	25	specific	specific	ADJ
dpc-4805	137	26	patient	patient	ADJ
dpc-4805	137	27	population	population	NOUN
dpc-4805	137	28	.	.	PUNCT
dpc-4805	138	1	this	this	DET
dpc-4805	138	2	finding	finding	NOUN
dpc-4805	138	3	is	be	AUX
dpc-4805	138	4	part	part	NOUN
dpc-4805	138	5	of	of	ADP
dpc-4805	138	6	the	the	DET
dpc-4805	138	7	now	now	ADV
dpc-4805	138	8	widespread	widespread	ADJ
dpc-4805	138	9	and	and	CCONJ
dpc-4805	138	10	shared	share	VERB
dpc-4805	138	11	belief	belief	NOUN
dpc-4805	138	12	that	that	SCONJ
dpc-4805	138	13	a	a	DET
dpc-4805	138	14	comprehensive	comprehensive	ADJ
dpc-4805	138	15	approach	approach	NOUN
dpc-4805	138	16	to	to	ADP
dpc-4805	138	17	the	the	DET
dpc-4805	138	18	psoriatic	psoriatic	ADJ
dpc-4805	138	19	figure	figure	NOUN
dpc-4805	138	20	3	3	NUM
dpc-4805	138	21	.	.	NOUN
dpc-4805	138	22	comparison	comparison	NOUN
dpc-4805	138	23	between	between	ADP
dpc-4805	138	24	males	male	NOUN
dpc-4805	138	25	(	(	PUNCT
dpc-4805	138	26	light	light	NOUN
dpc-4805	138	27	gray	gray	NOUN
dpc-4805	138	28	)	)	PUNCT
dpc-4805	138	29	and	and	CCONJ
dpc-4805	138	30	females	female	NOUN
dpc-4805	138	31	(	(	PUNCT
dpc-4805	138	32	dark	dark	ADJ
dpc-4805	138	33	gray	gray	NOUN
dpc-4805	138	34	)	)	PUNCT
dpc-4805	138	35	for	for	ADP
dpc-4805	138	36	weight	weight	NOUN
dpc-4805	138	37	and	and	CCONJ
dpc-4805	138	38	bdy	bdy	VERB
dpc-4805	138	39	mass	mass	ADJ
dpc-4805	138	40	index	index	NOUN
dpc-4805	138	41	at	at	ADP
dpc-4805	138	42	baseline	baseline	PROPN
dpc-4805	138	43	,	,	PUNCT
dpc-4805	138	44	w24	w24	PROPN
dpc-4805	138	45	and	and	CCONJ
dpc-4805	138	46	w48	w48	NOUN
dpc-4805	138	47	.	.	PUNCT
dpc-4805	139	1	original	original	ADJ
dpc-4805	139	2	article	article	NOUN
dpc-4805	139	3	|	|	ADV
dpc-4805	139	4	dermatol	dermatol	ADJ
dpc-4805	139	5	pract	pract	NOUN
dpc-4805	139	6	concept	concept	NOUN
dpc-4805	139	7	.	.	PUNCT
dpc-4805	140	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	140	2	7	7	NUM
dpc-4805	140	3	13	13	NUM
dpc-4805	140	4	.	.	PUNCT
dpc-4805	141	1	hao	hao	PROPN
dpc-4805	141	2	y	y	PROPN
dpc-4805	141	3	,	,	PUNCT
dpc-4805	141	4	zhu	zhu	PROPN
dpc-4805	141	5	yj	yj	PROPN
dpc-4805	141	6	,	,	PUNCT
dpc-4805	141	7	zou	zou	PROPN
dpc-4805	141	8	s	s	PROPN
dpc-4805	141	9	,	,	PUNCT
dpc-4805	141	10	qx	qx	INTJ
dpc-4805	141	11	et	et	PROPN
dpc-4805	141	12	al	al	PROPN
dpc-4805	141	13	.	.	PROPN
dpc-4805	141	14	metabolic	metabolic	PROPN
dpc-4805	141	15	syndrome	syndrome	NOUN
dpc-4805	141	16	and	and	CCONJ
dpc-4805	141	17	psoriasis	psoriasis	NOUN
dpc-4805	141	18	:	:	PUNCT
dpc-4805	141	19	mechanisms	mechanism	NOUN
dpc-4805	141	20	and	and	CCONJ
dpc-4805	141	21	future	future	ADJ
dpc-4805	141	22	directions	direction	NOUN
dpc-4805	141	23	.	.	PUNCT
dpc-4805	142	1	front	front	ADJ
dpc-4805	142	2	immunol	immunol	NOUN
dpc-4805	142	3	.	.	PUNCT
dpc-4805	143	1	2021	2021	NUM
dpc-4805	143	2	jul	jul	PROPN
dpc-4805	143	3	23:12:711060	23:12:711060	PROPN
dpc-4805	143	4	.	.	PUNCT
dpc-4805	144	1	pmid	pmid	NOUN
dpc-4805	144	2	:	:	PUNCT
dpc-4805	144	3	34367173	34367173	NUM
dpc-4805	144	4	pmcid	pmcid	NOUN
dpc-4805	144	5	:	:	PUNCT
dpc-4805	144	6	pmc8343100	pmc8343100	PROPN
dpc-4805	144	7	doi	doi	NOUN
dpc-4805	144	8	:	:	PUNCT
dpc-4805	144	9	10.3389	10.3389	NUM
dpc-4805	144	10	/	/	SYM
dpc-4805	144	11	fimmu.2021.711060	fimmu.2021.711060	NOUN
dpc-4805	144	12	14	14	NUM
dpc-4805	144	13	.	.	PUNCT
dpc-4805	145	1	manzo	manzo	PROPN
dpc-4805	145	2	margiotta	margiotta	PROPN
dpc-4805	145	3	f	f	PROPN
dpc-4805	145	4	,	,	PUNCT
dpc-4805	145	5	michelucci	michelucci	VERB
dpc-4805	145	6	a	a	DET
dpc-4805	145	7	,	,	PUNCT
dpc-4805	145	8	capalbo	capalbo	NOUN
dpc-4805	145	9	e	e	NOUN
dpc-4805	145	10	,	,	PUNCT
dpc-4805	145	11	et	et	PROPN
dpc-4805	145	12	al	al	PROPN
dpc-4805	145	13	.	.	PROPN
dpc-4805	145	14	efficacy	efficacy	PROPN
dpc-4805	145	15	of	of	ADP
dpc-4805	145	16	risankizumab	risankizumab	PROPN
dpc-4805	145	17	after	after	ADP
dpc-4805	145	18	intra	intra	ADJ
dpc-4805	145	19	-	-	ADJ
dpc-4805	145	20	class	class	ADJ
dpc-4805	145	21	switching	switching	NOUN
dpc-4805	145	22	between	between	ADP
dpc-4805	145	23	anti	anti	NOUN
dpc-4805	145	24	il-23	il-23	NOUN
dpc-4805	145	25	antagonists	antagonist	NOUN
dpc-4805	145	26	:	:	PUNCT
dpc-4805	145	27	a	a	DET
dpc-4805	145	28	multi	multi	ADJ
dpc-4805	145	29	-	-	ADJ
dpc-4805	145	30	center	center	ADJ
dpc-4805	145	31	,	,	PUNCT
dpc-4805	145	32	retrospective	retrospective	ADJ
dpc-4805	145	33	,	,	PUNCT
dpc-4805	145	34	real	real	ADJ
dpc-4805	145	35	-	-	PUNCT
dpc-4805	145	36	life	life	NOUN
dpc-4805	145	37	observation	observation	NOUN
dpc-4805	145	38	.	.	PUNCT
dpc-4805	146	1	ital	ital	PROPN
dpc-4805	146	2	j	j	PROPN
dpc-4805	146	3	dermatol	dermatol	NOUN
dpc-4805	146	4	venereol	venereol	NOUN
dpc-4805	146	5	.	.	PUNCT
dpc-4805	147	1	2024	2024	NUM
dpc-4805	147	2	feb;159(1):64	feb;159(1):64	PROPN
dpc-4805	147	3	-	-	PUNCT
dpc-4805	147	4	65	65	NUM
dpc-4805	147	5	.	.	PUNCT
dpc-4805	148	1	pmid	pmid	NOUN
dpc-4805	148	2	:	:	PUNCT
dpc-4805	148	3	37997317	37997317	NUM
dpc-4805	148	4	doi	doi	NOUN
dpc-4805	148	5	:	:	PUNCT
dpc-4805	148	6	10.23736	10.23736	NUM
dpc-4805	148	7	/	/	SYM
dpc-4805	148	8	s2784	s2784	PROPN
dpc-4805	148	9	-	-	PUNCT
dpc-4805	148	10	8671.23.07648	8671.23.07648	NUM
dpc-4805	148	11	-	-	PUNCT
dpc-4805	148	12	x	x	SYM
dpc-4805	148	13	15	15	NUM
dpc-4805	148	14	.	.	PUNCT
dpc-4805	149	1	prignano	prignano	PROPN
dpc-4805	149	2	f	f	PROPN
dpc-4805	149	3	,	,	PUNCT
dpc-4805	149	4	pescitelli	pescitelli	PROPN
dpc-4805	149	5	l	l	PROPN
dpc-4805	149	6	,	,	PUNCT
dpc-4805	149	7	trovato	trovato	PROPN
dpc-4805	149	8	e	e	PROPN
dpc-4805	149	9	,	,	PUNCT
dpc-4805	149	10	et	et	PROPN
dpc-4805	149	11	al	al	PROPN
dpc-4805	149	12	.	.	PROPN
dpc-4805	150	1	tuscany	tuscany	PROPN
dpc-4805	150	2	consensus	consensus	PROPN
dpc-4805	150	3	for	for	ADP
dpc-4805	150	4	the	the	DET
dpc-4805	150	5	treatment	treatment	NOUN
dpc-4805	150	6	of	of	ADP
dpc-4805	150	7	moderate	moderate	ADJ
dpc-4805	150	8	-	-	PUNCT
dpc-4805	150	9	severe	severe	ADJ
dpc-4805	150	10	psoriasis	psoriasis	NOUN
dpc-4805	150	11	:	:	PUNCT
dpc-4805	150	12	update	update	VERB
dpc-4805	150	13	and	and	CCONJ
dpc-4805	150	14	focus	focus	VERB
dpc-4805	150	15	on	on	ADP
dpc-4805	150	16	practical	practical	ADJ
dpc-4805	150	17	guidelines	guideline	NOUN
dpc-4805	150	18	for	for	ADP
dpc-4805	150	19	place	place	NOUN
dpc-4805	150	20	in	in	ADP
dpc-4805	150	21	therapy	therapy	NOUN
dpc-4805	150	22	of	of	ADP
dpc-4805	150	23	anti	anti	ADJ
dpc-4805	150	24	-	-	ADJ
dpc-4805	150	25	il-17	il-17	ADJ
dpc-4805	150	26	and	and	CCONJ
dpc-4805	150	27	anti	anti	ADJ
dpc-4805	150	28	-	-	ADJ
dpc-4805	150	29	il-23	il-23	ADJ
dpc-4805	150	30	biologics	biologic	NOUN
dpc-4805	150	31	.	.	PUNCT
dpc-4805	151	1	ital	ital	PROPN
dpc-4805	151	2	j	j	PROPN
dpc-4805	151	3	dermatol	dermatol	NOUN
dpc-4805	151	4	venereol	venereol	NOUN
dpc-4805	151	5	.	.	PUNCT
dpc-4805	152	1	2022	2022	NUM
dpc-4805	152	2	dec;157(6):469	dec;157(6):469	NOUN
dpc-4805	152	3	-	-	ADJ
dpc-4805	152	4	479	479	NUM
dpc-4805	152	5	.	.	PUNCT
dpc-4805	153	1	pmid	pmid	NOUN
dpc-4805	153	2	:	:	PUNCT
dpc-4805	153	3	35785927	35785927	NUM
dpc-4805	153	4	doi	doi	NOUN
dpc-4805	153	5	:	:	PUNCT
dpc-4805	153	6	10.23736	10.23736	NUM
dpc-4805	153	7	/s2784	/s2784	NOUN
dpc-4805	153	8	-	-	PUNCT
dpc-4805	153	9	8671.22.07355	8671.22.07355	NUM
dpc-4805	153	10	-	-	SYM
dpc-4805	153	11	8	8	NUM
dpc-4805	153	12	16	16	NUM
dpc-4805	153	13	.	.	PUNCT
dpc-4805	154	1	gooderham	gooderham	PROPN
dpc-4805	154	2	m	m	PROPN
dpc-4805	154	3	,	,	PUNCT
dpc-4805	154	4	papp	papp	PROPN
dpc-4805	154	5	ka	ka	PROPN
dpc-4805	154	6	.	.	PROPN
dpc-4805	154	7	apremilast	apremilast	PROPN
dpc-4805	154	8	in	in	ADP
dpc-4805	154	9	the	the	DET
dpc-4805	154	10	treatment	treatment	NOUN
dpc-4805	154	11	of	of	ADP
dpc-4805	154	12	psoriasis	psoriasis	NOUN
dpc-4805	154	13	and	and	CCONJ
dpc-4805	154	14	psoriatic	psoriatic	ADJ
dpc-4805	154	15	arthritis	arthritis	NOUN
dpc-4805	154	16	.	.	PUNCT
dpc-4805	155	1	skin	skin	NOUN
dpc-4805	155	2	therapy	therapy	NOUN
dpc-4805	155	3	letter	letter	NOUN
dpc-4805	155	4	.	.	PUNCT
dpc-4805	156	1	2015	2015	NUM
dpc-4805	156	2	sep	sep	NOUN
dpc-4805	156	3	-	-	PUNCT
dpc-4805	156	4	oct;20(5):1	oct;20(5):1	NOUN
dpc-4805	156	5	-	-	PUNCT
dpc-4805	156	6	6	6	NUM
dpc-4805	156	7	.	.	PUNCT
dpc-4805	157	1	pmid	pmid	NOUN
dpc-4805	157	2	:	:	PUNCT
dpc-4805	157	3	26382906	26382906	NUM
dpc-4805	157	4	17	17	NUM
dpc-4805	157	5	.	.	PUNCT
dpc-4805	158	1	guerra	guerra	PROPN
dpc-4805	158	2	p	p	X
dpc-4805	158	3	,	,	PUNCT
dpc-4805	158	4	di	di	PROPN
dpc-4805	158	5	cesare	cesare	PROPN
dpc-4805	158	6	a	a	PROPN
dpc-4805	158	7	,	,	PUNCT
dpc-4805	158	8	rosi	rosi	PROPN
dpc-4805	158	9	e	e	PROPN
dpc-4805	158	10	,	,	PUNCT
dpc-4805	158	11	et	et	PROPN
dpc-4805	158	12	al	al	PROPN
dpc-4805	158	13	.	.	PUNCT
dpc-4805	158	14	effects	effect	NOUN
dpc-4805	158	15	on	on	ADP
dpc-4805	158	16	lipid	lipid	NOUN
dpc-4805	158	17	profile	profile	NOUN
dpc-4805	158	18	after	after	ADP
dpc-4805	158	19	one	one	NUM
dpc-4805	158	20	year	year	NOUN
dpc-4805	158	21	of	of	ADP
dpc-4805	158	22	apremilast	apremilast	NOUN
dpc-4805	158	23	therapy	therapy	NOUN
dpc-4805	158	24	in	in	ADP
dpc-4805	158	25	patients	patient	NOUN
dpc-4805	158	26	with	with	ADP
dpc-4805	158	27	psoriasis	psoriasis	NOUN
dpc-4805	158	28	:	:	PUNCT
dpc-4805	158	29	a	a	DET
dpc-4805	158	30	monocentric	monocentric	ADJ
dpc-4805	158	31	experience	experience	NOUN
dpc-4805	158	32	.	.	PUNCT
dpc-4805	159	1	life	life	NOUN
dpc-4805	159	2	(	(	PUNCT
dpc-4805	159	3	basel	basel	PROPN
dpc-4805	159	4	)	)	PUNCT
dpc-4805	159	5	.	.	PUNCT
dpc-4805	160	1	2024	2024	NUM
dpc-4805	160	2	mar	mar	PROPN
dpc-4805	160	3	16;14(3):395	16;14(3):395	PROPN
dpc-4805	160	4	.	.	PUNCT
dpc-4805	161	1	pmid	pmid	PROPN
dpc-4805	161	2	:	:	PUNCT
dpc-4805	161	3	38541719	38541719	NUM
dpc-4805	161	4	pmcid	pmcid	NOUN
dpc-4805	161	5	:	:	PUNCT
dpc-4805	161	6	pmc10971498	pmc10971498	NOUN
dpc-4805	161	7	doi	doi	NOUN
dpc-4805	161	8	:	:	PUNCT
dpc-4805	161	9	10.3390	10.3390	NUM
dpc-4805	161	10	/life14030395	/life14030395	SYM
dpc-4805	161	11	18	18	NUM
dpc-4805	161	12	.	.	X
dpc-4805	161	13	ferguson	ferguson	PROPN
dpc-4805	161	14	ld	ld	PROPN
dpc-4805	161	15	,	,	PUNCT
dpc-4805	161	16	cathcart	cathcart	PROPN
dpc-4805	161	17	s	s	PROPN
dpc-4805	161	18	,	,	PUNCT
dpc-4805	161	19	rimmer	rimmer	PROPN
dpc-4805	161	20	d	d	PROPN
dpc-4805	161	21	,	,	PUNCT
dpc-4805	161	22	et	et	PROPN
dpc-4805	161	23	al	al	PROPN
dpc-4805	161	24	.	.	PROPN
dpc-4805	161	25	effect	effect	NOUN
dpc-4805	161	26	of	of	ADP
dpc-4805	161	27	the	the	DET
dpc-4805	161	28	phosphodiesterase	phosphodiesterase	NOUN
dpc-4805	161	29	4	4	NUM
dpc-4805	161	30	inhibitor	inhibitor	NOUN
dpc-4805	161	31	apremilast	apremilast	NOUN
dpc-4805	161	32	on	on	ADP
dpc-4805	161	33	cardiometabolic	cardiometabolic	ADJ
dpc-4805	161	34	outcomes	outcome	NOUN
dpc-4805	161	35	in	in	ADP
dpc-4805	161	36	psoriatic	psoriatic	ADJ
dpc-4805	161	37	disease	disease	NOUN
dpc-4805	161	38	-	-	PUNCT
dpc-4805	161	39	results	result	NOUN
dpc-4805	161	40	of	of	ADP
dpc-4805	161	41	the	the	DET
dpc-4805	161	42	immune	immune	ADJ
dpc-4805	161	43	metabolic	metabolic	NOUN
dpc-4805	161	44	associations	association	NOUN
dpc-4805	161	45	in	in	ADP
dpc-4805	161	46	psoriatic	psoriatic	ADJ
dpc-4805	161	47	arthritis	arthritis	NOUN
dpc-4805	161	48	study	study	NOUN
dpc-4805	161	49	.	.	PUNCT
dpc-4805	162	1	rheumatology	rheumatology	NOUN
dpc-4805	162	2	.	.	PUNCT
dpc-4805	163	1	2022	2022	NUM
dpc-4805	163	2	mar	mar	PROPN
dpc-4805	163	3	2	2	NUM
dpc-4805	163	4	;	;	PUNCT
dpc-4805	163	5	61(3):1026	61(3):1026	PROPN
dpc-4805	163	6	-	-	PUNCT
dpc-4805	163	7	1034	1034	NUM
dpc-4805	163	8	.	.	PUNCT
dpc-4805	164	1	pmid	pmid	NOUN
dpc-4805	164	2	:	:	PUNCT
dpc-4805	164	3	34097014	34097014	NUM
dpc-4805	164	4	pmcid	pmcid	NOUN
dpc-4805	164	5	:	:	PUNCT
dpc-4805	164	6	pmc8889283	pmc8889283	PROPN
dpc-4805	164	7	doi	doi	PROPN
dpc-4805	164	8	:	:	PUNCT
dpc-4805	164	9	10.1093	10.1093	NUM
dpc-4805	164	10	/	/	SYM
dpc-4805	164	11	rheumatology	rheumatology	NOUN
dpc-4805	164	12	/	/	SYM
dpc-4805	164	13	keab474	keab474	PROPN
dpc-4805	164	14	19	19	NUM
dpc-4805	164	15	.	.	PUNCT
dpc-4805	165	1	kosmas	kosmas	PROPN
dpc-4805	165	2	ce	ce	PROPN
dpc-4805	165	3	,	,	PUNCT
dpc-4805	165	4	rodriguez	rodriguez	PROPN
dpc-4805	165	5	polanco	polanco	PROPN
dpc-4805	165	6	s	s	PROPN
dpc-4805	165	7	,	,	PUNCT
dpc-4805	165	8	bousvarou	bousvarou	PROPN
dpc-4805	165	9	md	md	PROPN
dpc-4805	165	10	,	,	PUNCT
dpc-4805	165	11	et	et	PROPN
dpc-4805	165	12	al	al	PROPN
dpc-4805	165	13	.	.	PUNCT
dpc-4805	166	1	the	the	DET
dpc-4805	166	2	triglyceride	triglyceride	ADJ
dpc-4805	166	3	/	/	SYM
dpc-4805	166	4	high	high	ADJ
dpc-4805	166	5	-	-	PUNCT
dpc-4805	166	6	density	density	NOUN
dpc-4805	166	7	lipoprotein	lipoprotein	ADJ
dpc-4805	166	8	cholesterol	cholesterol	NOUN
dpc-4805	166	9	(	(	PUNCT
dpc-4805	166	10	tg	tg	PROPN
dpc-4805	166	11	/	/	SYM
dpc-4805	166	12	hdl	hdl	PROPN
dpc-4805	166	13	-	-	PUNCT
dpc-4805	166	14	c	c	NOUN
dpc-4805	166	15	)	)	PUNCT
dpc-4805	166	16	ratio	ratio	NOUN
dpc-4805	166	17	as	as	ADP
dpc-4805	166	18	a	a	DET
dpc-4805	166	19	risk	risk	NOUN
dpc-4805	166	20	marker	marker	NOUN
dpc-4805	166	21	for	for	ADP
dpc-4805	166	22	metabolic	metabolic	NOUN
dpc-4805	166	23	syndrome	syndrome	NOUN
dpc-4805	166	24	and	and	CCONJ
dpc-4805	166	25	cardiovascular	cardiovascular	ADJ
dpc-4805	166	26	disease	disease	NOUN
dpc-4805	166	27	.	.	PUNCT
dpc-4805	167	1	diagnostics	diagnostic	NOUN
dpc-4805	167	2	(	(	PUNCT
dpc-4805	167	3	basel	basel	PROPN
dpc-4805	167	4	)	)	PUNCT
dpc-4805	167	5	.	.	PUNCT
dpc-4805	168	1	2023	2023	NUM
dpc-4805	168	2	mar	mar	PROPN
dpc-4805	168	3	1;13(5):929	1;13(5):929	NUM
dpc-4805	168	4	.	.	PUNCT
dpc-4805	169	1	pmid	pmid	NOUN
dpc-4805	169	2	:	:	PUNCT
dpc-4805	169	3	36900073	36900073	NUM
dpc-4805	169	4	pmcid	pmcid	NOUN
dpc-4805	169	5	:	:	PUNCT
dpc-4805	169	6	pmc10001260	pmc10001260	PROPN
dpc-4805	169	7	doi	doi	PROPN
dpc-4805	169	8	:	:	PUNCT
dpc-4805	169	9	10.3390	10.3390	NUM
dpc-4805	169	10	/diagnostics13050929	/diagnostics13050929	SYM
dpc-4805	169	11	20	20	NUM
dpc-4805	169	12	.	.	PUNCT
dpc-4805	170	1	crowley	crowley	PROPN
dpc-4805	170	2	j	j	PROPN
dpc-4805	170	3	,	,	PUNCT
dpc-4805	170	4	diamant	diamant	NOUN
dpc-4805	170	5	d	d	PROPN
dpc-4805	170	6	,	,	PUNCT
dpc-4805	170	7	joly	joly	PROPN
dpc-4805	170	8	p	p	PROPN
dpc-4805	170	9	,	,	PUNCT
dpc-4805	170	10	et	et	PROPN
dpc-4805	170	11	al	al	PROPN
dpc-4805	170	12	.	.	PUNCT
dpc-4805	171	1	long	long	ADJ
dpc-4805	171	2	-	-	PUNCT
dpc-4805	171	3	term	term	NOUN
dpc-4805	171	4	safety	safety	NOUN
dpc-4805	171	5	and	and	CCONJ
dpc-4805	171	6	tolerability	tolerability	NOUN
dpc-4805	171	7	of	of	ADP
dpc-4805	171	8	apremilast	apremilast	NOUN
dpc-4805	171	9	in	in	ADP
dpc-4805	171	10	patients	patient	NOUN
dpc-4805	171	11	with	with	ADP
dpc-4805	171	12	psoriasis	psoriasis	NOUN
dpc-4805	171	13	:	:	PUNCT
dpc-4805	171	14	pooled	pool	VERB
dpc-4805	171	15	safety	safety	NOUN
dpc-4805	171	16	analysis	analysis	NOUN
dpc-4805	171	17	for	for	ADP
dpc-4805	171	18	≥156	≥156	NOUN
dpc-4805	171	19	 	 	SPACE
dpc-4805	171	20	weeks	week	NOUN
dpc-4805	171	21	from	from	ADP
dpc-4805	171	22	2	2	NUM
dpc-4805	171	23	phase	phase	NOUN
dpc-4805	171	24	3	3	NUM
dpc-4805	171	25	,	,	PUNCT
dpc-4805	171	26	randomized	randomize	VERB
dpc-4805	171	27	,	,	PUNCT
dpc-4805	171	28	controlled	control	VERB
dpc-4805	171	29	trials	trial	NOUN
dpc-4805	171	30	(	(	PUNCT
dpc-4805	171	31	esteem	esteem	NOUN
dpc-4805	171	32	1	1	NUM
dpc-4805	171	33	and	and	CCONJ
dpc-4805	171	34	2	2	NUM
dpc-4805	171	35	)	)	PUNCT
dpc-4805	171	36	.	.	PUNCT
dpc-4805	172	1	j	j	PROPN
dpc-4805	172	2	am	be	AUX
dpc-4805	172	3	acad	acad	ADJ
dpc-4805	172	4	dermatol	dermatol	NOUN
dpc-4805	172	5	.	.	PUNCT
dpc-4805	173	1	2017	2017	NUM
dpc-4805	173	2	aug;77(2	aug;77(2	NOUN
dpc-4805	173	3	):	):	PUNCT
dpc-4805	173	4	310	310	NUM
dpc-4805	173	5	-	-	NUM
dpc-4805	173	6	317.e1	317.e1	NUM
dpc-4805	173	7	.	.	PUNCT
dpc-4805	174	1	pmid	pmid	NOUN
dpc-4805	174	2	:	:	PUNCT
dpc-4805	174	3	28416342	28416342	NUM
dpc-4805	174	4	doi	doi	NOUN
dpc-4805	174	5	:	:	PUNCT
dpc-4805	174	6	10.1016	10.1016	NUM
dpc-4805	174	7	/	/	SYM
dpc-4805	174	8	j.jaad.2017.01.052	j.jaad.2017.01.052	PROPN
dpc-4805	174	9	21	21	NUM
dpc-4805	174	10	.	.	PUNCT
dpc-4805	175	1	shah	shah	NOUN
dpc-4805	175	2	bj	bj	PROPN
dpc-4805	175	3	,	,	PUNCT
dpc-4805	175	4	mistry	mistry	PROPN
dpc-4805	175	5	d	d	PROPN
dpc-4805	175	6	,	,	PUNCT
dpc-4805	175	7	chaudhary	chaudhary	PROPN
dpc-4805	175	8	n	n	CCONJ
dpc-4805	175	9	,	,	PUNCT
dpc-4805	175	10	shah	shah	PROPN
dpc-4805	175	11	a.	a.	PROPN
dpc-4805	175	12	real	real	ADJ
dpc-4805	175	13	-	-	PUNCT
dpc-4805	175	14	world	world	NOUN
dpc-4805	175	15	efficacy	efficacy	NOUN
dpc-4805	175	16	and	and	CCONJ
dpc-4805	175	17	safety	safety	NOUN
dpc-4805	175	18	of	of	ADP
dpc-4805	175	19	apremilast	apremilast	ADJ
dpc-4805	175	20	monotherapy	monotherapy	NOUN
dpc-4805	175	21	in	in	ADP
dpc-4805	175	22	the	the	DET
dpc-4805	175	23	management	management	NOUN
dpc-4805	175	24	of	of	ADP
dpc-4805	175	25	moderate	moderate	ADJ
dpc-4805	175	26	-	-	PUNCT
dpc-4805	175	27	to	to	ADP
dpc-4805	175	28	-	-	PUNCT
dpc-4805	175	29	severe	severe	ADJ
dpc-4805	175	30	psoriasis	psoriasis	NOUN
dpc-4805	175	31	.	.	PUNCT
dpc-4805	176	1	indian	indian	ADJ
dpc-4805	176	2	dermatol	dermatol	NOUN
dpc-4805	176	3	online	online	PROPN
dpc-4805	176	4	j.	j.	PROPN
dpc-4805	176	5	2020	2020	NUM
dpc-4805	176	6	jan	jan	PROPN
dpc-4805	176	7	13;11(1):51	13;11(1):51	NUM
dpc-4805	176	8	-	-	SYM
dpc-4805	176	9	57	57	NUM
dpc-4805	176	10	.	.	PUNCT
dpc-4805	177	1	pmid	pmid	NOUN
dpc-4805	177	2	:	:	PUNCT
dpc-4805	177	3	32055509	32055509	NUM
dpc-4805	177	4	pmcid	pmcid	NOUN
dpc-4805	177	5	:	:	PUNCT
dpc-4805	177	6	pmc7001393	pmc7001393	NOUN
dpc-4805	177	7	doi	doi	NOUN
dpc-4805	177	8	:	:	PUNCT
dpc-4805	177	9	10.4103	10.4103	NUM
dpc-4805	177	10	/	/	SYM
dpc-4805	177	11	idoj.idoj_169_19	idoj.idoj_169_19	NOUN
dpc-4805	177	12	22	22	NUM
dpc-4805	177	13	.	.	PUNCT
dpc-4805	178	1	abraham	abraham	PROPN
dpc-4805	178	2	tm	tm	PROPN
dpc-4805	178	3	,	,	PUNCT
dpc-4805	178	4	pedley	pedley	PROPN
dpc-4805	178	5	a	a	X
dpc-4805	178	6	,	,	PUNCT
dpc-4805	178	7	massaro	massaro	PROPN
dpc-4805	178	8	jm	jm	PROPN
dpc-4805	178	9	,	,	PUNCT
dpc-4805	178	10	hoffmann	hoffmann	PROPN
dpc-4805	178	11	u	u	PROPN
dpc-4805	178	12	,	,	PUNCT
dpc-4805	178	13	fox	fox	PROPN
dpc-4805	178	14	cs	cs	PROPN
dpc-4805	178	15	.	.	PROPN
dpc-4805	178	16	association	association	PROPN
dpc-4805	178	17	between	between	ADP
dpc-4805	178	18	visceral	visceral	ADJ
dpc-4805	178	19	and	and	CCONJ
dpc-4805	178	20	subcutaneous	subcutaneous	ADJ
dpc-4805	178	21	adipose	adipose	ADJ
dpc-4805	178	22	depots	depot	NOUN
dpc-4805	178	23	and	and	CCONJ
dpc-4805	178	24	incident	incident	NOUN
dpc-4805	178	25	cardiovascular	cardiovascular	ADJ
dpc-4805	178	26	disease	disease	NOUN
dpc-4805	178	27	risk	risk	NOUN
dpc-4805	178	28	factors	factor	NOUN
dpc-4805	178	29	.	.	PUNCT
dpc-4805	179	1	circulation	circulation	NOUN
dpc-4805	179	2	.	.	PUNCT
dpc-4805	180	1	2015	2015	NUM
dpc-4805	180	2	oct	oct	NOUN
dpc-4805	180	3	27;132(17):1639	27;132(17):1639	PROPN
dpc-4805	180	4	-	-	SYM
dpc-4805	180	5	47	47	NUM
dpc-4805	180	6	.	.	PUNCT
dpc-4805	181	1	pmid	pmid	NOUN
dpc-4805	181	2	:	:	PUNCT
dpc-4805	181	3	26294660	26294660	NUM
dpc-4805	181	4	pmcid	pmcid	NOUN
dpc-4805	181	5	:	:	PUNCT
dpc-4805	181	6	pmc4779497	pmc4779497	NOUN
dpc-4805	181	7	doi	doi	NOUN
dpc-4805	181	8	:	:	PUNCT
dpc-4805	181	9	10.1161	10.1161	NUM
dpc-4805	181	10	/	/	SYM
dpc-4805	181	11	circulationaha.114.015000	circulationaha.114.015000	PROPN
dpc-4805	181	12	23	23	NUM
dpc-4805	181	13	.	.	PUNCT
dpc-4805	182	1	kawai	kawai	PROPN
dpc-4805	182	2	t	t	PROPN
dpc-4805	182	3	,	,	PUNCT
dpc-4805	182	4	autieri	autieri	PROPN
dpc-4805	182	5	mv	mv	PROPN
dpc-4805	182	6	,	,	PUNCT
dpc-4805	182	7	scalia	scalia	PROPN
dpc-4805	182	8	r.	r.	PROPN
dpc-4805	182	9	adipose	adipose	ADP
dpc-4805	182	10	tissue	tissue	NOUN
dpc-4805	182	11	inflammation	inflammation	NOUN
dpc-4805	182	12	and	and	CCONJ
dpc-4805	182	13	metabolic	metabolic	ADJ
dpc-4805	182	14	dysfunction	dysfunction	NOUN
dpc-4805	182	15	in	in	ADP
dpc-4805	182	16	obesity	obesity	NOUN
dpc-4805	182	17	.	.	PUNCT
dpc-4805	182	18	am	be	AUX
dpc-4805	182	19	j	j	PROPN
dpc-4805	182	20	physiol	physiol	PROPN
dpc-4805	182	21	cell	cell	PROPN
dpc-4805	182	22	physiol	physiol	PROPN
dpc-4805	182	23	.	.	PUNCT
dpc-4805	183	1	2021	2021	NUM
dpc-4805	183	2	mar	mar	PROPN
dpc-4805	183	3	1;320(3):c375	1;320(3):c375	PROPN
dpc-4805	183	4	-	-	PUNCT
dpc-4805	183	5	c391	c391	PROPN
dpc-4805	183	6	.	.	PUNCT
dpc-4805	184	1	pmid	pmid	PROPN
dpc-4805	184	2	:	:	PUNCT
dpc-4805	184	3	33356944	33356944	NUM
dpc-4805	184	4	pmcid	pmcid	NOUN
dpc-4805	184	5	:	:	PUNCT
dpc-4805	184	6	pmc8294624	pmc8294624	NOUN
dpc-4805	184	7	doi	doi	NOUN
dpc-4805	184	8	:	:	PUNCT
dpc-4805	184	9	10.1152	10.1152	NUM
dpc-4805	184	10	/	/	SYM
dpc-4805	184	11	ajpcell.00379.2020	ajpcell.00379.2020	DET
dpc-4805	184	12	24	24	NUM
dpc-4805	184	13	.	.	PUNCT
dpc-4805	185	1	gelfand	gelfand	PROPN
dpc-4805	185	2	jm	jm	PROPN
dpc-4805	185	3	,	,	PUNCT
dpc-4805	185	4	shin	shin	PROPN
dpc-4805	185	5	db	db	PROPN
dpc-4805	185	6	,	,	PUNCT
dpc-4805	185	7	armstrong	armstrong	PROPN
dpc-4805	185	8	aw	aw	INTJ
dpc-4805	185	9	,	,	PUNCT
dpc-4805	185	10	et	et	PROPN
dpc-4805	185	11	al	al	PROPN
dpc-4805	185	12	.	.	PROPN
dpc-4805	185	13	association	association	PROPN
dpc-4805	185	14	of	of	ADP
dpc-4805	185	15	apremilast	apremilast	NOUN
dpc-4805	185	16	with	with	ADP
dpc-4805	185	17	vascular	vascular	ADJ
dpc-4805	185	18	inflammation	inflammation	NOUN
dpc-4805	185	19	and	and	CCONJ
dpc-4805	185	20	cardiometabolic	cardiometabolic	NOUN
dpc-4805	185	21	function	function	NOUN
dpc-4805	185	22	in	in	ADP
dpc-4805	185	23	patients	patient	NOUN
dpc-4805	185	24	with	with	ADP
dpc-4805	185	25	psoriasis	psoriasis	NOUN
dpc-4805	185	26	:	:	PUNCT
dpc-4805	185	27	the	the	DET
dpc-4805	185	28	vip	vip	NOUN
dpc-4805	185	29	-	-	PUNCT
dpc-4805	185	30	a	a	DET
dpc-4805	185	31	phase	phase	NOUN
dpc-4805	185	32	4	4	NUM
dpc-4805	185	33	,	,	PUNCT
dpc-4805	185	34	open	open	ADJ
dpc-4805	185	35	-	-	PUNCT
dpc-4805	185	36	label	label	NOUN
dpc-4805	185	37	,	,	PUNCT
dpc-4805	185	38	nonrandomized	nonrandomize	VERB
dpc-4805	185	39	clinical	clinical	ADJ
dpc-4805	185	40	trial2	trial2	NOUN
dpc-4805	185	41	.	.	PUNCT
dpc-4805	186	1	jama	jama	PROPN
dpc-4805	186	2	dermatology	dermatology	PROPN
dpc-4805	186	3	.	.	PUNCT
dpc-4805	187	1	2022	2022	NUM
dpc-4805	187	2	dec	dec	PROPN
dpc-4805	187	3	1;158(12):1394	1;158(12):1394	PROPN
dpc-4805	187	4	-	-	SYM
dpc-4805	187	5	1403	1403	NUM
dpc-4805	187	6	.	.	PUNCT
dpc-4805	188	1	pmid	pmid	NOUN
dpc-4805	188	2	:	:	PUNCT
dpc-4805	188	3	36129688	36129688	NUM
dpc-4805	188	4	pmcid	pmcid	NOUN
dpc-4805	188	5	:	:	PUNCT
dpc-4805	188	6	pmc9494263	pmc9494263	ADJ
dpc-4805	188	7	doi	doi	NOUN
dpc-4805	188	8	:	:	PUNCT
dpc-4805	188	9	10.1001	10.1001	NUM
dpc-4805	188	10	/	/	SYM
dpc-4805	188	11	jamadermatol.2022.3862	jamadermatol.2022.3862	NOUN
dpc-4805	188	12	through	through	ADP
dpc-4805	188	13	further	further	ADJ
dpc-4805	188	14	research	research	NOUN
dpc-4805	188	15	and	and	CCONJ
dpc-4805	188	16	clinical	clinical	ADJ
dpc-4805	188	17	practice	practice	NOUN
dpc-4805	188	18	,	,	PUNCT
dpc-4805	188	19	we	we	PRON
dpc-4805	188	20	can	can	AUX
dpc-4805	188	21	pave	pave	VERB
dpc-4805	188	22	the	the	DET
dpc-4805	188	23	way	way	NOUN
dpc-4805	188	24	for	for	ADP
dpc-4805	188	25	more	more	ADV
dpc-4805	188	26	personalized	personalized	ADJ
dpc-4805	188	27	and	and	CCONJ
dpc-4805	188	28	holistic	holistic	ADJ
dpc-4805	188	29	approaches	approach	NOUN
dpc-4805	188	30	to	to	ADP
dpc-4805	188	31	psoriasis	psoriasis	NOUN
dpc-4805	188	32	care	care	NOUN
dpc-4805	188	33	,	,	PUNCT
dpc-4805	188	34	ultimately	ultimately	ADV
dpc-4805	188	35	empowering	empower	VERB
dpc-4805	188	36	individuals	individual	NOUN
dpc-4805	188	37	to	to	PART
dpc-4805	188	38	better	well	ADV
dpc-4805	188	39	cope	cope	VERB
dpc-4805	188	40	with	with	ADP
dpc-4805	188	41	the	the	DET
dpc-4805	188	42	challenges	challenge	NOUN
dpc-4805	188	43	posed	pose	VERB
dpc-4805	188	44	by	by	ADP
dpc-4805	188	45	this	this	DET
dpc-4805	188	46	chronic	chronic	ADJ
dpc-4805	188	47	condition	condition	NOUN
dpc-4805	188	48	.	.	PUNCT
dpc-4805	189	1	references	reference	NOUN
dpc-4805	189	2	1	1	NUM
dpc-4805	189	3	.	.	PUNCT
dpc-4805	190	1	mustansir	mustansir	NOUN
dpc-4805	190	2	sahi	sahi	PROPN
dpc-4805	191	1	f	f	PROPN
dpc-4805	191	2	,	,	PUNCT
dpc-4805	191	3	masood	masood	PROPN
dpc-4805	191	4	a	a	PROPN
dpc-4805	191	5	,	,	PUNCT
dpc-4805	191	6	danawar	danawar	NOUN
dpc-4805	191	7	na	na	NOUN
dpc-4805	191	8	,	,	PUNCT
dpc-4805	191	9	mekaiel	mekaiel	NOUN
dpc-4805	191	10	a	a	PRON
dpc-4805	191	11	,	,	PUNCT
dpc-4805	191	12	haider	haider	PROPN
dpc-4805	191	13	malik	malik	PROPN
dpc-4805	191	14	b.	b.	PROPN
dpc-4805	191	15	association	association	PROPN
dpc-4805	191	16	between	between	ADP
dpc-4805	191	17	psoriasis	psoriasis	NOUN
dpc-4805	191	18	and	and	CCONJ
dpc-4805	191	19	depression	depression	NOUN
dpc-4805	191	20	:	:	PUNCT
dpc-4805	191	21	a	a	DET
dpc-4805	191	22	traditional	traditional	ADJ
dpc-4805	191	23	review	review	NOUN
dpc-4805	191	24	.	.	PUNCT
dpc-4805	192	1	cureus	cureus	NOUN
dpc-4805	192	2	2020	2020	NUM
dpc-4805	192	3	aug	aug	PROPN
dpc-4805	192	4	13;12(8):e9708	13;12(8):e9708	NUM
dpc-4805	192	5	.	.	PUNCT
dpc-4805	193	1	pmid	pmid	NOUN
dpc-4805	193	2	:	:	PUNCT
dpc-4805	193	3	32944430	32944430	NUM
dpc-4805	193	4	pmcid	pmcid	NOUN
dpc-4805	193	5	:	:	PUNCT
dpc-4805	193	6	pmc7489316	pmc7489316	ADJ
dpc-4805	193	7	doi	doi	NOUN
dpc-4805	193	8	:	:	PUNCT
dpc-4805	193	9	10.7759	10.7759	NUM
dpc-4805	193	10	/	/	SYM
dpc-4805	193	11	cureus.9708	cureus.9708	PROPN
dpc-4805	193	12	2	2	NUM
dpc-4805	193	13	.	.	PUNCT
dpc-4805	193	14	blackstone	blackstone	PROPN
dpc-4805	193	15	b	b	PROPN
dpc-4805	193	16	,	,	PUNCT
dpc-4805	193	17	patel	patel	PROPN
dpc-4805	193	18	r	r	PROPN
dpc-4805	193	19	,	,	PUNCT
dpc-4805	193	20	bewley	bewley	NOUN
dpc-4805	193	21	a.	a.	NOUN
dpc-4805	193	22	assessing	assess	VERB
dpc-4805	193	23	and	and	CCONJ
dpc-4805	193	24	improving	improve	VERB
dpc-4805	193	25	psychological	psychological	ADJ
dpc-4805	193	26	well	well	ADV
dpc-4805	193	27	-	-	PUNCT
dpc-4805	193	28	being	being	NOUN
dpc-4805	193	29	in	in	ADP
dpc-4805	193	30	psoriasis	psoriasis	NOUN
dpc-4805	193	31	:	:	PUNCT
dpc-4805	193	32	considerations	consideration	NOUN
dpc-4805	193	33	for	for	ADP
dpc-4805	193	34	the	the	DET
dpc-4805	193	35	clinician	clinician	NOUN
dpc-4805	193	36	.	.	PUNCT
dpc-4805	194	1	psoriasis	psoriasis	NOUN
dpc-4805	194	2	(	(	PUNCT
dpc-4805	194	3	auckland	auckland	PROPN
dpc-4805	194	4	,	,	PUNCT
dpc-4805	194	5	n.z	n.z	PROPN
dpc-4805	194	6	.	.	PROPN
dpc-4805	194	7	)	)	PUNCT
dpc-4805	194	8	12	12	NUM
dpc-4805	194	9	(	(	PUNCT
dpc-4805	194	10	2022	2022	NUM
dpc-4805	194	11	):	):	PUNCT
dpc-4805	194	12	25–33	25–33	NUM
dpc-4805	194	13	.	.	PUNCT
dpc-4805	195	1	pmid	pmid	NOUN
dpc-4805	195	2	:	:	PUNCT
dpc-4805	195	3	35371967	35371967	NUM
dpc-4805	195	4	pmcid	pmcid	NOUN
dpc-4805	195	5	:	:	PUNCT
dpc-4805	195	6	pmc8965012	pmc8965012	PROPN
dpc-4805	195	7	doi	doi	PROPN
dpc-4805	195	8	:	:	PUNCT
dpc-4805	195	9	10.2147	10.2147	NUM
dpc-4805	195	10	/	/	SYM
dpc-4805	195	11	ptt.s328447	ptt.s328447	NOUN
dpc-4805	195	12	3	3	NUM
dpc-4805	195	13	.	.	PUNCT
dpc-4805	196	1	zafiriou	zafiriou	NOUN
dpc-4805	196	2	e	e	PROPN
dpc-4805	196	3	,	,	PUNCT
dpc-4805	196	4	karampinis	karampinis	PROPN
dpc-4805	196	5	e	e	NOUN
dpc-4805	196	6	,	,	PUNCT
dpc-4805	196	7	roussaki	roussaki	NOUN
dpc-4805	196	8	-	-	PUNCT
dpc-4805	196	9	schulze	schulze	NOUN
dpc-4805	196	10	av	av	NOUN
dpc-4805	196	11	.	.	PUNCT
dpc-4805	196	12	psoriasis	psoriasis	NOUN
dpc-4805	196	13	and	and	CCONJ
dpc-4805	196	14	exposome	exposome	NOUN
dpc-4805	196	15	:	:	PUNCT
dpc-4805	196	16	unveiling	unveil	VERB
dpc-4805	196	17	the	the	DET
dpc-4805	196	18	inner	inner	NOUN
dpc-4805	196	19	and	and	CCONJ
dpc-4805	196	20	the	the	DET
dpc-4805	196	21	external	external	ADJ
dpc-4805	196	22	contributors	contributor	NOUN
dpc-4805	196	23	of	of	ADP
dpc-4805	196	24	psoriasis	psoriasis	NOUN
dpc-4805	196	25	disease	disease	NOUN
dpc-4805	196	26	.	.	PUNCT
dpc-4805	197	1	psoriasis	psoriasis	NOUN
dpc-4805	197	2	recent	recent	ADJ
dpc-4805	197	3	advances	advance	NOUN
dpc-4805	197	4	in	in	ADP
dpc-4805	197	5	diagnosis	diagnosis	NOUN
dpc-4805	197	6	and	and	CCONJ
dpc-4805	197	7	treatment	treatment	NOUN
dpc-4805	197	8	,	,	PUNCT
dpc-4805	197	9	a	a	DET
dpc-4805	197	10	c.	c.	PROPN
dpc-4805	197	11	di	di	PROPN
dpc-4805	197	12	pierre	pierre	PROPN
dpc-4805	197	13	vereecken	vereecken	VERB
dpc-4805	197	14	(	(	PUNCT
dpc-4805	197	15	intechopen	intechopen	ADJ
dpc-4805	197	16	,	,	PUNCT
dpc-4805	197	17	2024	2024	NUM
dpc-4805	197	18	)	)	PUNCT
dpc-4805	197	19	,	,	PUNCT
dpc-4805	197	20	https://	https://	PROPN
dpc-4805	197	21	doi.org/10.5772/intechopen.1003889	doi.org/10.5772/intechopen.1003889	PROPN
dpc-4805	197	22	.	.	PUNCT
dpc-4805	198	1	4	4	X
dpc-4805	198	2	.	.	X
dpc-4805	198	3	guillet	guillet	VERB
dpc-4805	198	4	c	c	NOUN
dpc-4805	198	5	,	,	PUNCT
dpc-4805	198	6	seeli	seeli	PROPN
dpc-4805	198	7	c	c	X
dpc-4805	198	8	,	,	PUNCT
dpc-4805	198	9	nina	nina	PROPN
dpc-4805	198	10	m	m	PROPN
dpc-4805	198	11	,	,	PUNCT
dpc-4805	198	12	maul	maul	PROPN
dpc-4805	198	13	lv	lv	PROPN
dpc-4805	198	14	,	,	PUNCT
dpc-4805	198	15	maul	maul	PROPN
dpc-4805	198	16	jt	jt	PROPN
dpc-4805	198	17	.	.	PUNCT
dpc-4805	199	1	the	the	DET
dpc-4805	199	2	impact	impact	NOUN
dpc-4805	199	3	of	of	ADP
dpc-4805	199	4	gender	gender	NOUN
dpc-4805	199	5	and	and	CCONJ
dpc-4805	199	6	sex	sex	NOUN
dpc-4805	199	7	in	in	ADP
dpc-4805	199	8	psoriasis	psoriasis	NOUN
dpc-4805	199	9	:	:	PUNCT
dpc-4805	199	10	what	what	PRON
dpc-4805	199	11	to	to	PART
dpc-4805	199	12	be	be	AUX
dpc-4805	199	13	aware	aware	ADJ
dpc-4805	199	14	of	of	ADP
dpc-4805	199	15	when	when	SCONJ
dpc-4805	199	16	treating	treat	VERB
dpc-4805	199	17	women	woman	NOUN
dpc-4805	199	18	with	with	ADP
dpc-4805	199	19	psoriasis	psoriasis	NOUN
dpc-4805	199	20	.	.	PUNCT
dpc-4805	200	1	int	int	NOUN
dpc-4805	200	2	j	j	PROPN
dpc-4805	200	3	womens	womens	PROPN
dpc-4805	200	4	dermatol	dermatol	NOUN
dpc-4805	200	5	.	.	PUNCT
dpc-4805	201	1	2022	2022	NUM
dpc-4805	201	2	apr	apr	VERB
dpc-4805	201	3	13	13	NUM
dpc-4805	201	4	;	;	PUNCT
dpc-4805	201	5	8(2):e010	8(2):e010	NUM
dpc-4805	201	6	.	.	PUNCT
dpc-4805	202	1	pmid	pmid	NOUN
dpc-4805	202	2	:	:	PUNCT
dpc-4805	202	3	35619672	35619672	NUM
dpc-4805	202	4	pmcid	pmcid	NOUN
dpc-4805	202	5	:	:	PUNCT
dpc-4805	202	6	pmc9112394	pmc9112394	X
dpc-4805	202	7	doi	doi	PROPN
dpc-4805	202	8	:	:	PUNCT
dpc-4805	202	9	10.1097	10.1097	NUM
dpc-4805	202	10	/	/	SYM
dpc-4805	202	11	jw9.0000000000000010	jw9.0000000000000010	NOUN
dpc-4805	202	12	5	5	NUM
dpc-4805	202	13	.	.	X
dpc-4805	202	14	de	de	PROPN
dpc-4805	202	15	simone	simone	PROPN
dpc-4805	202	16	c	c	NOUN
dpc-4805	202	17	,	,	PUNCT
dpc-4805	202	18	calabrese	calabrese	ADJ
dpc-4805	202	19	l	l	NOUN
dpc-4805	202	20	,	,	PUNCT
dpc-4805	202	21	balato	balato	NOUN
dpc-4805	202	22	a	a	PRON
dpc-4805	202	23	,	,	PUNCT
dpc-4805	202	24	et	et	PROPN
dpc-4805	202	25	al	al	PROPN
dpc-4805	202	26	.	.	PUNCT
dpc-4805	203	1	psoriasis	psoriasis	NOUN
dpc-4805	203	2	and	and	CCONJ
dpc-4805	203	3	its	its	PRON
dpc-4805	203	4	management	management	NOUN
dpc-4805	203	5	in	in	ADP
dpc-4805	203	6	women	woman	NOUN
dpc-4805	203	7	of	of	ADP
dpc-4805	203	8	childbearing	childbeare	VERB
dpc-4805	203	9	age	age	NOUN
dpc-4805	203	10	:	:	PUNCT
dpc-4805	203	11	tools	tool	NOUN
dpc-4805	203	12	to	to	PART
dpc-4805	203	13	increase	increase	VERB
dpc-4805	203	14	awareness	awareness	NOUN
dpc-4805	203	15	in	in	ADP
dpc-4805	203	16	dermatologists	dermatologist	NOUN
dpc-4805	203	17	and	and	CCONJ
dpc-4805	203	18	patients	patient	NOUN
dpc-4805	203	19	.	.	PUNCT
dpc-4805	204	1	ital	ital	PROPN
dpc-4805	204	2	j	j	PROPN
dpc-4805	204	3	dermatol	dermatol	NOUN
dpc-4805	204	4	venereol	venereol	NOUN
dpc-4805	204	5	.	.	PUNCT
dpc-4805	205	1	2020	2020	NUM
dpc-4805	205	2	aug;155(4):434	aug;155(4):434	NOUN
dpc-4805	205	3	-	-	NOUN
dpc-4805	205	4	440	440	NUM
dpc-4805	205	5	.	.	PUNCT
dpc-4805	206	1	pmid	pmid	NOUN
dpc-4805	206	2	:	:	PUNCT
dpc-4805	206	3	33050681	33050681	NUM
dpc-4805	206	4	doi	doi	NOUN
dpc-4805	206	5	:	:	PUNCT
dpc-4805	206	6	10.23736	10.23736	NUM
dpc-4805	206	7	/	/	SYM
dpc-4805	206	8	s0392	s0392	NOUN
dpc-4805	206	9	-	-	PUNCT
dpc-4805	206	10	0488.20.06748	0488.20.06748	NOUN
dpc-4805	206	11	-	-	PUNCT
dpc-4805	206	12	6	6	NUM
dpc-4805	206	13	6	6	NUM
dpc-4805	206	14	.	.	PUNCT
dpc-4805	207	1	hägg	hägg	NOUN
dpc-4805	207	2	d	d	PROPN
dpc-4805	207	3	,	,	PUNCT
dpc-4805	207	4	sundström	sundström	ADV
dpc-4805	207	5	a	a	PRON
dpc-4805	207	6	,	,	PUNCT
dpc-4805	207	7	eriksson	eriksson	PROPN
dpc-4805	207	8	m	m	PROPN
dpc-4805	207	9	,	,	PUNCT
dpc-4805	207	10	schmitt	schmitt	VERB
dpc-4805	207	11	-	-	PUNCT
dpc-4805	207	12	egenolf	egenolf	NOUN
dpc-4805	207	13	m.	m.	NOUN
dpc-4805	207	14	severity	severity	NOUN
dpc-4805	207	15	of	of	ADP
dpc-4805	207	16	psoriasis	psoriasis	NOUN
dpc-4805	207	17	differs	differ	VERB
dpc-4805	207	18	between	between	ADP
dpc-4805	207	19	men	man	NOUN
dpc-4805	207	20	and	and	CCONJ
dpc-4805	207	21	women	woman	NOUN
dpc-4805	207	22	:	:	PUNCT
dpc-4805	207	23	a	a	DET
dpc-4805	207	24	study	study	NOUN
dpc-4805	207	25	of	of	ADP
dpc-4805	207	26	the	the	DET
dpc-4805	207	27	clinical	clinical	ADJ
dpc-4805	207	28	outcome	outcome	NOUN
dpc-4805	207	29	measure	measure	NOUN
dpc-4805	207	30	psoriasis	psoriasis	NOUN
dpc-4805	207	31	area	area	NOUN
dpc-4805	207	32	and	and	CCONJ
dpc-4805	207	33	severity	severity	NOUN
dpc-4805	207	34	index	index	NOUN
dpc-4805	207	35	(	(	PUNCT
dpc-4805	207	36	pasi	pasi	NOUN
dpc-4805	207	37	)	)	PUNCT
dpc-4805	207	38	in	in	ADP
dpc-4805	207	39	5438	5438	NUM
dpc-4805	207	40	swedish	swedish	ADJ
dpc-4805	207	41	register	register	NOUN
dpc-4805	207	42	patients	patient	NOUN
dpc-4805	207	43	.	.	PUNCT
dpc-4805	208	1	am	be	AUX
dpc-4805	208	2	j	j	PROPN
dpc-4805	208	3	clin	clin	PROPN
dpc-4805	208	4	dermatol	dermatol	NOUN
dpc-4805	208	5	.	.	PUNCT
dpc-4805	209	1	2017	2017	NUM
dpc-4805	209	2	aug;18(4):583	aug;18(4):583	NOUN
dpc-4805	209	3	-	-	PUNCT
dpc-4805	209	4	590	590	NUM
dpc-4805	209	5	.	.	PUNCT
dpc-4805	210	1	pmid	pmid	NOUN
dpc-4805	210	2	:	:	PUNCT
dpc-4805	210	3	28342016	28342016	NUM
dpc-4805	210	4	pmcid	pmcid	NOUN
dpc-4805	210	5	:	:	PUNCT
dpc-4805	210	6	pmc5506504	pmc5506504	PROPN
dpc-4805	210	7	doi	doi	NOUN
dpc-4805	210	8	:	:	PUNCT
dpc-4805	210	9	10.1007	10.1007	NUM
dpc-4805	210	10	/	/	SYM
dpc-4805	210	11	s40257	s40257	NOUN
dpc-4805	210	12	-	-	PUNCT
dpc-4805	210	13	017	017	NUM
dpc-4805	210	14	-	-	PUNCT
dpc-4805	210	15	0274	0274	NUM
dpc-4805	210	16	-	-	SYM
dpc-4805	210	17	0	0	NUM
dpc-4805	210	18	7	7	NUM
dpc-4805	210	19	.	.	PUNCT
dpc-4805	211	1	gottlieb	gottlieb	PROPN
dpc-4805	211	2	ab	ab	PROPN
dpc-4805	211	3	,	,	PUNCT
dpc-4805	211	4	ryan	ryan	PROPN
dpc-4805	211	5	c	c	PROPN
dpc-4805	211	6	,	,	PUNCT
dpc-4805	211	7	murase	murase	NOUN
dpc-4805	211	8	je	je	X
dpc-4805	211	9	.	.	PUNCT
dpc-4805	211	10	clinical	clinical	ADJ
dpc-4805	211	11	considerations	consideration	NOUN
dpc-4805	211	12	for	for	ADP
dpc-4805	211	13	the	the	DET
dpc-4805	211	14	management	management	NOUN
dpc-4805	211	15	of	of	ADP
dpc-4805	211	16	psoriasis	psoriasis	NOUN
dpc-4805	211	17	in	in	ADP
dpc-4805	211	18	women	woman	NOUN
dpc-4805	211	19	.	.	PUNCT
dpc-4805	212	1	int	int	PROPN
dpc-4805	212	2	j	j	PROPN
dpc-4805	212	3	womens	womens	PROPN
dpc-4805	212	4	dermatol	dermatol	NOUN
dpc-4805	212	5	.	.	PUNCT
dpc-4805	213	1	2019	2019	NUM
dpc-4805	213	2	apr	apr	NOUN
dpc-4805	213	3	10;5(3):141	10;5(3):141	NUM
dpc-4805	213	4	-	-	SYM
dpc-4805	213	5	150	150	NUM
dpc-4805	213	6	.	.	PUNCT
dpc-4805	214	1	pmid	pmid	NOUN
dpc-4805	214	2	:	:	PUNCT
dpc-4805	214	3	31360745	31360745	NUM
dpc-4805	214	4	pmcid	pmcid	NOUN
dpc-4805	214	5	:	:	PUNCT
dpc-4805	214	6	pmc6637092	pmc6637092	NOUN
dpc-4805	214	7	doi	doi	PROPN
dpc-4805	214	8	:	:	PUNCT
dpc-4805	214	9	10.1016	10.1016	NUM
dpc-4805	214	10	/	/	SYM
dpc-4805	214	11	j.ijwd.2019.04.021	j.ijwd.2019.04.021	PROPN
dpc-4805	214	12	8	8	NUM
dpc-4805	214	13	.	.	PUNCT
dpc-4805	215	1	adachi	adachi	PROPN
dpc-4805	215	2	a	a	PROPN
dpc-4805	215	3	,	,	PUNCT
dpc-4805	215	4	honda	honda	NOUN
dpc-4805	215	5	t.	t.	NOUN
dpc-4805	215	6	regulatory	regulatory	ADJ
dpc-4805	215	7	roles	role	NOUN
dpc-4805	215	8	of	of	ADP
dpc-4805	215	9	estrogens	estrogen	NOUN
dpc-4805	215	10	in	in	ADP
dpc-4805	215	11	psoriasis	psoriasis	NOUN
dpc-4805	215	12	.	.	PUNCT
dpc-4805	216	1	j	j	PROPN
dpc-4805	216	2	clin	clin	PROPN
dpc-4805	216	3	med	med	PROPN
dpc-4805	216	4	.	.	PUNCT
dpc-4805	217	1	2022	2022	NUM
dpc-4805	217	2	aug	aug	PROPN
dpc-4805	217	3	20;11(16):4890	20;11(16):4890	NUM
dpc-4805	217	4	.	.	PUNCT
dpc-4805	218	1	pmid	pmid	PROPN
dpc-4805	218	2	:	:	PUNCT
dpc-4805	218	3	36013129	36013129	NUM
dpc-4805	218	4	pmcid	pmcid	NOUN
dpc-4805	218	5	:	:	PUNCT
dpc-4805	218	6	pmc9409683	pmc9409683	ADJ
dpc-4805	218	7	doi	doi	NOUN
dpc-4805	218	8	:	:	PUNCT
dpc-4805	218	9	10.3390	10.3390	NUM
dpc-4805	218	10	/	/	SYM
dpc-4805	218	11	jcm11164890	jcm11164890	NOUN
dpc-4805	218	12	.	.	PUNCT
dpc-4805	219	1	9	9	X
dpc-4805	219	2	.	.	X
dpc-4805	219	3	barros	barros	PROPN
dpc-4805	219	4	g	g	PROPN
dpc-4805	219	5	,	,	PUNCT
dpc-4805	219	6	duran	duran	NOUN
dpc-4805	219	7	p	p	NOUN
dpc-4805	219	8	,	,	PUNCT
dpc-4805	219	9	vera	vera	NOUN
dpc-4805	219	10	i	i	NOUN
dpc-4805	219	11	,	,	PUNCT
dpc-4805	219	12	bermúdez	bermúdez	PROPN
dpc-4805	219	13	v.	v.	ADP
dpc-4805	219	14	exploring	explore	VERB
dpc-4805	219	15	the	the	DET
dpc-4805	219	16	links	link	NOUN
dpc-4805	219	17	between	between	ADP
dpc-4805	219	18	obesity	obesity	NOUN
dpc-4805	219	19	and	and	CCONJ
dpc-4805	219	20	psoriasis	psoriasis	NOUN
dpc-4805	219	21	:	:	PUNCT
dpc-4805	219	22	a	a	DET
dpc-4805	219	23	comprehensive	comprehensive	ADJ
dpc-4805	219	24	review	review	NOUN
dpc-4805	219	25	.	.	PUNCT
dpc-4805	220	1	int	int	PROPN
dpc-4805	220	2	j	j	PROPN
dpc-4805	220	3	mol	mol	ADP
dpc-4805	220	4	sci	sci	PROPN
dpc-4805	220	5	.	.	PROPN
dpc-4805	220	6	2022	2022	NUM
dpc-4805	220	7	jul	jul	PROPN
dpc-4805	220	8	6;23(14):7499	6;23(14):7499	PROPN
dpc-4805	220	9	.	.	PUNCT
dpc-4805	221	1	pmid	pmid	NOUN
dpc-4805	221	2	:	:	PUNCT
dpc-4805	221	3	35886846	35886846	NUM
dpc-4805	221	4	pmcid	pmcid	NOUN
dpc-4805	221	5	:	:	PUNCT
dpc-4805	221	6	pmc9321445	pmc9321445	PROPN
dpc-4805	221	7	doi	doi	PROPN
dpc-4805	221	8	:	:	PUNCT
dpc-4805	221	9	10.3390	10.3390	NUM
dpc-4805	221	10	/	/	SYM
dpc-4805	221	11	ijms23147499	ijms23147499	PROPN
dpc-4805	221	12	10	10	NUM
dpc-4805	221	13	.	.	PUNCT
dpc-4805	222	1	trovato	trovato	PROPN
dpc-4805	222	2	e	e	PROPN
dpc-4805	222	3	,	,	PUNCT
dpc-4805	222	4	rubegni	rubegni	VERB
dpc-4805	222	5	p	p	NOUN
dpc-4805	222	6	,	,	PUNCT
dpc-4805	222	7	prignano	prignano	PROPN
dpc-4805	222	8	f.	f.	PROPN
dpc-4805	222	9	place	place	NOUN
dpc-4805	222	10	in	in	ADP
dpc-4805	222	11	therapy	therapy	NOUN
dpc-4805	222	12	of	of	ADP
dpc-4805	222	13	anti	anti	NOUN
dpc-4805	222	14	-	-	ADJ
dpc-4805	222	15	il-17	il-17	NUM
dpc-4805	222	16	and	and	CCONJ
dpc-4805	222	17	23	23	NUM
dpc-4805	222	18	in	in	ADP
dpc-4805	222	19	psoriasis	psoriasis	NOUN
dpc-4805	222	20	according	accord	VERB
dpc-4805	222	21	to	to	ADP
dpc-4805	222	22	the	the	DET
dpc-4805	222	23	severity	severity	NOUN
dpc-4805	222	24	of	of	ADP
dpc-4805	222	25	comorbidities	comorbiditie	NOUN
dpc-4805	222	26	:	:	PUNCT
dpc-4805	222	27	a	a	DET
dpc-4805	222	28	focus	focus	NOUN
dpc-4805	222	29	on	on	ADP
dpc-4805	222	30	cardiovascular	cardiovascular	ADJ
dpc-4805	222	31	disease	disease	NOUN
dpc-4805	222	32	and	and	CCONJ
dpc-4805	222	33	metabolic	metabolic	NOUN
dpc-4805	222	34	syndrome	syndrome	NOUN
dpc-4805	222	35	.	.	PUNCT
dpc-4805	223	1	expert	expert	NOUN
dpc-4805	223	2	opin	opin	NOUN
dpc-4805	223	3	biol	biol	NOUN
dpc-4805	223	4	ther	ther	ADV
dpc-4805	223	5	.	.	PUNCT
dpc-4805	224	1	2022	2022	NUM
dpc-4805	224	2	dec;22(12):1443	dec;22(12):1443	NOUN
dpc-4805	224	3	-	-	PUNCT
dpc-4805	224	4	1448	1448	NUM
dpc-4805	224	5	.	.	PUNCT
dpc-4805	225	1	pmid	pmid	NOUN
dpc-4805	225	2	:	:	PUNCT
dpc-4805	225	3	35726639	35726639	NUM
dpc-4805	225	4	doi	doi	NOUN
dpc-4805	225	5	:	:	PUNCT
dpc-4805	225	6	10.1080/14712598.2022.2093106	10.1080/14712598.2022.2093106	NUM
dpc-4805	225	7	11	11	NUM
dpc-4805	225	8	.	.	PUNCT
dpc-4805	226	1	vata	vata	PROPN
dpc-4805	226	2	d	d	PROPN
dpc-4805	226	3	,	,	PUNCT
dpc-4805	226	4	tarcau	tarcau	PROPN
dpc-4805	226	5	bm	bm	PROPN
dpc-4805	226	6	,	,	PUNCT
dpc-4805	226	7	popescu	popescu	PROPN
dpc-4805	226	8	ia	ia	PROPN
dpc-4805	226	9	,	,	PUNCT
dpc-4805	226	10	et	et	PROPN
dpc-4805	226	11	al	al	PROPN
dpc-4805	226	12	.	.	PUNCT
dpc-4805	226	13	update	update	NOUN
dpc-4805	226	14	on	on	ADP
dpc-4805	226	15	obesity	obesity	NOUN
dpc-4805	226	16	in	in	ADP
dpc-4805	226	17	psoriasis	psoriasis	NOUN
dpc-4805	226	18	patients	patient	NOUN
dpc-4805	226	19	.	.	PUNCT
dpc-4805	227	1	life	life	NOUN
dpc-4805	227	2	(	(	PUNCT
dpc-4805	227	3	basel	basel	PROPN
dpc-4805	227	4	)	)	PUNCT
dpc-4805	227	5	.	.	PUNCT
dpc-4805	228	1	2023	2023	NUM
dpc-4805	228	2	sep	sep	PROPN
dpc-4805	228	3	22;13(10):1947	22;13(10):1947	NUM
dpc-4805	228	4	.	.	PUNCT
dpc-4805	229	1	pmid	pmid	NOUN
dpc-4805	229	2	:	:	PUNCT
dpc-4805	229	3	37895330	37895330	NUM
dpc-4805	229	4	pmcid	pmcid	NOUN
dpc-4805	229	5	:	:	PUNCT
dpc-4805	229	6	pmc10608303	pmc10608303	PROPN
dpc-4805	229	7	doi	doi	PROPN
dpc-4805	229	8	:	:	PUNCT
dpc-4805	229	9	10.3390	10.3390	NUM
dpc-4805	229	10	/	/	SYM
dpc-4805	229	11	life13101947	life13101947	PROPN
dpc-4805	229	12	12	12	NUM
dpc-4805	229	13	.	.	PUNCT
dpc-4805	230	1	duchnik	duchnik	PROPN
dpc-4805	231	1	e	e	PROPN
dpc-4805	231	2	,	,	PUNCT
dpc-4805	231	3	kruk	kruk	PROPN
dpc-4805	231	4	j	j	PROPN
dpc-4805	231	5	,	,	PUNCT
dpc-4805	231	6	tuchowska	tuchowska	VERB
dpc-4805	231	7	a	a	PRON
dpc-4805	231	8	,	,	PUNCT
dpc-4805	231	9	marchlewicz	marchlewicz	NOUN
dpc-4805	231	10	m.	m.	NOUN
dpc-4805	231	11	the	the	DET
dpc-4805	231	12	impact	impact	NOUN
dpc-4805	231	13	of	of	ADP
dpc-4805	231	14	diet	diet	NOUN
dpc-4805	231	15	and	and	CCONJ
dpc-4805	231	16	physical	physical	ADJ
dpc-4805	231	17	activity	activity	NOUN
dpc-4805	231	18	on	on	ADP
dpc-4805	231	19	psoriasis	psoriasis	NOUN
dpc-4805	231	20	:	:	PUNCT
dpc-4805	231	21	a	a	DET
dpc-4805	231	22	narrative	narrative	NOUN
dpc-4805	231	23	review	review	NOUN
dpc-4805	231	24	of	of	ADP
dpc-4805	231	25	the	the	DET
dpc-4805	231	26	current	current	ADJ
dpc-4805	231	27	evidence	evidence	NOUN
dpc-4805	231	28	.	.	PUNCT
dpc-4805	232	1	nutrients	nutrient	NOUN
dpc-4805	232	2	.	.	PUNCT
dpc-4805	233	1	2023	2023	NUM
dpc-4805	233	2	feb	feb	NOUN
dpc-4805	233	3	7;15(4):840	7;15(4):840	NUM
dpc-4805	233	4	.	.	PUNCT
dpc-4805	234	1	pmid	pmid	NOUN
dpc-4805	234	2	:	:	PUNCT
dpc-4805	234	3	36839198	36839198	NUM
dpc-4805	234	4	pmcid	pmcid	NOUN
dpc-4805	234	5	:	:	PUNCT
dpc-4805	234	6	pmc9958594	pmc9958594	PROPN
dpc-4805	234	7	doi	doi	NOUN
dpc-4805	234	8	:	:	PUNCT
dpc-4805	234	9	10.3390	10.3390	NUM
dpc-4805	234	10	/	/	SYM
dpc-4805	234	11	nu15040840	nu15040840	PROPN
dpc-4805	234	12	8	8	NUM
dpc-4805	234	13	original	original	ADJ
dpc-4805	234	14	article	article	NOUN
dpc-4805	234	15	|	|	ADV
dpc-4805	234	16	dermatol	dermatol	ADJ
dpc-4805	234	17	pract	pract	NOUN
dpc-4805	234	18	concept	concept	NOUN
dpc-4805	234	19	.	.	PUNCT
dpc-4805	235	1	2025;15(1):4805	2025;15(1):4805	NUM
dpc-4805	235	2	derm	derm	NOUN
dpc-4805	235	3	venereol	venereol	NOUN
dpc-4805	235	4	.	.	PUNCT
dpc-4805	236	1	2021	2021	NUM
dpc-4805	236	2	jan	jan	PROPN
dpc-4805	236	3	4;101(1):adv00354	4;101(1):adv00354	PROPN
dpc-4805	236	4	.	.	PUNCT
dpc-4805	237	1	pmid	pmid	NOUN
dpc-4805	237	2	:	:	PUNCT
dpc-4805	237	3	33269405	33269405	NUM
dpc-4805	237	4	pmcid	pmcid	NOUN
dpc-4805	237	5	:	:	PUNCT
dpc-4805	237	6	pmc9309850	pmc9309850	NOUN
dpc-4805	237	7	doi	doi	NOUN
dpc-4805	237	8	:	:	PUNCT
dpc-4805	237	9	10.2340/00015555	10.2340/00015555	NUM
dpc-4805	237	10	-	-	SYM
dpc-4805	237	11	3711	3711	NUM
dpc-4805	237	12	29	29	NUM
dpc-4805	237	13	.	.	PUNCT
dpc-4805	238	1	kuryłowicz	kuryłowicz	ADJ
dpc-4805	238	2	a.	a.	NOUN
dpc-4805	238	3	estrogens	estrogen	NOUN
dpc-4805	238	4	in	in	ADP
dpc-4805	238	5	adipose	adipose	ADJ
dpc-4805	238	6	tissue	tissue	NOUN
dpc-4805	238	7	physiology	physiology	NOUN
dpc-4805	238	8	and	and	CCONJ
dpc-4805	238	9	obesity	obesity	NOUN
dpc-4805	238	10	related	relate	VERB
dpc-4805	238	11	dysfunction	dysfunction	NOUN
dpc-4805	238	12	.	.	PUNCT
dpc-4805	239	1	biomedicines	biomedicine	NOUN
dpc-4805	239	2	.	.	PUNCT
dpc-4805	240	1	2023	2023	NUM
dpc-4805	240	2	feb	feb	PROPN
dpc-4805	240	3	24;11(3):690	24;11(3):690	NUM
dpc-4805	240	4	.	.	PUNCT
dpc-4805	241	1	pmid	pmid	NOUN
dpc-4805	241	2	:	:	PUNCT
dpc-4805	241	3	36979669	36979669	NUM
dpc-4805	241	4	pmcid	pmcid	NOUN
dpc-4805	241	5	:	:	PUNCT
dpc-4805	241	6	pmc10045924	pmc10045924	PROPN
dpc-4805	241	7	doi	doi	PROPN
dpc-4805	241	8	:	:	PUNCT
dpc-4805	241	9	10.3390	10.3390	NUM
dpc-4805	241	10	/biomedicines11030690	/biomedicines11030690	SYM
dpc-4805	241	11	30	30	NUM
dpc-4805	241	12	.	.	PUNCT
dpc-4805	242	1	wajchenberg	wajchenberg	PROPN
dpc-4805	242	2	bl	bl	PROPN
dpc-4805	242	3	.	.	PUNCT
dpc-4805	242	4	subcutaneous	subcutaneous	ADJ
dpc-4805	242	5	and	and	CCONJ
dpc-4805	242	6	visceral	visceral	ADJ
dpc-4805	242	7	adipose	adipose	ADJ
dpc-4805	242	8	tissue	tissue	NOUN
dpc-4805	242	9	:	:	PUNCT
dpc-4805	242	10	their	their	PRON
dpc-4805	242	11	relation	relation	NOUN
dpc-4805	242	12	to	to	ADP
dpc-4805	242	13	the	the	DET
dpc-4805	242	14	metabolic	metabolic	NOUN
dpc-4805	242	15	syndrome	syndrome	NOUN
dpc-4805	242	16	.	.	PUNCT
dpc-4805	243	1	endocr	endocr	PROPN
dpc-4805	243	2	rev	rev	PROPN
dpc-4805	243	3	.	.	PROPN
dpc-4805	243	4	2000	2000	NUM
dpc-4805	243	5	dec;21(6):697	dec;21(6):697	PROPN
dpc-4805	243	6	-	-	PUNCT
dpc-4805	243	7	738	738	NUM
dpc-4805	243	8	.	.	PUNCT
dpc-4805	244	1	pmid	pmid	NOUN
dpc-4805	244	2	:	:	PUNCT
dpc-4805	244	3	11133069	11133069	NUM
dpc-4805	244	4	doi	doi	NOUN
dpc-4805	244	5	:	:	PUNCT
dpc-4805	244	6	10.1210	10.1210	NUM
dpc-4805	244	7	/	/	SYM
dpc-4805	244	8	edrv	edrv	ADJ
dpc-4805	244	9	.21.6.0415	.21.6.0415	NOUN
dpc-4805	244	10	31	31	NUM
dpc-4805	244	11	.	.	PUNCT
dpc-4805	245	1	garenc	garenc	PROPN
dpc-4805	245	2	c	c	PROPN
dpc-4805	245	3	,	,	PUNCT
dpc-4805	245	4	pérusse	pérusse	PROPN
dpc-4805	245	5	l	l	NOUN
dpc-4805	245	6	,	,	PUNCT
dpc-4805	245	7	chagnon	chagnon	NOUN
dpc-4805	245	8	yc	yc	PROPN
dpc-4805	245	9	,	,	PUNCT
dpc-4805	245	10	rankinen	rankinen	PROPN
dpc-4805	245	11	t	t	PROPN
dpc-4805	245	12	,	,	PUNCT
dpc-4805	245	13	gagnon	gagnon	PROPN
dpc-4805	245	14	j	j	PROPN
dpc-4805	245	15	,	,	PUNCT
dpc-4805	245	16	borecki	borecki	PROPN
dpc-4805	245	17	ib	ib	PROPN
dpc-4805	245	18	,	,	PUNCT
dpc-4805	245	19	et	et	PROPN
dpc-4805	245	20	al	al	PROPN
dpc-4805	245	21	.	.	PUNCT
dpc-4805	246	1	the	the	DET
dpc-4805	246	2	alpha2	alpha2	NOUN
dpc-4805	246	3	-	-	PUNCT
dpc-4805	246	4	adrenergic	adrenergic	ADJ
dpc-4805	246	5	receptor	receptor	NOUN
dpc-4805	246	6	gene	gene	NOUN
dpc-4805	246	7	and	and	CCONJ
dpc-4805	246	8	body	body	NOUN
dpc-4805	246	9	fat	fat	ADJ
dpc-4805	246	10	content	content	NOUN
dpc-4805	246	11	and	and	CCONJ
dpc-4805	246	12	distribution	distribution	NOUN
dpc-4805	246	13	:	:	PUNCT
dpc-4805	246	14	the	the	DET
dpc-4805	246	15	heritage	heritage	NOUN
dpc-4805	246	16	family	family	NOUN
dpc-4805	246	17	study	study	NOUN
dpc-4805	246	18	.	.	PUNCT
dpc-4805	247	1	mol	mol	ADP
dpc-4805	247	2	med	med	PROPN
dpc-4805	247	3	.	.	PUNCT
dpc-4805	247	4	2002	2002	NUM
dpc-4805	247	5	feb;8(2):88	feb;8(2):88	NOUN
dpc-4805	247	6	-	-	PUNCT
dpc-4805	247	7	94	94	NUM
dpc-4805	247	8	.	.	PUNCT
dpc-4805	248	1	pmid	pmid	NOUN
dpc-4805	248	2	:	:	PUNCT
dpc-4805	248	3	12080184	12080184	NUM
dpc-4805	248	4	pmcid	pmcid	NOUN
dpc-4805	248	5	:	:	PUNCT
dpc-4805	248	6	pmc2039973	pmc2039973	NOUN
dpc-4805	248	7	32	32	NUM
dpc-4805	248	8	.	.	PUNCT
dpc-4805	249	1	lönnqvist	lönnqvist	PROPN
dpc-4805	249	2	f	f	PROPN
dpc-4805	249	3	,	,	PUNCT
dpc-4805	249	4	thörne	thörne	VERB
dpc-4805	249	5	a	a	DET
dpc-4805	249	6	,	,	PUNCT
dpc-4805	249	7	large	large	ADJ
dpc-4805	249	8	v	v	NOUN
dpc-4805	249	9	,	,	PUNCT
dpc-4805	249	10	arner	arner	NOUN
dpc-4805	249	11	p.	p.	NOUN
dpc-4805	249	12	sex	sex	NOUN
dpc-4805	249	13	differences	difference	NOUN
dpc-4805	249	14	in	in	ADP
dpc-4805	249	15	visceral	visceral	ADJ
dpc-4805	249	16	fat	fat	ADJ
dpc-4805	249	17	lipolysis	lipolysis	NOUN
dpc-4805	249	18	and	and	CCONJ
dpc-4805	249	19	metabolic	metabolic	NOUN
dpc-4805	249	20	complications	complication	NOUN
dpc-4805	249	21	of	of	ADP
dpc-4805	249	22	obesity	obesity	NOUN
dpc-4805	249	23	.	.	PUNCT
dpc-4805	250	1	arterioscler	arterioscler	PROPN
dpc-4805	250	2	thromb	thromb	PROPN
dpc-4805	250	3	vasc	vasc	PROPN
dpc-4805	250	4	biol	biol	PROPN
dpc-4805	250	5	.	.	PUNCT
dpc-4805	251	1	1997	1997	NUM
dpc-4805	251	2	jul;17(7):1472	jul;17(7):1472	NOUN
dpc-4805	251	3	-	-	PUNCT
dpc-4805	251	4	80	80	NUM
dpc-4805	251	5	.	.	PUNCT
dpc-4805	252	1	pmid	pmid	NOUN
dpc-4805	252	2	:	:	PUNCT
dpc-4805	252	3	9261282	9261282	NUM
dpc-4805	252	4	doi	doi	NOUN
dpc-4805	252	5	:	:	PUNCT
dpc-4805	252	6	10.1161/01.atv.17.7.1472	10.1161/01.atv.17.7.1472	NUM
dpc-4805	252	7	25	25	NUM
dpc-4805	252	8	.	.	PUNCT
dpc-4805	253	1	jensen	jensen	PROPN
dpc-4805	253	2	p	p	PROPN
dpc-4805	253	3	,	,	PUNCT
dpc-4805	253	4	christensen	christensen	PROPN
dpc-4805	253	5	r	r	PROPN
dpc-4805	253	6	,	,	PUNCT
dpc-4805	253	7	zachariae	zachariae	NOUN
dpc-4805	253	8	c	c	NOUN
dpc-4805	253	9	,	,	PUNCT
dpc-4805	253	10	et	et	PROPN
dpc-4805	253	11	al	al	PROPN
dpc-4805	253	12	.	.	PUNCT
dpc-4805	254	1	long	long	ADJ
dpc-4805	254	2	-	-	PUNCT
dpc-4805	254	3	term	term	NOUN
dpc-4805	254	4	effects	effect	NOUN
dpc-4805	254	5	of	of	ADP
dpc-4805	254	6	weight	weight	NOUN
dpc-4805	254	7	reduction	reduction	NOUN
dpc-4805	254	8	on	on	ADP
dpc-4805	254	9	the	the	DET
dpc-4805	254	10	severity	severity	NOUN
dpc-4805	254	11	of	of	ADP
dpc-4805	254	12	psoriasis	psoriasis	NOUN
dpc-4805	254	13	in	in	ADP
dpc-4805	254	14	a	a	DET
dpc-4805	254	15	cohort	cohort	NOUN
dpc-4805	254	16	derived	derive	VERB
dpc-4805	254	17	from	from	ADP
dpc-4805	254	18	a	a	DET
dpc-4805	254	19	randomized	randomized	ADJ
dpc-4805	254	20	trial	trial	NOUN
dpc-4805	254	21	:	:	PUNCT
dpc-4805	254	22	a	a	DET
dpc-4805	254	23	prospective	prospective	ADJ
dpc-4805	254	24	observational	observational	ADJ
dpc-4805	254	25	follow	follow	NOUN
dpc-4805	254	26	-	-	PUNCT
dpc-4805	254	27	up	up	ADP
dpc-4805	254	28	study	study	NOUN
dpc-4805	254	29	.	.	PUNCT
dpc-4805	255	1	am	be	AUX
dpc-4805	255	2	j	j	PROPN
dpc-4805	255	3	clin	clin	PROPN
dpc-4805	255	4	nutr	nutr	PROPN
dpc-4805	255	5	.	.	PROPN
dpc-4805	255	6	2016	2016	NUM
dpc-4805	255	7	aug;104(2):259	aug;104(2):259	NOUN
dpc-4805	255	8	-	-	PUNCT
dpc-4805	255	9	65	65	NUM
dpc-4805	255	10	.	.	PUNCT
dpc-4805	256	1	pmid	pmid	NOUN
dpc-4805	256	2	:	:	PUNCT
dpc-4805	256	3	27334236	27334236	NUM
dpc-4805	256	4	doi	doi	NOUN
dpc-4805	256	5	:	:	PUNCT
dpc-4805	256	6	10.3945	10.3945	NUM
dpc-4805	256	7	/	/	SYM
dpc-4805	256	8	ajcn.115.125849	ajcn.115.125849	VERB
dpc-4805	256	9	26	26	NUM
dpc-4805	256	10	.	.	PUNCT
dpc-4805	257	1	powell	powell	PROPN
dpc-4805	257	2	-	-	PUNCT
dpc-4805	257	3	wiley	wiley	PROPN
dpc-4805	257	4	tf	tf	PROPN
dpc-4805	257	5	,	,	PUNCT
dpc-4805	257	6	poirier	poirier	PROPN
dpc-4805	257	7	p	p	PROPN
dpc-4805	257	8	,	,	PUNCT
dpc-4805	257	9	burke	burke	PROPN
dpc-4805	257	10	le	le	PROPN
dpc-4805	257	11	,	,	PUNCT
dpc-4805	257	12	et	et	PROPN
dpc-4805	257	13	al	al	PROPN
dpc-4805	257	14	.	.	PROPN
dpc-4805	257	15	obesity	obesity	NOUN
dpc-4805	257	16	and	and	CCONJ
dpc-4805	257	17	cardiovascular	cardiovascular	ADJ
dpc-4805	257	18	disease	disease	NOUN
dpc-4805	257	19	:	:	PUNCT
dpc-4805	257	20	a	a	DET
dpc-4805	257	21	scientific	scientific	ADJ
dpc-4805	257	22	statement	statement	NOUN
dpc-4805	257	23	from	from	ADP
dpc-4805	257	24	the	the	DET
dpc-4805	257	25	american	american	PROPN
dpc-4805	257	26	heart	heart	PROPN
dpc-4805	257	27	association	association	PROPN
dpc-4805	257	28	.	.	PUNCT
dpc-4805	258	1	circulation	circulation	NOUN
dpc-4805	258	2	.	.	PUNCT
dpc-4805	259	1	2021	2021	NUM
dpc-4805	259	2	may	may	AUX
dpc-4805	259	3	25;143(21):e984	25;143(21):e984	NUM
dpc-4805	259	4	-	-	PUNCT
dpc-4805	259	5	e1010	e1010	NOUN
dpc-4805	259	6	.	.	PUNCT
dpc-4805	260	1	pmid	pmid	NOUN
dpc-4805	260	2	:	:	PUNCT
dpc-4805	260	3	33882682	33882682	NUM
dpc-4805	260	4	pmcid	pmcid	NOUN
dpc-4805	260	5	:	:	PUNCT
dpc-4805	260	6	pmc8493650	pmc8493650	NOUN
dpc-4805	260	7	doi	doi	NOUN
dpc-4805	260	8	:	:	PUNCT
dpc-4805	260	9	10.1161	10.1161	NUM
dpc-4805	260	10	/	/	SYM
dpc-4805	260	11	cir	cir	NOUN
dpc-4805	260	12	.0000000000000973	.0000000000000973	NOUN
dpc-4805	260	13	27	27	NUM
dpc-4805	260	14	.	.	PUNCT
dpc-4805	261	1	li	li	PROPN
dpc-4805	261	2	q	q	PROPN
dpc-4805	261	3	,	,	PUNCT
dpc-4805	261	4	patrick	patrick	PROPN
dpc-4805	261	5	mt	mt	PROPN
dpc-4805	261	6	,	,	PUNCT
dpc-4805	261	7	sreeskandarajan	sreeskandarajan	PROPN
dpc-4805	261	8	s	s	PROPN
dpc-4805	261	9	,	,	PUNCT
dpc-4805	261	10	kang	kang	PROPN
dpc-4805	261	11	j	j	PROPN
dpc-4805	261	12	,	,	PUNCT
dpc-4805	261	13	kahlenberg	kahlenberg	PROPN
dpc-4805	261	14	jm	jm	PROPN
dpc-4805	261	15	,	,	PUNCT
dpc-4805	261	16	gudjonsson	gudjonsson	PROPN
dpc-4805	261	17	je	je	PROPN
dpc-4805	261	18	.	.	PUNCT
dpc-4805	261	19	large	large	ADJ
dpc-4805	261	20	-	-	PUNCT
dpc-4805	261	21	scale	scale	NOUN
dpc-4805	261	22	epidemiological	epidemiological	ADJ
dpc-4805	261	23	analysis	analysis	NOUN
dpc-4805	261	24	of	of	ADP
dpc-4805	261	25	common	common	ADJ
dpc-4805	261	26	skin	skin	NOUN
dpc-4805	261	27	diseases	disease	NOUN
dpc-4805	261	28	to	to	PART
dpc-4805	261	29	identify	identify	VERB
dpc-4805	261	30	shared	share	VERB
dpc-4805	261	31	and	and	CCONJ
dpc-4805	261	32	unique	unique	ADJ
dpc-4805	261	33	comorbidities	comorbiditie	NOUN
dpc-4805	261	34	and	and	CCONJ
dpc-4805	261	35	demographic	demographic	ADJ
dpc-4805	261	36	factors	factor	NOUN
dpc-4805	261	37	.	.	PUNCT
dpc-4805	262	1	front	front	ADJ
dpc-4805	262	2	immunol	immunol	NOUN
dpc-4805	262	3	.	.	PUNCT
dpc-4805	263	1	2024	2024	NUM
dpc-4805	263	2	jan	jan	PROPN
dpc-4805	263	3	8:14:1309549	8:14:1309549	NUM
dpc-4805	263	4	.	.	PUNCT
dpc-4805	264	1	pmid	pmid	NOUN
dpc-4805	264	2	:	:	PUNCT
dpc-4805	264	3	38259463	38259463	NUM
dpc-4805	264	4	pmcid	pmcid	NOUN
dpc-4805	264	5	:	:	PUNCT
dpc-4805	264	6	pmc10800546	pmc10800546	NOUN
dpc-4805	264	7	doi	doi	NOUN
dpc-4805	264	8	:	:	PUNCT
dpc-4805	264	9	10.3389	10.3389	NUM
dpc-4805	264	10	/	/	SYM
dpc-4805	264	11	fimmu.2023.1309549	fimmu.2023.1309549	PROPN
dpc-4805	264	12	28	28	NUM
dpc-4805	264	13	.	.	PUNCT
dpc-4805	265	1	hernández	hernández	PROPN
dpc-4805	265	2	-	-	PUNCT
dpc-4805	265	3	fernández	fernández	PROPN
dpc-4805	265	4	cp	cp	PROPN
dpc-4805	265	5	,	,	PUNCT
dpc-4805	265	6	carretero	carretero	NOUN
dpc-4805	265	7	g	g	PROPN
dpc-4805	265	8	,	,	PUNCT
dpc-4805	265	9	et	et	PROPN
dpc-4805	265	10	al	al	PROPN
dpc-4805	265	11	.	.	PROPN
dpc-4805	265	12	effect	effect	NOUN
dpc-4805	265	13	of	of	ADP
dpc-4805	265	14	sex	sex	NOUN
dpc-4805	265	15	in	in	ADP
dpc-4805	265	16	systemic	systemic	ADJ
dpc-4805	265	17	psoriasis	psoriasis	NOUN
dpc-4805	265	18	therapy	therapy	NOUN
dpc-4805	265	19	:	:	PUNCT
dpc-4805	265	20	differences	difference	NOUN
dpc-4805	265	21	in	in	ADP
dpc-4805	265	22	prescription	prescription	NOUN
dpc-4805	265	23	,	,	PUNCT
dpc-4805	265	24	effectiveness	effectiveness	NOUN
dpc-4805	265	25	and	and	CCONJ
dpc-4805	265	26	safety	safety	NOUN
dpc-4805	265	27	in	in	ADP
dpc-4805	265	28	the	the	DET
dpc-4805	265	29	biobadaderm	biobadaderm	NOUN
dpc-4805	265	30	prospective	prospective	ADJ
dpc-4805	265	31	cohort	cohort	NOUN
dpc-4805	265	32	.	.	PUNCT
dpc-4805	266	1	acta	acta	PROPN